Influenza vaccination of health care workers by Riphagen-Dalhuisen, Josien
  
 University of Groningen
Influenza vaccination of health care workers
Riphagen-Dalhuisen, Josien
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2013
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Riphagen-Dalhuisen, J. (2013). Influenza vaccination of health care workers. [S.n.].
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the





Health Care Workers 
Josien Riphagen-Dalhuisen 
STELLING EN 








1. In ziekenhuizen dient het personeel beter te warden voorgelicht over de gevaren van 
influenza voor henzelf en hun patienten. (dit proefschrift) 
2. De vaccinatiegraad onder ziekenhuispersoneel zal stijgen als de influenza 
vaccinatiecampagne wordt toegespitst op determinanten die voor hen bevorderend 
of belemmerend zijn om het vaccin te nemen. (dit proefschrift) 
3. Een gestructureerde influenza vaccinatiecampagne gericht op ziekenhuispersoneel 
kan bijdragen aan een hogere vaccinatiegraad, mits er voldoende blootstelling aan 
de componenten is. (dit proefschrift) 
4. Hoewel verplichte vaccinatie een oplossing zou kunnen zijn voor de lage influenza 
vaccinatiegraad onder ziekenhuispersoneel, bestaat hier op dit moment nog geen 
draagvlak voor onder ziekenhuismanagements. (dit proefschrift) 
5. Een hogere influenza vaccinatiegraad onder ziekenhuispersoneel is gerelateerd aan 
een lagere morbiditeit door influenza en/of een longontsteking onder opgenomen 
patienten. (dit proefschrift) 
6. Het implementeren van een gestructureerde influenza vaccinatiecampagne is 
kostenbesparend voor ziekenhuizen. (dit proefschrift) 
7. Maak van een ziekenhuis geen ziekmaakhuis. 
8. Studying a deadly virus is risky, not studying it is riskier. (The Economist, 2013) 
9. Hij die weet dat hij niets weet, weet meer dan hij die niet weet dat hij niets weet. 
(onbekend) 
10. Een promotietraject is vergelijkbaar met een zwangerschap; naar het einde toe wordt 
het steeds zwaarder maar je houdt vol met het oog op het uiteindelijke resultaat. 
Josien Riphagen-Dalhuisen 
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Influenza is one of the major respiratory person-to-person transmittable viral infections in 
humans. The disease itself comes in two distinct forms: (1 ) seasonal epidemics which 
occur every year in the winter period, and (2) (global) pandemics that occur with 
unpredictable frequency and which can occur in any season. Influenza signs and 
symptoms are characterized by sudden onset of fever, cough, headache, myalgia, sore 
throat, runny nose and overall malaise/general discomfort.1 Influenza-like illness (ILi) 
("flu") has the same symptoms but can be caused by other viruses, like adenovirus, 
respiratory syncytial virus or para-influenza virus. Influenza occurs among persons of all 
ages, though transmission is highest among (school) children.2 The incubation period 
varies from a short one day to three days during which signs and symptoms are 
developing. Almost half of the infected patients remain asymptomatic but carry the virus 
and can transmit the virus.3 Most symptomatic patients recover within a week from 
influenza without seeking medical attention. However, influenza can cause severe illness 
and even death in risk groups like elderly patients and patients with underlying 
cardiovascular and respiratory disorders. Patients who are immunocompromised, for 
instance because of cancer or diabetes, are also more prone to complications from viral 
pneumonia or viral myocarditis, or secondary bacterial infections like pneumonia or 
acute otitis media. Deaths occur especially in vulnerable populations, such as the elderly 
and chronically ill patients.4 
Although seasonal influenza is commonly a self-limiting disease among healthy 
persons, there are only very few other diseases that annually have such a massive 
impact on society because of the large numbers of medical consultations in primary and 
secondary care and associated productivity loss which both come with a high economic 
burden.5 Over the past decade seasonal influenza in Europe has resulted in an 
estimated 80,000 to 500,000 deaths per year, depending on the severity of the flu 
outbreak. Direct influenza-associated health care costs for Europe are estimated at more 
than €50 million per million of population per year (i.e. for the whole of Europe €2.5 
billion/yr), and costs are likely to increase further due to an ageing of  the population.6 
Pandemic influenza arises when new influenza strains enter the human 
population by transmission from farm animal species. These viruses are antigenically 
very different from seasonal influenza strains and are therefore not or very poorly 
contained by pre-existing immunity. For this reason they can spread very easily in the 
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entire population. In fact, recent epidemiological data show that during the last 
pandemic, the 2009 Mexican Flu, about 24% of the entire world population and nearly 
50% of children between 5 and 19 years of age had been infected.7 Fortunately, the 
Mexican Flu virus caused relatively mild symptoms. Nevertheless, an estimated 31 ,000 
Europeans died during the pandemic from respiratory disease or associated 
cardiovascular failure.8 The costs associated with pandemics are estimated to double or 
triple those of seasonal influenza and would th_us be €5-€7.5 billion for Europe. 
Vaccination has proven to be an effective measure against influenza in reducing 
morbidity among adults both during seasonal epidemics and pandemics.9·11 Osterholm et 
al. demonstrated in a meta-analysis among 31 eligible studies during seasonal influenza 
a pooled efficacy for trivalent inactivated influenza vaccine of 59% (95% Cl 51 - 67%) in 
adults aged 1 8  to 65 years.9 Jefferson et al. also conducted a large review and found 
that when matched with circulating strains, vaccination is effective in preventing 
symptoms of influenza in healthy adults and has a modest positive effect on work 
absenteeism. 12 Importantly, despite some methodological constraints Thomas et al. 
showed in a meta-analysis that vaccinating HCWs in long-term care is beneficial for both 
patient morbidity and mortality.13 During the 2009 influenza newH1 N1 pandemic, several 
studies determined the efficacy of the pandemic vaccines.11 
In the Netherlands, like in most European countries, general practitioners (GPs) 
are the main distribution channel for delivering influenza vaccination to risk groups. 
Among risk persons the highest influenza vaccine coverage in Europe has been 
achieved because of the GP-based national influenza vaccination program; 14 vaccine 
coverage is currently around 80% among the elderly, 90% among patients with 
cardiovascular disease and 70% among patients with chronic respiratory disorders. 15 
Following recommendations by the WHO, since 2007, the Dutch Health Council 
has been recommending influenza vaccination of risk groups like adults aged over 60 
years and younger persons with risk-elevating conditions as well as of health care 
workers (HCWs) to indirectly protect their patients.16 HCWs serve as an important vector 
in transmitting the influenza virus to their patients, and literature has shown that up to 
75% of HCWs continue their work while being symptomatic, resulting in an even higher 
risk of transmission. 17 Despite the fact that the majority of risk patients who are 
hospitalized during an influenza epidemic have been vaccinated against influenza, there 
are two main reasons why indirect protection remains important: (1 ) hospitalized patients 
are already more prone to infections because of their underlying illness and are at 
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greater risk of dying from influenza as a result of exacerbation of underlying conditions, 
and (2) because of immunosenescence the influenza vaccine is less efficacious in older 
persons and immunocompromised patients, which limits the development of a proper 
immune response to vaccination and affects their ability to resist influenza.18•19 Since the 
world population is aging, the numbers of persons with inadequate protection to the 
influenza virus will also increase. Therefore it is most important for HCWs to be 
immunized, not only to protect themselves but especially to protect their patients. 
However, despite recommendations from the WHO and the Dutch Health 
Council, vaccine uptake among HCWs remains low in the Netherlands as in other 
European countries. In 2011 , Maltezou et al. demonstrated that all 27 European Union 
Member States and three additional European countries (Norway, Switzerland and 
Russic:1) have been recommending HCWs to get vaccinated against influenza.20 
Kroneman et al. showed that vaccine uptake rates among HCWs remain low, varying 
from a low 1 5% in the UK and Germany to the highest coverage of 25% of HCWs in 
Romania.21 Dutch guidelines for vaccinating staff in nursing homes (2004) and hospitals 
(2007) may have created more awareness among HCWs that annual influenza 
vaccination is important, but so far have failed to reach the objective of the majority of 
HCWs being vaccinated each year. 
AIM AND OBJECTIVES OF THIS THESIS 
This thesis aims to assess the factors associated with influenza vaccine uptake among 
HCWs, how to increase vaccine coverage and to determine the impact of a targeted 
multi-faceted hospital-based intervention program to raise immunization rates among 
HCWs. 
The following research questions will be addressed: 
1 .  Which factors are reported by administrators of Dutch general hospitals regarding 
influenza vaccine uptake among HCWs? 
2. How do administrators of Dutch general hospitals and nursing homes perceive 
seasonal influenza and vaccination and what is the vaccine coverage in both settings? 
3 .  Which predictors are most important in seasonal influenza vaccine acceptance among 
hospital HCWs? 
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4. Which factors determine influenza vaccine uptake among hospitals-based HCWs in 
the Netherlands? 
5. How can we develop a structured influenza vaccination program targeted at changing 
behaviour in hospital staff, and is such a program successful? 
6. What is the effect of a multi-faceted influenza vaccination program on vaccine 
coverage among HCWs, and what are the effects on patient morbidity? 
7. Is the implementation of a multi-faceted influenza vaccination program among Dutch 
HCWs cost-effective? 
OUTLINE OF THIS THESIS 
In this thesis we focus on factors associated with increasing influenza vaccine uptake 
among HCWs, and on the impact of such a program. In chapter 2 we first describe the 
factors associated with influenza vaccine uptake among HCWs according to 
administrators of Dutch general hospitals. Chapter 3 combines these outcomes with the 
factors mentioned by the administrators of nursing homes, and compares these factors 
between both health settings. In chapter 4 a meta-analysis on the predictors of seasonal 
influenza vaccination among hospital HCWs is presented. Chapter 5 describes the 
factors associated with influenza vaccine uptake among HCWs in the Dutch university 
medical centers. Chapter 6 demonstrates the de·velopment of a multi-faceted program in 
order to change vaccination behaviour and its evaluation. Chapter 7 describes the 
effects of this multi-faceted program on HCWs' influenza vaccine coverage and on 
patient morbidity. In chapter 8 we performed a cost-effectiveness analysis of the 
implemented vaccination program, and finally we concluded with a general discussion of 
our findings and future perspectives in chapter 9. 
11 
REFERENCES 
1. van Essen G, Bueving H, Voordouw A, et al. NHG-Standaard Influenza en lnfluenzavaccinatie [Guideline 
'Influenza and lnfluenzavaccination' from the Dutch College of General Practitioners]. Huisarts Wet 2008;51. 
2. Wallinga J, Teunis P, Kretzschmar M. Using data on social contacts to estimate age-specific transmission 
parameters for respiratory-spread infectious agents. Am J Epidemiol 2006;164:936-944. 
3. Elder AG, O'Donnell B, McCruden EA, et al. Incidence and recall of influenza in a cohort of Glasgow 
healthcare workers during the 1993-4 epidemic: results of serum testing and questionnaire. BMJ 
1996;313:1241-1242. 
4. Influenza: WHO Fact Sheet 2009. Available at: http://www.who.int/mediacentre/factsheets/fs211 /en. 
5. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003;362:1733-1745. 
6. Proposal for a council recommendation on seasonal influenza vaccination. Available at: 
http://ec.europa.eu/health/ph threats/com/lnfluenza/docs/seasonflu rec2009 en.pdf. 
7. Van Kerkhove MD, Hirve S, Koukounari A, et al. Estimating age-specific cumulative incidence for the 
2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries. 
Influenza Other Respi Viruses 2013 Jan 21. 
8. Dawood FS, Iuliano AD, Reed C, et al. Estimated global mortality associated with the first 12 months of 
2009 pandemic influenza A H1 N1 virus circulation: a modelling study. Lancet Infect Dis 2012;12:687-695. 
9. Osterholm MT, Kelley NS, Sommer A, et al. Efficacy and effectiveness of influenza vaccines: a systematic 
review and meta-analysis. Lancet Infect Dis 2012;12:36-44. 
10. Nichol KL. Efficacy and effectiveness of influenza vaccination. Vaccine 2008;26 Suppl 4: D17-22. 
11. Gefenaite G, Tacken M, Bos J, et al. Effectiveness of A(H1 N1)pdm09 influenza vaccine in adults 
recommended for annual influenza vaccination. PloS One, PLoS One. 2013;8:e66125 
12. Jefferson T, Di Pietrantonj C, Rivetti A, et al. Vaccines for preventing influenza in healthy adults. 
Cochrane Database Syst Rev 2010;(7):CD001269. 
13. Thomas RE, Jefferson T, Lasserson TJ. Influenza vaccination for healthcare workers who work with the 
elderly. Cochrane Database Syst Rev 2010;(2):CD005187. 
14. van Essen GA, Palache AM, Forleo E, at al. Influenza vaccination in 2000: recommendations and 
vaccine use in 50 developed and rapidly developing countries. Vaccine 2003;21:1780-1785. 
15. Kroneman M, Paget WJ, Meuwissen LE, et al. An approach to monitoring influenza vaccination uptake 
across Europe. Euro Surveill 2008;13:18874. 
16. Health Council of the Netherlands. Influenza vaccination: revision of the indication. Publication no. 
2007/09. 2007. The Hague, Health Council of the Netherlands. 
17. Weingarten S, Riedinger M, Bolton LB, et al. Barriers to influenza vaccine acceptance. A survey of 
physicians and nurses. Am J Infect Control 1989;17:202-207. 
18. Jefferson T, Rivetti D, Rivetti A, et al. Efficacy and effectiveness of influenza vaccines in elderly people: 
a systematic review. Lancet 2005;366:1165-1174. 
12 
19. Song JY, Cheong HJ, Hwang IS, et al. Long-term immunogenicity of influenza vaccine among the 
elderly: Risk factors for poor immune response and persistence. Vaccine 2010;28:3929-3935. 
20. Maltezou HC, Wicker S, Borg M, et al. Vaccination policies for health-care workers in acute health-care 
facilities in Europe. Vaccine 2011 ;29:9557-9562. 
21. Kroneman M, Paget WJ, van Essen GA. Influenza vaccination in Europe: an inventory of strategies to 




Contributing factors to influenza vaccine uptake in 
general hospitals: an explorative management 
questionnaire study from the Netherlands 








Background The influenza vaccination rate in hospitals among health care workers in 
Europe remains low. As there is a lack of research about management factors we 
assessed factors reported by administrators of general hospitals that are associated with 
the influenza vaccine uptake among health care workers. 
Methods All 81 general hospitals in the Netherlands were approached to participate in 
a self-administered questionnaire study. The questionnaire was directed at the hospital 
administrators. The following factors were addressed: beliefs about the effectiveness of 
the influenza vaccine, whether the hospital had a written policy on influenza vaccination 
and how the hospital informed their staff about influenza vaccination. The questionnaire 
also included questions about mandatory vaccination, whether it was free of charge and 
how delivered as well as the vaccination campaign costs. The outcome of this one­
season survey is the self-reported overall influenza vaccination rate of health care 
workers. 
Results In all, 79 of 81 hospitals that were approached were willing to participate and 
therefore received a questionnaire. Of these, 42 were returned (response rate 52%). 
Overall influenza vaccination rate among health care workers in our sample was 1 7.7% 
(95% confidence interval: 14.6% to 20.8%). Hospitals in which the administrators agreed 
with positive statements concerning the influenza vaccination had a slightly higher, but 
non-significant, vaccine uptake. There was a 9% higher vaccine uptake in hospitals that 
spent more than €1 250, - on the vaccination campaign (24.0% versus 1 5.0%; 95% 
confidence interval from 0.7% to 1 7. 3%). 
Conclusions Agreement with positive statements about management factors with 
regard to influenza vaccination were not associated with the uptake. More economic 




A large number of studies from different regions and among different healthy adult 
populations have demonstrated that seasonal influenza vaccination is effective in 
preventing influenza infection.1-5 In acute health care settings it is essential to protect 
patients against influenza because most of them are vulnerable at admission for 
infections and its complications. Because of person-to-person transmission and intensive 
contacts with patients, vaccination of health care workers has been suggested to 
indirectly benefit patients. 6 There is also some evidence that vaccinating health care 
workers against influenza reduces costs in health care by reducing the length of 
hospitalization and reducing absenteeism of health care workers, though some did not 
find an effect on absenteeism rates. 1·7·8 Lastly, there are ethical arguments in favour of 
vaccination, like health care workers' primary duty not to harm their patients. 
Despite the potential benefits of vaccination, its uptake in hospitals among health 
care workers in Europe remains low. In 2003 Kroneman et al. showed vaccine uptake 
rates among health care workers of five European countries ranging from 15% in the UK 
and Germany to 25% in Romania.9 More recently, the survey of Blank et al. also 
demonstrated low overall influenza vaccine coverage rates among health care workers 
in eleven European countries which ranged from 6.4% in Poland to 26.3% in Czech 
Republic in the 200712008 influenza season.10 Vaccination rates exceeding 50% are 
difficult to reach. 11·12 
To improve vaccine uptake, several behavioural factors are essential to be 
targeted and different methods should be applied to increase vaccine uptake.13 For 
example, in most studies a positive relation with knowledge about the vaccine's efficacy 
and side effects and the importance not to harm patients is found. Several interventions 
targeting these determinants can influence the uptake such as educational materials, 
interactive sessions, role models, facilitating access like the use of mobile carts and the 
dedication of a person to coordinate the campaign. Some hospitals in the Netherlands 
have already implemented a vaccination campaign, but the relevant management 
factors have been under-explored in the worldwide literature. In this study a 
questionnaire was used to assess and quantify the factors reported by administrators of 
the general hospitals in the Netherlands regarding influenza vaccine uptake among 
health care workers. 
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METHODS 
All 81 Dutch general hospitals were approached for this study in December 2010. 
University hospitals were excluded because there was already an intervention program 
implemented in these hospitals as part of an ongoing trial [registration no. 
NCT01481 467]. These 81 hospitals were contacted by telephone for participation and 79 
out of 81 hospitals were willing to participate. The questionnaire was sent on December 
6th 2010 to the participating 79 hospitals and, if necessary, after two weeks a reminder 
was sent. In the beginning/mid January the hospital managements that did not return the 
questionnaire were contacted again by telephone as a reminder. 
The hospitals in the Netherlands are all publicly funded, not private nor specialty 
clinics, and we did not contact university medical centers, since they were part of a trial 
on influenza vaccination uptake. In the Netherlands all persons with risk-elevating 
conditions can get the vaccine via their general practitioner. Among HCWs this 
proportion is less than 5%.6 
The following items were assessed in the self-administered questionnaire: the 
overall influenza vaccination rate of health care workers in the hospital, the opinion 
about the effectiveness of the influenza vaccine, whether the hospital had a written 
policy on influenza vaccination and how the hospital informed their staff about influenza 
vaccine, e.g. personal by mail or letter, through general written information by posters or 
the intranet, or in the form of group meetings. The questionnaire also included questions 
about mandatory vaccination and, whether it was free of charge and how it was 
organized and about the program costs. 
The study was part of a trial [registration no. NCT01481 467] and the protocol of 
the trial was waived by the medical ethical committee of the University Medical Center 
Groningen for ethical approval according to the Dutch Law of Research with Humans 
(No. 2009.267). The study was conducted in accordance with the Dutch Law for the 
Protection of Personal Data (Wet Bescherming Persoonsgegevens) and the Declaration 
of Helsinki [http://www.wma.net/e/policy/b3 .htm]. 
Statistical analysis 
Data were analyzed using SPSS version 1 8.0. To determine which predictors were 
associated with mean influenza vaccination rates independent t-tests were used. 
1 8  
95% confidence intervals (95% Cl) were calculated to determine statistical significance 
at a p-level of 5%. 
RESULTS 
A questionnaire was sent to 79 of a total of 81 hospitals. Eventually, the questionnaire 
was returned by 42 hospitals (52% response rate). The size of the hospitals ranged from 
600 to 5,500 health care workers. The average vaccination rate for influenza in this 
sample was 1 7. 7% (median value 1 6.0%, minimum 0.5% and maximum 45.4%, 95% Cl 
1 4.6% to 20.8%). 
Health care workers were invited for influenza vaccination personally by mail in 
26% of hospitals, and 100% used general written information for all health care workers. 
Only 3 %  organized information meetings about influenza vaccination. In all, 100% of the 
hospitals supplied their health care workers with influenza vaccination free of charge. 
Vaccines were administered at the departments in 58% of hospitals, 84% had mobile 
carts, 97% had a central location to administer vaccines and only 4% vaccinated at 
special request. 
As shown in Table 1 ,  the majority of management of hospitals agreed with the 
first three items (vaccination effects mortality and both health care workers and hospital 
managements have a special responsibility in protecting patients and offering 
vaccination). Thirty of the 42 hospital administrators (71 .4%) believed that vaccinating 
against influenza has an effect on mortality of patients in the hospital. However, when 
vaccination rates remain too low only three hospitals (7.1 %) would consider 
implementing a mandatory vaccination program. 
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Table 1 Agreement of hospital management on questions concerning influenza vaccination 
( n =42) 
Question/statement 
Vaccinating against influenza has effect on mortality of patients in the 
hospita l . 
Health care workers with patient contact have a special responsibility in 
preventing infection of their patients. 
The management of the hospital has a moral responsibility of offering 
influenza vaccination to their health care workers. 
An intervention program with the purpose to stimu late vaccination has 
a positive effect on vaccination rate. 
The management of the hospital would implement such an intervention 
program to raise vaccination rate. 
The management of the hospital considers mandatory vaccination 
when vaccination rate remains too low. 
A mandatory vaccination against influenza will reduce costs in the 
hospital .  
The vaccine against influenza is effective. 
Management of 
hospital that agrees, 
n (%) 





3 (7. 1 )  
1 2  (28.6) 
29 (69.0) 
Half of the hospital managements thought that an intervention program could 
raise the vaccination rate. Further, 19 administrators (45.2%) believed that an 
intervention program would have a positive effect on vaccination rate. Management of 
29 hospitals (69.0%) believed that the vaccine is effective against influenza. 
In Table 2 is shown how the factors were related to the average vaccination rate. 
When health care workers are personally informed about influenza vaccination, the 
average vaccination rate is somewhat higher than any other form of providing 
information (1 8.9% compared to 1 5.6%, 95%CI -2.97% to 9.70%). The managements' 
positive beliefs about the effect of vaccination on mortality of patients was associated 
with an average vaccination rate of 19.0% compared to 1 6.7% when there were negative 
beliefs about this effect. 
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Table 2 Agreement of management of hospitals (n=42) with possible predictors of vaccination 
rate and mean vaccination rate 
Predictor Agreement Agreement Mean difference 
Yes n (%) No n (%) (95% Cl) 
Health care workers are personally informed 24/38 (1 8.9) 1 4/38 (1 5.6) 3.36 (-2.97 to 9.70) 
about influenza vaccination 
Agreement with the effect of vaccination on 27/33 (1 9 .0) 6/33 (1 6.7) 2.24 (-6.50 to 1 0.98) 
mortality of patients 
Agreement of management with the 32/35 (1 8.8) 3/35 (1 0.0) 8.78 (-2.75 to 20.32) 
statement that they are responsible for 
offering the vaccine to health care workers 
Believing that an intervention program to 18/26 (1 6 .5) 8/26 (1 7.3) -0.85 (-8. 1 5  to 6.46) 
stimulate vaccination has a positive effect on 
vaccination rate 
Hospitals willing to implement an intervention 20/25 (1 7 .4) 5/25 (1 2.7) 4.70 (-2.66 to 1 2.06) 
program 
Hospitals willing to implement mandatory 3/33 (1 8.0) 30/33 (1 7.5) 0.51 (-1 1 .49 to 12 .51 ) 
vaccination 
Believing that mandatory vaccination will 1 1 /24 (1 6 .7) 1 3/24 (1 5.6) 1 .08 (-5.23 to 7.38) 
reduce costs 
Believing that the vaccine against influenza 27/32 (1 8.7) 5/32 (14.2) 4.48 (-5.20 to 1 4. 1 6) 
is effective 
C l ,  confidence interval 
In hospitals where management agreed to be responsible for offering the vaccine 
to health care workers an average vaccination rate of 1 8.8% was observed opposed to 
10.0% in hospitals in which management disagreed with being responsible. 
In all, 11 out of 42 hospital management believed mandatory vaccination will 
reduce costs. Of these hospitals, the ones that agreed had an average vaccination rate 
of 1 6.7% and the ones that disagreed had an average vaccination rate of 1 5.6%. When 
asked if they wanted to implement a mandatory vaccination only three hospitals were 
willing to do so. 
The costs of the annual flu campaign and the actual vaccination differed a lot 
between general hospitals. The average costs for the annual influenza vaccination 
campaign in 2010 were €640.3 8  per hospital with a minimum of €0.00 and a maximum of 
€2000.00 (standard deviation 563 .21 ). The average costs for vaccination were €41 98.54 
per hospital with a minimum of €0.00 and a maximum of €1 4262.50 (standard deviation 
3 643 .61 ). 
In Figure 1 the costs of the vaccination campaigns are compared to the 
vaccination rate, showing a higher vaccine uptake among HCWs in hospitals which 
spent more money on their vaccination campaign. To assess if a more expensive 
influenza campaign is correlated with a higher vaccination rate an independent t-test 
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was performed. Only four hospitals spent more than €1 250 on the influenza campaign. 
The average vaccination rate of these hospitals was 24.0% compared to 1 5.0% of 
hospitals that spent less than €1 250 (mean difference 8.97; p<0.05), demonstrating a 
higher vaccine uptake among HCWs in hospitals which spent more than €1 250 on their 
vaccination campaign. These differences remained if analyzed according to size of the 
hospital (25% versus 1 8% in hospitals with less than 2,000 health care workers and 23 % 
and 1 4% in hospitals with more than 2000 health care workers). 
Figure 1 Average vaccination rate at different cut-off points of influenza campaign costs in 


















-+- Hospitals � cut-off 
point 
--Hospitals < cut-off 
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For €1 250 the mean difference is statistically significant with p<0.05. 
DISCUSSION 
In this study we found that agreement of hospital management with positive statements 
about influenza vaccination was not associated with influenza vaccine uptake. The 
average influenza vaccination rate among health care workers in our sample of Dutch 
hospitals was low; less than one in five received the vaccine. However, this is similar to 
the European situation.9-11 In theory, one would expect that health care workers that are 
better informed about influenza vaccination, e.g. by personal information, have a higher 
vaccination rate because of a better understanding of the need to be vaccinated. As can 
be seen in Table 2 there is no significant difference in mean vaccine uptake between 
hospitals that personally inform their health care workers and hospitals that do not. This 
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could be explained by the fact that hospitals invest only marginal in informing their health 
care workers in the proper way or they fail to deliver the personal messages to their staff. 
The total response rate in the general hospitals was 52% which is quite high for a 
questionnaire study. However, response bias might have influenced the results. Since it 
is unknown what the actual current characteristics are of the non-responder hospitals, 
we were not able to compare them with the responders. We do believe however that the 
potential for selection bias is not large and more depending on the time and availability 
of the contact person (which is highly unlikely to be associated with the type of hospital). 
Importantly, there was a large variation in size of hospitals and agreements with 
statements, hence the associations between factors and vaccine uptake are most likely 
not influenced by this type of bias. Also, the average vaccination rate in our sample 
could not be weighted by the size of the hospitals to obtain a national estimate, so the 
1 7% as observed in this study should not be directly accepted as a national estimate. 
However, as mentioned above, the sample may be assumed as rather representative of 
the total hospital population. Further, we asked about the percentage of health care 
workers being vaccinated and did not actually count vaccinees and total number of 
health care workers. Since it is important for quality management and for financial 
reasons, most hospitals do have accurate figures on this preventive method. In addition, 
another limitation of this study is that we have not taken into account other potential 
confounders in our analyses, like age structure of the hospital and hospital size. Lastly, it 
is unknown how many HCWs in these hospitals were already vaccinated against 
influenza by their general practitioner. 
Most of the factors contributing to a slightly higher vaccination rate were only 
marginally related to a higher vaccine uptake. The questionnaires were directed at 
management of the hospital - for this reason the statements are the statements of the 
management and not necessarily of the whole hospital. Although in general it appeared 
that the studied beliefs of the administrators were not essential in raising the vaccine 
uptake, it may be that there are elements of these beliefs that may well be important. 
Detailed factors on how exactly HCWs were informed or motivated for vaccination could 
be of relevance and we therefore would advocate to study these in more detail using 
qualitative techniques such as focus groups in addition to what we already know from 
questionnaire studies. 14 The difference in vaccination costs can be explained by the fact 
that some hospitals have more health care workers than others. The correlation between 
investing in educational campaigns apparently leads to higher vaccination rates, even if 
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results were obtained from small or larger hospitals. Therefore, when hospitals invest in 
educational materials to inform their health care workers that vaccination against 
influenza will protect their patients, vaccination rates are expected to be higher. 
The fact that 11 hospitals think mandatory vaccination reduces costs but only 
three hospitals would want to implement mandatory vaccination is a bit contradictory. 
This contrast could be caused by the fact that hospital managements think the ethical 
concerns outweigh the health benefits, or the hospitals do not want to take away the 
freedom of choice from their medical staff. The lack of legal permission for mandatory 
vaccination will probably also play a big role in this matter. However, the ethical 
discussion about this subject is increasingly being raised. Such mandatory vaccination 
programs are more likely to reach a high vaccination rate (>90%) and these rates will 
probably be sustained for a long period of time. 12• 15•1 6  Van Delden et al. showed the pros 
and cons of mandatory vaccination, and concluded that the advantages of mandatory 
vaccination outweigh the burdens and risks. 12 However, in the Netherlands as in many 
European countries there is no legal basis for implementing mandatory vaccination in 
health care workers yet. Ethical discussions are currently ongoing but preferably vaccine 
uptake should be raised voluntarily. 
CONCLUSION 
In conclusion, agreement of hospital management with positive statements about 
influenza vaccination was not associated with the uptake. Economic investments were 
low and more economic investments were related with a higher vaccine uptake. 
Reasons for the higher uptake should be explored further preferably by more qualitative 
methods. When vaccine uptake remains too low, only a minority of the general hospital 
administrators would consider implementing a mandatory vaccination program, and such 
a policy may take some time and efforts before is generally accepted. 
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ABSTRACT 
Background Patients who receive acute or long-term health care in general hospitals or 
nursing homes need to be protected against influenza infection. Despite 
recommendations by the World Health Organization, influenza vaccine uptake among 
health care workers (HCWs) remains low. Management beliefs associated with this 
preventive measure have not been extensively explored. 
Methods We conducted a self-administered questionnaire study among administrators 
of all 81 Dutch hospitals and 31 0 nursing homes to assess and compare specific beliefs 
associated with influenza vaccine coverage among HCWs. 
Results In all, 1 85/31 0 (59.7%) nursing home questionnaires and 42/85 hospital 
questionnaires (49.2%) were returned. The reported mean vaccination rate among 
HCWs in nursing homes was 1 8.8% versus 1 7.7% in general hospitals. In 69.2% of 
nursing homes there was a written policy for influenza vaccination versus 23 .8% of 
general hospitals (p<.001 ). In 24.3% of nursing homes mandatory vaccination would be 
accepted when vaccine coverage remains low versus 8.6% of management in general 
hospitals (p=0.04). All other beliefs were not statistically significant different. 
Conclusion Despite recommendations, influenza vaccine coverage among HCWs 
remains low in both nursing homes and hospitals, and mandatory vaccination is not 
accepted. To increase vaccine coverage in both health care settings, written policies are 
needed and vaccine behaviour among HCWs needs to be targeted through well­
developed, structured, implementation programs. 
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INTRODUCTION 
Annually, influenza causes outbreaks in health care institutions. Patients who receive 
acute or long-term care need to be protected against this respiratory virus, because they 
are already more prone to infections and associated risk of complications. Evidence from 
trials and observational studies clearly showed that the seasonal influenza vaccination is 
effective in preventing infection with the influenza virus among adults.1 To reduce 
transmission of the virus to patients and the spread of the virus within institutions it is 
therefore recommended to immunize health care workers (HCWs).2•3 Despite scientific 
limitations,4 some four large trials showed considerable reductions in morbidity and 
mortality during influenza seasons in long-term care institutions with high uptake of the 
vaccine compared with controls.5·8 There is also evidence that vaccinating health care 
workers against influenza may reduce costs in health care by reducing the length of 
.hospitalization and reducing absenteeism of health care workers.9· 1 ° Further, because of 
herd immunity in health care institutions can not be reached, it is very important for all 
HCWs to be vaccinated.1 1 
In the Netherlands, influenza vaccine coverage of risk groups is among the 
highest in the world.12 Interestingly, vaccine uptake among HCWs remains low.13 In 
2004, the Dutch association of nursing homes physicians (Verenso) developed a 
guideline on influenza vaccination in which they recommend influenza vaccination for 
HCWs in nursing homes. 14 The association's goal was to prevent influenza and to limit 
any complications from such infection among residents. Residents often have an 
impaired immune system and immunization does not fully protect them.15 In the 
Netherlands ageing has led to more than 1 .9 million people who are aged 65 years or 
older and two percent of them resides in nursing homes. Because of these large 
numbers of risk patients and the expectation that the Dutch population will age further, it 
is of high importance to achieve effective protection in this group.16·1 7  
In 2007, the Dutch Health Council recommended influenza vaccination for HCWs 
in contact with high-risk patients, i.e. elderly and the chronically ill, in all health care 
institutions such as nursing homes and hospitals. Despite this recommendation, 
anecdotal reports indicate that vaccine uptake remains low among HCWs in both 
general hospitals (GH) and nursing homes (NH), and management factors have not 
been extensively studied. We therefore aimed to assess the influenza vaccine uptake 
among HCWs in both health care settings, and we also determined the possible effects 
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of the recommendations in both groups. Further, because of a lack of studies among 
managements of general hospitals, we aimed to compare the beliefs about influenza and 
vaccination among management staff of both GH and NH. 
METHODS 
Setting 
This self-administered questionnaire study was conducted in both nursing homes and 
general hospitals in the Netherlands. In 2011 , there were 85 general hospitals in the 
Netherlands providing secondary care, and eight university medical centers (UMCs) 
where tertiary care was taken care of. In total, the general hospitals had 1 76,000 
employees and the university medical centers had 60,500 HCWs. The total number of 
beds was 3 8,792 for the general hospitals and 7,723 for the UMCs.18 In 2004 there were 
3 42 nursing homes in the Netherlands with a total capacity of 63 ,027 beds. The total 
number of Dutch nursing homes was 310 in 2008 because of merging.19 Nursing homes 
provide long-term care for frail, mainly elderly people with somatic and/or psychogeriatric 
disorders. Within nursing homes care is provided by registered nurses as well as care 
workers. In 2011,  264,460 certified nurses were working in both hospitals and long-term 
care facilities.20 In 2010, 4,000 care workers were working in hospitals versus 77,700 
care workers in nursing homes.21 
Participants and methods 
In October and November 2008, a questionnaire was sent to the administrators of all 
310 Dutch NH.22 The following items were assessed: influenza vaccination rates in NH 
HCWs and residents in the preceding flu-season, whether there was a written policy 
about vaccinating HCWs against influenza, how they offered the influenza vaccination to 
their HCWs, whether the HCWs received information about the influenza vaccination, 
beliefs about effectiveness of the vaccine in reducing morbidity and mortality, beliefs 
about effectiveness of vaccinating HCWs in reducing costs, beliefs about the moral 
responsibility to offer the vaccine to HCWs, beliefs about the HCWs' special 
responsibility to prevent transmission of influenza to their patients and beliefs about 
mandatory vaccination. Respondents were asked to state to which extent they agreed or 
disagreed with the statements by means of a 5-point Likert scale. Reminders were sent 
after two and four weeks. 
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In December 2010, all 81 organizations of the 85 Dutch general hospitals were 
approached for participation in a similar questionnaire study. Items relevant to this study 
were identical to the NH study. 79 out of 81 hospitals were willing to participate and they 
received the questionnaire. Respondents were asked to state to which extent they 
agreed or disagreed with the statements by means of a 5-point Likert scale. After two 
and four weeks a reminder was sent. 
Statistical analysis 
Data were analyzed using SPSS (version 1 6.0). Questions on the 5-point Likert scale 
were dichotomized. The comparison between the hospitals and the nursing homes22 was 
made by merging the datasheets. Chi-square tests were used to test for statistically 
significant differences among comparison groups for binomial variables and t-tests were 
used for continuous variables. 
RESULTS 
Of the 310 distributed NH questionnaires, 1 85 were returned (59. 7% response rate). The 
average vaccination rate was 1 8.8% (median value 1 5%, 95% confidence interval (Cl) 
1 6.5 to 21 .1 %).The GH questionnaire was sent to 79 hospitals. Eventually, the 
questionnaire was returned by 42 hospitals (49.2% response rate). The average 
vaccination rate for influenza was 1 7.7% (median value 1 6.0%, 95% Cl = 1 4.6% to 
20.8%). There was no significant difference between the vaccination rate in hospitals 
and nursing homes (95% Cl -4.9 to 2. 7%). There was a large and significant difference 
between NH and GH in having a written policy (see Table 1 ). In ten (23 .8%) of 42 
hospitals there was a written policy for influenza vaccination, as is in 1 26 (69.2%) of the 
1 82 nursing homes (p<.001 ). Another statistically significant difference was the 
administrators' belief that the GH or NH will accept mandatory vaccination if vaccination 
rate remains low. Only 8.6% of the GH administrators agreed on this statement versus 
24.3 % of the NH administrators (p=0.04). Also, believing that mandatory vaccination is 
cost-effective was more common in NH than in GH (69.2% versus 46.2%, p=0.02). 
There was little difference in providing personal written information to HCWs in 
both health institutes which occurred in approximately 60% of both types of institutions. 
On the statement about the vaccine's effectiveness of both hospitals and nursing homes 
over 80% agreed. There was a slight difference regarding the view that HCWs have a 
3 1  
special responsibility. Of the general hospitals 95.0% of administrators agreed with this 
statement against 86.5% in the nursing homes (p=0 . 1 3 ). Administrators' beliefs about 
moral responsibility showed no difference between GH (89.7%) and NH (83 .2%) 
(p=0.31 ). 
Table 1 Comparison of admin istrators' beliefs about vaccination in general hospitals and nursing 
homes 
Factor Hospital Nursing home p-value 
Yes No Yes No 
n (%) n (%) n (%) n (%) 
1 . Written policy for 
vaccination 1 0  (23.8) 32 (76.2) 1 26 (69.2) 56 (30.8) <.001 
2. Personal written 
information 25 (59.5) 17 (40.5) 1 1 2  (60.9) 72 (39. 1 )  0 .87 
3. Vaccine is 
effective 30 (81 . 1 )  7 ( 1 8.9) 1 53 (82 .7) 32 (1 7.3) 0 .81  
4. Special responsibility 
of the HCW to protect 
patients. 38 (95.0) 2 (5.0) 1 60 (86.5) 25 ( 1 3.5) 0 . 1 3 
5. Moral responsibil ity of 
the management to offer 35 (89.7) 4 ( 1 0.3) 1 54 (83 .2) 31 (1 6.8) 0.31 
vaccination 
6. Mandatory vaccination 
if vaccination rate remains 3 (8.6) 32 (91 .4) 45 (24.3) 1 40 (75.7) 0.04 
low 
7. Mandatory vaccination 
is cost-effective 1 2  (46.2) 14 (53.8) 1 28 (69.2) 57 (30.8) 0.02 
In Bold p<0.05 
HCW, health care worker 
32 
DISCUSSION 
In all, in both nursing homes and general hospitals influenza vaccine coverage among 
health care workers remained far below the health objective exceeding 50%.23 Despite 
that both types of health care institutions did not differ in vaccine uptake rates, there 
were few remarkable differences in management views. Having a written policy was 
more common in nursing homes than in general hospitals, as NH already developed 
their influenza vaccination guideline in 2004. However, this did not affect vaccine uptake. 
A possible reason for the absence of an effect from having a policy is that the actual 
procedures to promote the vaccine uptake may not differ. A well designed policy, as we 
have already implemented in an earlier phase in nursing homes,24 may be more 
effective. 
With mandatory vaccination it is possible to reach a vaccination rate of 90% or 
more. For example, Rakita et al. showed a vaccine coverage of more than 98% after 
implementing mandatory vaccination.25 However, in our study only three (8.6%) out of 3 5  
hospitals agreed with the statement that mandatory vaccination should be implemented 
against 45 (24.3%) out of 1 85 nursing homes. This could be caused by the fact that 
hospitals and nursing homes believe that ethical objections in favour of autonomy 
outweigh the possible benefits of higher vaccination rates for their patients. Currently, 
there are ongoing ethical discussions about mandatory vaccination. Van Delden et al. 
showed that there are several arguments in favour of mandatory vaccination. For 
example the duty to do no harm to your patients and the moral responsibility of HCWs. 
However, it may be helpful to emphasize these arguments in the program.23 Another 
issue of course is that mandatory vaccination should have a legal basis which is not the 
case in the Netherlands at present. However, a recent study performed by Hakim et al. 
demonstrated that implementing mandatory vaccination was not always without 
problems.26 One hospital was even sued by its health care workers who were against it. 
The court however, favoured the continuation of mandatory vaccination because they 
argued that the need to protect patients and co-workers against influenza outweighed 
the objections. 
The statement on the cost-effectiveness also shows a difference between GH 
and NH. A majority of the nursing homes agreed with this statement whereas only a 
small minority of the hospitals agreed. The reason for this difference can be the size and 
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organizational structure which is mostly larger and more complex in GH compared to 
NH. Further research should be done to find out what the exact costs and benefits are.9 
The GH response rate of 53 .2% was not substantially lower than the 59.7% in the 
study performed by Looijmans-van den Akker.22 Hence we do not expect response bias 
to have influenced our results considerably.  The average influenza vaccination rate in 
GH and NH is respectively 1 7.7% and 1 8.8% (95% Cl -4.9 to 2.7). This is relatively low 
and can possibly be explained by the fact that GH and NH don't inform their HCWs in an 
optimal way. Looijmans-van den Akker et al showed that organizational determinants like 
HCWs receiving information through an information meeting and from a nursing home 
physician were associated with a higher influenza vaccine uptake among HCWs.27 So in 
theory, health care workers that are better informed about influenza vaccination, e.g. by 
personal information, can be expected to have a higher vaccination rate. 
Lastly, in order to increase vaccine uptake, it is important to focus on the GH and 
NH management staff first. Only if they are fully convinced of the need and importance 
for HCWs to get vaccinated against influenza, a change in vaccine uptake might be 
possible. Behavioural change at the level of HCWs is needed to achieve this. 
In order to achieve such a behavioural change a structured and multi-faceted 
communication program should be developed and implemented in general hospitals to 
change the beliefs of HCWs and to create awareness of the risks and the consequences 
of not getting vaccinated. This study was not aimed at assessing determinants of 
vaccine uptake. However Hopman et al. and Riphagen-Dalhuisen et al. conducted 
studies to determine the predictors of influenza vaccination compliance in hospital-based 
HCWs.28•29 Hopman et al. demonstrated a prediction model that proved to determine 
vaccine uptake among HCWs for over 95%. In future programs, these predictors should 
be taken into account. 
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Objective Vaccinating health care workers (HCWs) against influenza is one of the most 
important methods of decreasing influenza transmission among at-risk patients in health 
care facilities. However, despite recommendations, the rate of uptake of influenza 
vaccine among HCWs remains low. The objective of this meta-analysis was to determine 
the most important predictors of seasonal influenza vaccine acceptance among HCWs in 
hospitals. 
Method A literature search of PubMed and Embase resulted in 4586 hits. Screening of 
the titles, abstracts and full text identified 1 3  studies eligible for inclusion in the meta­
analysis. Based on the crude data, pooled risk ratios (Mantel-Haenszel risk ratios, 
mhRR) and their 95% Cls were calculated using Mantel-Haenszel analysis to estimate 
the associations of predictors with influenza vaccination status. 
Results and conclusion Knowing that the vaccine is effective (mhRR 2.22; 95% Cl 
1 .93 to 2.54}, being willing to prevent influenza transmission (mhRR 2.31 ; 95% Cl 1 .97 
to 2. 70), believing that influenza is highly contagious (RR 2.25; 95% Cl 1 .66 to 3 .05), 
believing that influenza prevention is important (mhRR 3 .63 ; 95% Cl 2.87 to 4.59) and 
having a family that is usually vaccinated (RR 2.32; 95% Cl 1 .64 to 3 .28) were 
statistically significantly associated with a twofold higher vaccine uptake. We therefore 
recommend targeting these predictors when developing new influenza vaccination 
implementation strategies for hospital HCWs. 
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INTRODUCTION 
Health care workers (HCWs) with influenza can transmit the virus to patients who are at 
increased risk of developing serious complications. Seasonal influenza vaccination 
reduces influenza-confirmed episodes among healthy adults by approximately 75% 
when matched with circulating strains 1 and there is evidence that vaccinating HCWs 
against influenza reduces the number of respiratory tract infections among these 
workers. 2•3 The main reason for vaccinating against influenza, however, is to prevent 
severe morbidity and mortality among patients, as shown by Hayward et al.4 In a recent 
Cochrane review,5 an overall reduction in all-cause mortality of 32% (95% Cl 16% to 
45%) was found in long-term care facilities in which some of the HCWs were vaccinated 
versus control homes. Although the included studies were heavily criticized by the 
authors, in most countries the evidence so far is still perceived as favouring vaccination. 
One of the studies from that review6 revealed that in the control homes 20% of a sample 
of 30 deaths were caused by influenza, while in the intervention homes none of the 
sampled deaths had evidence of influenza infection, giving a 100% reduction in deaths 
caused by influenza. In addition, Thomas et al. estimated a 29% reduction (95% Cl 10% 
to 45%) in influenza-like illness in intervention homes compared with control homes.5 It is 
well established that during influenza epidemics, the aetiological fraction of culture or 
PCR-confirmed influenza virus in elderly patients is high at between 55% and 67%. 7 
Recently, Van den Dool et al. 8 developed a mathematical model to predict the effects of 
increasing vaccine uptake among HCWs in hospitals. Assuming a 73% vaccine efficacy 
among HCWs, it was estimated that only seven of the workers needed to be vaccinated 
to prevent one influenza infection in a hospital patient. Another of their conclusions was 
that due to stochastic variations, more than 184 homes would be needed in each 
intervention arm to detect a statistically significant reduction in influenza episodes among 
patients between homes with zero and 50% vaccine uptake by HCWs. Therefore, a huge 
trial would be needed to confirm this assumption which in itself is less relevant from a 
clinical perspective. Meanwhile, current evidence supports the provision of large 
investments to improve vaccine uptake among HCWs, so waiting for more evidence is 
simply unethical. 
Despite evidence in favour of vaccinating HCWs, the uptake rate of seasonal influenza 
vaccine among HCWs remains far below target. For example, the vaccination rates in 
the studies included in our meta-analysis ranged from as low as 2 . 1  %9 to 62%. 10 Many 
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studies have examined possible predictors of influenza vaccination acceptance by 
HCWs, but due to small sample sizes, different study designs, settings, populations and 
assessed predictors, it is difficult to get an overall picture. Although current reviews 
provide some evidence regarding the most important predictors of acceptance of 
influenza vaccination in HCWs, 1 1 ·1 2  systematic or pooled data analysis is missing. 
Additionally, no distinction has been made between evidence from intervention and 
evidence from non-intervention studies. 
We therefore conducted a meta-analysis to assess the predictors of seasonal influenza 




A literature search was performed using PubMed and Embase on 9 December 2009 
using the following search strategy: ('Vaccines' (MeSH) OR 'Vaccination' (MeSH) OR 
' Immunization' (MeSH) OR 'vaccination' (TIAB) OR 'vaccin*' (TIAB)) AND ('influenza' 
(TIAB) OR 'influenza virus' (TIAB) OR 'influ*' (TIAB) OR 'flu' (TIAB) OR ' Influenza, 
Human' (MeSH) OR ' Influenza Vaccines' (MeSH)) AND ('HCWs' (TIAB) OR 'healthcare 
worker' (TIAB) OR 'hospital personnel' (TIAB) OR 'hospital staff ' (TIAB) OR 'staff ' 
(TIAB) OR 'personnel' (TIAB) OR 'Hospitals' (MeSH) OR 'Long- Term Care' (MeSH) OR 
'Nursing Homes' (MeSH) OR 'Patient Care' (MeSH) OR 'Health Personnel' (MeSH)) 
AND (English (LA) OR Dutch (LA)) NOT 'child' (MeSH Terms) NOT review(pt). 
We used MeSH terms for the PubMed search and Emtree terms for the Embase search. 
We limited our search to articles in the English or Dutch language. The studies were 
included in the meta-analysis if they were non-pandemic, non-intervention studies 
performed among HCWs working in hospitals, reported current influenza vaccination 
status and had available crude data on at least one predictor of interest for this study. 
Reference lists were scrutinized to identify other relevant studies, but none were found 
(Figure 1 ). 
During the selection procedure, articles were also independently judged on their quality 
according to several quality criteria by two reviewers (JRD, GG), and discussed with EH 
in case of disagreement. The main quality criteria were response rate, sample size, 
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number of included determinants, data collection methods, study design and vaccine 
uptake measures. 
Figure 1 Flowchart of literature search. 
1 081  records identified through 3505 records identified through 
Pubmed database screening Embase database screening 
62 records screened 53 records screened 
for inclus ion for inclus ion 
51 records excluded 42 records excluded 
based on the based on the 
exclusion criteria exclusion criteria 
I, 
1 1  eligible studies 1 1  eligible studies 
9 duplicates excluded -
l 
1 3  studies included 
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Predictors and outcome 
We classified the predictors for influenza vaccination into several groups according to 
behavioural and implementation models (see Table 1 ). 
Current influenza vaccination status was chosen as the outcome. 




Perceived benefits influenza vaccination 
Perceived risks and severity 
Characteristics of the predictors 
Gender (male vs. female) 
Age (40 years and older versus younger than 
40 years) 
Occupation (being a physician versus other 
HCWsa or being a nurse versus other HCWs8) 
Vaccine effectiveness 
Current recommendations 
Symptoms of disease 
Willingness to prevent transmission 




Perceived barriers to get vaccinated Fear related to vaccination 
Availabil ity of the vaccine 
Previous influenza and influenza vaccination Previous influenza vaccination 
History of influenza 
Other predictors 
Smoking 
Vaccination status of relatives 
Direct patient contact 
Prevention of influenza is important 
8Health care workers 
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Statistical analysis 
We calculated the average response rates (%) of the included studies and their 95% Cls 
using SPSS V.1 6.0. After the raw data were pooled, the risk ratios (RR) and Mantel­
Haenszel risk ratios (mhRR) and their 95% Cls were calculated using K. Rothman's 
Episheet. 13·14 When information about a predictor was available from only one study, RR 
instead of mhRR were calculated. 
Statistical heterogeneity between the studies was examined visually by comparing 
mhRR and 95% Cls in the forest plot across studies. 
RESULTS 
Description of the studies 
Our search resulted in 4586 hits. Abstracts, titles and full texts were screened and 
duplicates excluded, resulting in 1 3  eligible studies. 9·1 0·1s-25 All 1 3  studies included in the 
meta-analysis were cross-sectional. The total sample included 84 880 HCWs and the 
average response rate was 56.9% (see Table 2 for more details). Vaccination status was 
determined by questionnaire in 1 0  studies, and was known from clinical records in three 
studies.20•24·25 Twelve studies used a questionnaire during the same season that the 
vaccine was administered9•1 0 ·16-25 and one study used a questionnaire one season later. 15 
All studies included at least one demographic predictor (gender, age or occupation), 
eight studies included at least one behavioural predictor, and two studies included an 
organisational predictor. All studies were carried out in developed countries: six were 
performed in the USA,9·1 0·17·18·21 •22 three in Europe, 16·20·25 two in Canada 19·23 and one in 
Australia,24 and one study was a multi-nationality survey.1 5 In most of the studies, 
influenza vaccines were provided for free by the hospitals on an annual, voluntary basis. 
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Table 2 Characteristics of included studies 
Study Location and year of Response Study Provision of the vaccine 
the study rate (%) sample 
(n) 
AI-Tawfiq Multi-nationala , 2007 54.2 450 Unknown 
Seguin Belgium, 1 996 37.2 4,1 09 Free of charge to HCW who wish 
to be vaccinated 
Bull Australia, 2005 69.7 63,330 Coordinated by the infection 
control department during 
autumn 
Christian USA, 1 990 63.3 379 Offered to all employees 
annually, $2 administration fee. 
Christini USA, 2005 42.2 2,467 Free of charge, through 
advertised clinics and mobile 
carts, fact sheet is provided 
Lester Canada, 2000 58.0 1 , 1 95 Unknown 
Maltezou Greece, 2006 8.9 8,062 Unknown 
Nichol USA, 1 994 38.0 1 ,031 Annual influenza vaccination 
program, walk-in clinic, mobile 
carts 
Picciri l lo USA, 2004 87.0 230 Unknown 
Saluja Canada, 2000 80.5 426 Unknown 
Steiner USA, 1 999 84.2 2,200 Free influenza vaccination 
is offered during mandatory 
tuberculosis screening of all 
employees 
Tapiainen Switzerland, 2004 75.5 538 Free of charge for all HCWs 
Weingarten USA, 1 987 41 . 1  463 Available to hospital employees 
at a $5 charge 
Total 56.9 84,880 
(43.1 - 70.7) 
Average 
(95% CI) 
a Multi-national ity survey among HCWs from the UK, USA, South Africa and Saudi Arabia. 
b University Medical Hospital o r  Teaching Hospital .  
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Type of secondary Predictors per study 
care 







Public Hospital X 
UMCb X 
Community hospital X 
UMCb emergency X 
departments 
Tertiary care hospital X 
University children' s x 
hospital 
Acute care UMCb x 











Predictors of influenza vaccination in HCWs 
The results from the pooled analyses of the associations between influenza vaccination 
status and different predictors are shown in Table 3 .  The forest plot in Figure 2 presents 
the results graphically. 
Male gender, being aged 40 years and older and being a physician were the 
demographic predictors that were positively associated with being vaccinated, while 
being a nurse was negatively associated with vaccine uptake. Statistically significant 
factors resulting in a twofold higher vaccine uptake were knowing that the vaccine is 
effective, being willing to prevent influenza transmission, believing that influenza is highly 





Table 3 Results 




Perceived risks and severity 
Predictor 
Male gender 
40 years and older 
Being a physician 
Being a nurse 
The vaccine is effective 
Being aware of the CDC recommendations 
Getting influenza is safer 
Influenza appears as a heavy cold 
Will ing to prevent influenza transmission 
Will ing to protect risk group patients 
Willing to protect oneself 
Being at risk for influenza complications 
Believing that the vaccine transmits 
influenza 
Believing that the risk of getting influenza is 
small 
Believing that influenza is not a serious 
i l lness 
Believing that influenza is highly contagious 
Number of studies that included mhRR 95% Confidence 
the predictor Interval 
810,15-17,19,21-23 1 . 1 8  1 . 1 3 - 1 .23 
415, 16,20,23 1 .23 1 . 1 7  - 1 .28 
89, 15, 16, 18,20,21 ,23,24 1 . 1 6  1 . 1 3  - 1 .20 
89, 15, 16, 18,20,23-25 0.90 0.88 - 0.91  
315,16,21 2.22 1 .93 - 2.54 
1 *22 1 .29 0 .98 - 1 .70 
1 *15 0 .83 0 .56 - 1 .23 
1 *16 1 .53 1 . 1 8 - 1 .98 
315,16,21 2 .31  1 .97 - 2.70 
210,21 1 . 1 2  1 .06 - 1 . 1 8  
1 *15 1 .89 1 .40 - 2.54 
410, 15, 16,23 1 . 1 3  1 .08 - 1 . 1 9  
315,16,22 0 .67 0 .55 - 0.83 
315,16,22 0.73 0 .52 - 1 .03 
1 *15 1 .26 0.87 - 1 .83 
1 *16 2.25 1 .66 - 3.05 
Vl  
0  
P e r c e i v e d  b a r r i e r s  
P r e v i o u s  i n f l u e n z a  a n d  
i n f l u e n z a  v a c c i n a t i o n  
O t h e r  p r e d i c t o r s  
F e a r  r e l a t e d  t o  v a c c i n a t i o n  
F e a r  r e l a t e d  t o  i n j e c t i o n  
V a c c i n a t i o n  i s  u n p l e a s a n t  
C o n v e n i e n t  v a c c i n a t i o n  c l i n i c s  
V a c c i n a t i o n  f r e e  o f  c h a r g e  
P r e v i o u s  i n f l u e n z a  v a c c i n a t i o n  
H a v i n g  a  h i s t o r y  o f  i n f l u e n z a  
B e l i e v i n g  i n f l u e n z a  p r e v e n t i o n  i s  i m p o r t a n t  
P r e f e r r i n g  n a t u r a l /  a l t e r n a t i v e  m e d i c i n e  
F a m i l y  i s  u s u a l l y  v a c c i n a t e d  
H a v i n g  c o n t a c t  w i t h  c h i l d r e n  
H a v i n g  d i r e c t  p a t i e n t  c o n t a c t s  
S m o k i n g  s t a t u s  
1  
*
1 5  
0 . 7 4  0 . 4 9  - 1 . 1 5  
2
1 5 , 1 6  
1 . 0 5  0 . 8 4 - 1 . 2 9  
2
1 5 , 1 6  
0 . 6 8  0 . 4 9 - 0 . 9 2  
1  
*
1 5  
2 . 2 5  0 . 9 5 - 5 . 3 4  
2
1 5 , 2 2  
1 . 5 2  1 . 2 7 - 1 . 8 1  
5
1 0 , 1 6 , 20- 2 2  
1 . 5 1  1 . 4 7  - 1 . 5 5  
2
1 0 , 2 2  
1 . 0 7  1 . 0 2  - 1 . 1 3  
2
1 5 , 1 6  
3 . 6 3  2 . 8 7 - 4 . 5 9  
2
1 5 , 1 6  
0 . 2 6  0 . 1 2 - 0 . 5 5  
1
*
1 6  
2 . 3 2  1 . 6 4 - 3 . 2 8  
1  
*
1 0  
1 . 0 8  1 . 0 4 - 1 . 1 3  
4
1 0 , 1 6 , 1 7 , 2 1  





1 . 0 1  0 . 6 6 - 1 . 5 3  
*
W h e n  t h e  i n f o r m a t i o n  a b o u t  a  p r e d i c t o r  w a s  a v a i l a b l e  f r o m  o n l y  o n e  s t u d y ,  r i s k  r a t i o s  ( R R )  a n d  n o t  M a n t e l - H a e n s z e l  r i s k  r a t i o s  ( m h R R )  w e r e  c a l c u l a t e d .  
Figure 2 Forest plot (number of studies with this specific predictor, total number of 
persons per predictor). CDC, Centers for Disease Control and Prevention.  
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DISCUSSION 
With this meta-analysis we aimed to determine the most important predictors of 
acceptance of seasonal influenza vaccination by HCWs in hospitals. Our results showed 
that the strongest predictors were knowing that the vaccine is effective, being willing to 
prevent influenza transmission, believing that influenza is highly contagious, believing 
that it is important to prevent influenza and having a family that is usually vaccinated. 
Other predictors had a weaker association but might be helpful in developing future 
influenza vaccination campaigns. Our findings are consistent with the results of previous 
reviews which also suggested that raising awareness about vaccine effectiveness and 
the risks of influenza makes vaccination more likely to be accepted.1 1 · 12 
Although it seemed that there were many more predictors of influenza vaccination 
acceptance in HCWs, the risk ratios of many predictors were close to 1 .  This suggests 
that interventions focusing on these predictors most likely would not achieve a significant 
increase in vaccination uptake rates in HCWs as these predictors have little impact on 
vaccine acceptance. 
We also looked at demographic characteristics to determine if they predicted vaccination 
status. We found that being male, being older than 40 years and being a physician 
increased the chances of being vaccinated, while being a nurse was associated with less 
vaccination. However, the risk ratios only differed very slightly from 1 for these 
predictors. Nevertheless, these population characteristics could be used in 
implementation programs to define specific target groups according to age, gender and 
occupation. 
In addition, in our study we assessed the predictors of influenza vaccination in non­
intervention studies performed in similar settings, namely (teaching) hospitals. We 
deliberately excluded intervention studies because merging the results from intervention 
and non-intervention studies might have introduced bias: knowledge derived from an 
educational campaign used in an intervention study could have influenced a particular 
predictor, which would not have occurred in a non-intervention study. 
Regarding heterogeneity, most predictors point in the same direction with overlapping 
risk ratios. Therefore, these predictors are fairly homogeneous. 
The fact that our study was unsuitable for multivariate analysis should be taken into 
account when interpreting the results. It might be that some predictors contain other 
information. For example, male gender was found to be a predictor of influenza vaccine 
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acceptance. However, it is likely that there are more male than female physicians, and 
therefore the relative risks might be overestimated. We were not able to address the 
issue of how the predictors interacted with one another. 
Finally, this meta-analysis was performed with the underlying purpose of providing 
evidence for use in future influenza vaccination campaigns among HCWs in hospitals 
during common epidemics, so we described the factors that were associated with 
seasonal influenza vaccine uptake. Pandemic influenza is different from seasonal 
influenza in many ways, but some of the described factors might also be important in a 
pandemic. Some reports on pandemic influenza vaccination have shown predictors 
similar to those described here, although other predictors also might play a role in 
vaccine uptake.26'27 Influenza vaccination will only be successful in HCWs if they are 
properly educated and if the vaccine is easily accessible. Therefore, we recommend 
targeting these predictors when developing new influenza vaccination implementation 
strategies for hospital HCWs. 
CONCLUSIONS 
Our main aim was to assess the predictors for seasonal influenza vaccination in HCWs 
in hospitals. Our meta-analysis provided information on the strength of the predictors of 
current influenza vaccination status. Future studies could use this information for their 
interventions and target the predictors that seem to have the most influence on vaccine 
uptake, and also focus on educating HCWs in order to prevent misinformation. 
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A questionnaire study was performed in all eight University Medical Centers in the 
Netherlands to determine the predictors of influenza vaccination compliance in hospital­
based health care workers (HCWs). Demographical, behavioural and organizational 
determinants were assessed based on behavioural and implementation models. 
Multivariable regression analysis was applied to assess the independent predictors for 
influenza vaccine uptake. Age >40 years, the presence of a chronic il lness, awareness 
of personal risk and awareness of risk of infecting patients, trust in the effectiveness of 
the vaccine to reduce the risk of infecting patients, the HCWs' duty to do no harm and 
their duty to ensure continuity of care, finding vaccination useful despite the constant 
flow of visitors and having knowledge of the Health Council's advice, social influence 
and convenient time for vaccination were all independently associated with vaccine 
uptake. The accuracy of the prediction model was very high (area under the receiver 
operating curve: 0.95). Intervention programs to increase influenza vaccine uptake 
among HCWs should target the relevant determinants identified in this study. 
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INTRODUCTION 
Influenza is a highly contagious respiratory tract infection causing significant morbidity 
and mortality in high risk groups, especially when antigenic drift has occurred as in the 
case of swine-like H1 N1 influenza. While the overall uptake of influenza vaccines is high, 
uptake among health care workers (HCWs) is sometimes incomplete. Since 30-50% of 
influenza cases are asymptomatic, HCWs have substantial rates of both clinical and 
subclinical influenza during influenza seasons when they often continue to work. 1•3 
Indirect protection of patients by immunisation of HCWs has therefore been proposed. 
Significant decreases in mortality in care home patients have been observed even 
though their vaccination coverage was only 50%.4-6 Other advantages of such a vaccine 
strategy include the personal benefit to HCWs of a decreased risk of influenza and less 
disruption of services through staff absences. Burls et al. and Demicheli et al. reviewed 
the literature and observed reductions of influenza-like illness in vaccinated HCWs 
ranging from 68% to 90% with about 40% fewer days of absence. 7·8 Since uptake among 
HCWs remains low, more information is needed about barriers to HCWs' uptake of 
influenza vaccine. So far, research that has already been performed among HCWs in 
hospitals shows that there are a number of different determinants responsible for low 
vaccine uptake. To our knowledge these studies are less comprehensive than the study 
reported here. Several studies did not use sufficient determinants in all relevant fields. 
For example, neither Walker et al. nor Maltezou et al. investigated behavioural 
determinants.9• 1 0  Also, there are studies that have only investigated the primary reason 
for refusing or accepting influenza vaccination.11 The purpose of this study is to identify 
the factors which determine influenza vaccine uptake among hospital-based HCWs 
which may help to plan future influenza vaccination campaigns. 
METHODS 
Study population 
In November and December 2008, all eight University Medical Centers (UMCs) in the 
Netherlands took part in a questionnaire study. Four or five wards per hospital were 
selected to participate. The selected wards included patients at medium and high risk for 
influenza including intensive care units, internal medicine, neonatology and paediatric 
wards. Self-administered paper questionnaires were distributed on these wards among 
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all HCWs (mainly physicians, nurses, and nursing assistants) in November - December 
2008. 
Outcome measure 
The primary outcome measure was self-reported compliance with influenza vaccination 
prior to the influenza season 2008/2009. The question to divide study subjects into 
compliant or not was the following: 'Did you receive influenza vaccination this year 
(2008)?' The possible answers were: 'No', 'No, but I still intend to' or 'Yes'. Those who 
responded positive were regarded as compliant with influenza vaccination; those who 
responded negative were regarded non-compliant. Since it is impossible to predict how 
many of the 'No, but I still intend to' respondents actually would have taken the vaccine, 
those HCWs (N = 42, 3 .2%) were excluded from the final analysis. 
Determinants of influenza vaccination compliance 
An anonymous, self-administered, 52-item paper questionnaire was used to assess 
determinants of influenza vaccination compliance. This questionnaire was based on a 
review of the literature and a questionnaire previously developed by our research group 
to determine the factors influencing influenza vaccination compliance among HCWs in 
care homes. 12 The aim was to assess demographic, behavioural and organizational 
determinants. 
Determinants 
Demographical determinants included sex, age and the presence of a chronic illness for 
which influenza vaccination is indicated . Also, the profession, number of years working in 
health care, type of shift working, type of ward and occurrence of an influenza outbreak 
in the last three years were assessed (Table 1 and Table 2). The Health Belief Model 
contains five domains: perceived susceptibility, perceived severity, perceived benefits, 
perceived barriers and cues to action, and 25 questions focused on these domains.13 
The Behavioural Intention Model comprises two more domains: attitude and social 
influences. A further 1 2  questions were posed to assess these domains. 14 The ASE 
Model adds self-efficacy to attitude and social influences. 15 Four questions addressing 
self-efficacy were included in the questionnaire. Respondents were asked to answer 
most propositions on a five-point Likert scale ranging from 'strongly agree' to 'strongly 
disagree'. Organizational determinants were assessed by six questions. The current 
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situation concerning available information about influenza vaccination and the 
organization around the administration of influenza vaccination were studied. The 
respondents were asked if the information provided was sufficient and if the organization 
of the administration of influenza vaccination was adequate. 
Table 1 Baseline characteristics of study and target population 
Characteristic Study subjects Target populations 
Personal data 
Male gender 1 9.2% 1 9.4% 
Mean age (years) 40.4 40.7 
Profession 
Physician 1 54 ( 1 2 . 1 %) ( 1 0.8%) 
a Based on statistics from the medical officers of the participating hospitals. 
Statistical analysis 
Data were analysed using SPSS (Version 14 .0 ;  SPSS, Inc., Chicago, IL, USA). 
Questions on the five-point Likert scale were dichotomized [agree (number 1 -2 of the 
scale) versus uncertain and disagree (number 3-5 of the scale)] in agreement with 
previous studies. Because clustering effects at a hospital level could have been been 
present, we performed Generalized Estimation Equation analysis with the UMCs as the 
clustering variable to obtain odds ratios and 95% confidence intervals (Cls). The area 
under the receiver operating characteristic (ROC) curve (AUC) was estimated after 







by Van Houwelingen et al. where df is based on the number of candidate variables 
(df = 65).16 The ROC indicates how well the prediction model is able to discriminate 
between those who did not take the vaccine versus those who took the vaccine. An ROC 
area of 0.5 indicates no discrimination (or tossing of a coin) and an area of 1 .0 indicates 
perfect discrimination. 
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T a b l e  2  U n i v a r i a t e  a n a l y s i s :  d e m o g r a p h i c  d e t e r m i n a n t s  a s s o c i a t e d  w i t h  i n f l u e n z a  v a c c i n a t i o n  c o m p l i a n c e  a m o n g  h e a l t h  c a r e  w o r k e r s  
D e t e r m i n a n t s  V a c c i n a t e d  ( n = 4 6 6 )  
U n v a c c i n a t e d  ( n  =  7 7 2 )  O d d s  r a t i o  ( 9 5 %  C l )  
D e m o g r a p h i c  
M a l e  g e n d e r  
3 4 3 / 4 6 5  ( 7 3 . 8 % )  6 4 8 / 7 5 9  ( 8 5 . 4 % )  2 . 0 8  ( 1 . 5 6 - 2 . 7 7 )  
A g e  >  4 0  y e a r s  
2 9 5 / 4 5 7  ( 6 4 . 6 % )  3 6 8 / 7 4 8  ( 4 9 . 2 % )  1 . 8 8  ( 1 . 4 8 - 2 . 3 9 )  
C h r o n i c  i l l n e s s  
6 0 / 4 6 4  ( 1 2 . 9 % )  1 0 0 / 7 7 2  ( 1 3 . 9 % )  3 . 9 4  ( 2 . 7 7 - 5 . 5 9 )  
P r o fe s s i o n a l  d a t a  
W o r k i n g  > 2 0  y e a r s  i n  h e a l t h  c a r e  2 5 5 / 4 5 9  ( 5 5 . 6 % )  3 3 6 / 7 5 1  ( 4 4 . 7 % )  1 . 5 4  ( 1 . 2 2 - 1 . 9 5 )  
W o r k i n g  n o  e v e n i n g  o r  n i g h t  s h i f t s  1 7 1 / 4 6 6  ( 3 6 . 7 % )  1 6 2 / 7 7 2  ( 2 1 . 0 % )  2 . 1 8  ( 1 . 6 9 - 2 . 8 2 )  
I n f l u e n z a  o u t b r e a k  i n  l a s t  t h r e e  y e a r s  7 0 / 4 6 2  ( 1 5 . 2 % )  
6 5 / 7 6 9  ( 8 . 5 % )  1 . 9 3  ( 1 . 3 5 - 2 . 7 7 )  
P ro fe s s i o n  
N u r s i n g  a s s i s t a n t  v s .  n u r s e  
3 5 / 2 9 5  ( 1 1 . 9 % )  1 4 / 6 3 1  ( 2 . 2 % )  5 . 9 3  ( 3 . 1 4 - 1 1 . 2 1 )  
P h y s i c i a n  v s .  n u r s e  9 7 / 3 5 7  ( 2 7 . 2 % )  
4 2 / 6 5 9  ( 6 . 4 % )  5 . 4 8  ( 3 .  7 1 - 8 . 1 0 )  
Ty p e  o f  w a r d  
I n t e r n a l  m e d i c i n e  v s  I C U  1 2 9 / 2 9 3  ( 4 4 . 0 % )  1 7 0 / 4 9 1  ( 3 4 . 6 % )  1 . 4 9  ( 1 . 1 0 - 2 . 0 0 )  
N e o n a t o l o g y  v s  I C U  
7 0 / 2 3 4  ( 2 9 . 9 % )  
1 0 6 / 4 2 7  ( 2 4 . 8 % )  1 . 2 9  ( 0 . 9 1 - 1 . 8 5 )  
P a e d i a t r i c s  v s  I C U  
7 3 / 2 3 7  ( 3 0 . 8 % )  8 9 / 4 1 0  ( 2 1 . 7 % )  1 . 6 1  ( 1 . 1 2 - 2 . 3 1 )  
C l ,  c o n f i d e n c e  i n t e r v a l ;  I C U ,  i n t e n s i v e  c a r e  u n i t ;  N S ,  n o n - s i g n i f i c a n t  
P - v a l u e  
< 0 . 0 0 1  
< 0 . 0 0 1  
N S  
< 0 . 0 0 1  
< 0 . 0 0 1  
< 0 . 0 0 1  
< 0 . 0 0 1  
< 0 . 0 0 1  
0 . 0 1 0  
N S  
0 . 0 1 1  
RESULTS 
Study population 
The response rate was 39% (1295/3324 distributed questionnaires). The mean age of 
respondents was 40.4 years (range 19-69 years; SD: 10.7) and 80.8% were female 
(Table 1). In all Dutch hospitals in 2005, the mean age of HCWs was 40.7 years and 
80.6% were female. Profession was distributed as 12. 1 % physicians, 71.5% nurses and 
4.1 % nursing assistants. 
Outcome measure 
Of all respondents, 37.6% (N = 466) were vaccinated against influenza. Influenza uptake 
was 69.8% among physicians, 29.6% among nurses and 71 .4% among nursing 
assistants. In the preceding 2007-2008 influenza season 29.2% of respondents 
(N = 370) received influenza vaccination (respectively 47.4%, 23.6% and 59.6%). 
Determinants univariately associated with influenza vaccination uptake 
Nearly all demographic determinants were univariately associated with influenza vaccine 
uptake (Table 2). In the domain 'perceived susceptibility' the determinant that most 
strongly predicted vaccine uptake was 'awareness of risk to infect patients' (Table 4 ). 
Concerning 'perceived severity', the danger to patients was the most strongly associated 
determinant. Reduction of work pressure was appreciated as an important benefit of 
influenza vaccination. In the domain 'perceived barriers', 'vaccination is useful despite 
the constant flow of visitors' was important. Among the cues to action 'having knowledge 
of the content of the advice of the Dutch Health Council' was most important. 
Furthermore, 'ensuring continuity of care and all HCWs should get vaccinated' were 
attitudes univariately associated with vaccine uptake. The head of department and the 
people surrounding the HCW also influence uptake. Respondents reported that they 
would definitely get influenza vaccination if it was available at a convenient time, if it 
could be administered on their own ward, if they would be rewarded, and if they would 
get a reminder (Table 3). Available information, especially from the internet, from the 
medical officer and sufficient information were all univariately associated with vaccine 
uptake. Finally, flexible day and time of execution were important in vaccine uptake. 
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T a b l e  3  U n i v a r i a t e  a n a l y s i s :  o r g a n i z a t i o n a l  d e t e r m i n a n t s  a s s o c i a t e d  w i t h  i n f l u e n z a  v a c c i n a t i o n  c o m p l i a n c e  a m o n g  h e a l t h  c a r e  w o r k e r s  
.;,.  
D e t e r m i n a n t s  
V a c c i n a t e d  ( n
=
4 6 6 )  
U n v a c c i n a t e d  ( n
=
7 7 2 )  O d d s  r a t i o  ( 9 5 %  C l )  
P - v a l u e  
I n fo r m a t i o n  
I n f o r m a t i o n  r e c e i v e d  
4 3 6 / 4 6 4  ( 9 4 . 0 % )  
6 9 3 / 7 7 1  ( 8 9 . 9 % )  1 . 7 5  ( 1 . 1 2 - 2 . 7 4 )  0 . 0 1 5  
I n f o r m a t i o n  r e c e i v e d  . . . .  
- b y  p o s t e r / l e a f l e t  
2 5 4 / 4 6 4  ( 5 4 . 7 % )  
3 8 6 / 7 7 1  ( 5 0 . 1  % )  1 . 2 1  ( 0 . 9 6 - 1 . 5 2 )  N S  
- b y  l e t t e r  
2 1 0 / 4 6 4  ( 4 5 . 3 % )  3 6 3 / 7 7 1  ( 4 7 . 1 % )  0 . 9 3  ( 0 . 7 4 - 1 . 1 7 )  N S  
- t h r o u g h  a n  i n f o r m a t i o n  m e e t i n g  5 / 4 6 4  ( 1 . 1  % )  1 0 / 7 7 1  ( 1 . 3 % )  0 . 8 3  ( 0 . 2 8 - 2 . 4 4 )  N S  
- t h r o u g h  t h e  m e d i a  
5 3 / 4 6 4  ( 1 1 . 4 % )  1 1 9 / 7 7 1  ( 1 5 . 4 % )  0 . 7 1  ( 0 . 5 0 - 1 . 0 0 )  N S  
- b y  i n t e r n e t  
9 9 / 4 6 4  ( 2 1 . 3 % )  
1 2 8 / 7 7 1  ( 1 6 . 6 % )  1 . 3 6  ( 1 . 0 2 - 1 . 8 3 )  
0 . 0 4 1  
- f r o m  t h e  c l i n i c a l  o f f i c e r  4 9 / 4 6 4  ( 1 0 . 6 % )  4 3 / 7 7 1  ( 5 . 6 % )  2 . 0 0  ( 1 . 3 0 - 3 . 0 6 )  0 . 0 0 2  
R e c e i v e d  i n f o r m a t i o n  i s  s u f f i c i e n t  
4 0 6 / 4 5 5  ( 8 9 . 2 % )  5 6 0 / 7 2 5  ( 7 7 . 2 % )  2 . 4 4  ( 1 . 7 3 - 3 . 4 4 )  
< 0 . 0 0 1  
I m p o r t a n t  t o  r e c e i v e  i n fo r m a t i o n  b y  p o s t e r / l e a f l e t  
3 3 5 / 4 4 4  ( 7 5 . 5 % )  
3 5 0 / 7 2 8  ( 4 8 . 1  % )  3 . 3 2  ( 2 . 5 6 - 4 . 3 1 )  < 0 . 0 0 1  
I m p o r t a n t  t o  r e c e i v e  i n f o r m a t i o n  b y  l e t t e r  
3 8 9 / 4 5 3  ( 8 5 . 9 % )  4 5 8 / 7 3 4  ( 6 2 . 4 % )  3 . 6 6  ( 2 . 7 0 - 4 . 9 6 )  < 0 . 0 0 1  
I m p o r t a n t  t o  r e c e i v e  i n f o r m a t i o n  t h r o u g h  a n  i n f o r m a t i o n  m e e t i n g  
4 9 / 4 1 2  ( 1 2 . 3 % )  
8 8 / 7 0 2  ( 1 2 . 5 % )  0 . 9 4  ( 0 . 6 5 - 1 . 3 7 )  
N S  
I m p o r t a n t  t o  r e c e i v e  i n fo r m a t i o n  f r o m  t h e  c l i n i c a l  o f f i c e r  
1 3 6 / 4 4 2  ( 3 2 . 2 % )  
1 4 1 / 7 0 1  ( 2 0 . 1 % )  1 . 8 9  ( 1 . 4 3 - 2 . 4 9 )  < 0 . 0 0 1  
I m p o r t a n t  t o  r e c e i v e  i n fo r m a t i o n  b y  i n t e r n e t  
2 1 5 / 4 2 4  ( 5 0 .  7 % )  
2 4 8 / 7 0 7  ( 3 5 . 1  % )  
1 . 9 0  ( 1 . 4 9 - 2 . 4 3 )  < 0 . 0 0 1  
I m p o r t a n t  t o  r e c e i v e  i n f o r m a t i o n  t h r o u g h  t h e  m e d i a  
1 8 2 / 4 2 5  ( 4 2 . 8 % )  
1 9 9 / 7 1 0  ( 2 8 . 0 % )  1 . 9 2  ( 1 . 4 9 - 2 . 4 8 )  < 0 . 0 0 1  
E x e c u t i o n  
E x e c u t i o n  o f  v a c c i n a t i o n  i s  o r g a n i s e d  4 5 8 / 4 6 1  ( 9 9 . 3 % )  
7 4 2 / 7 4 7  ( 9 9 . 3 % )  1 . 0 3  ( 0 . 2 5 - 4 . 3 3 )  
N S  
E x e c u t i o n  o f  v a c c i n a t i o n  i s  o r g a n i s e d  
- a t  a  f i x e d  d a y  a n d  t i m e  
7 3 / 4 6 1  ( 1 5 . 8 % )  1 2 9 / 7 4 7  ( 1 7 . 3 % )  0 . 9 0  ( 0 . 6 6 - 1 . 2 3 )  N S  
- a t  a  f i x e d  d a y ,  b u t  a t  a  f l e x i b l e  t i m e  
1 7 / 4 6 1  ( 3 . 7 % )  5 7 / 7 4 7  ( 7 . 6 % )  0 . 4 6  ( 0 . 2 7 - 0 . 8 1 )  0 . 0 0 6  
- a t  a  f l e x i b l e  d a y  a n d  t i m e  
3 2 0 / 4 6 1  ( 6 9 . 4 % )  3 7 8 / 7 4 7  ( 5 0 . 6 % )  2 . 2 2  ( 1 . 7 4 - 2 . 8 3 )  
< 0 . 0 0 1  
E x e c u t i o n  i s  a t  a n  a d e q u a t e  n u m b e r  o f  m o m e n t s  
4 1 2 / 4 5 9  ( 8 9 . 8 % )  6 2 0 / 7 1 6  ( 8 6 . 6 % )  1 . 3 6  ( 0 . 9 4 - 1 . 9 7 )  
N S  
C l ,  c o n f i d e n c e  i n t e r v a l ;  N S ,  n o n - s i g n i f i c a n t .  
Table 4 Univariate analysis: behavioural determinants associated with influenza vaccination compliance among health care workers (HCWs) 
Determinants Vaccinated (n=466) Unvaccinated (n=772) Odds ratio (95% Cl) P-value 
Perceived susceptibility 
High personal risk for influenza infection 1 59/466 (34.1 %) 55n72 (7. 1 %) 6.75 (4.83-9.43) <0.001 
Aware of risk to infect patients 400/466 (85.8%) 346/771 (44.9%) 7.44 (5.53-1 0.01 ) <0.001 
During an epidemic HCWs are more likely to get influenza infection 387/463 (83.6%) 503n62 (66.0%) 2.62 (1 .97-3.50) <0.001 
Perceived severity 
Influenza is dangerous for me 201/465 (43.2%) 1 40/772 (1 8 . 1  %) 3.44 (2.65-4.45) <0.001 
I nfluenza is dangerous for my patients 465/466 (99.8%) 23n10 (2.9%) 1 4.32 (1 .93-1 06.37) <0.001 
Perceived benefits 
Vaccination reduces the personal risk of influenza 1 1 8/464 (25.4%) 94n65 (1 2 .3%) 2.43 ( 1 .80-3.29) <0.001 
Vaccination reduces the risk to infect patients 81 /464 (1 7.5%) 24n64 (3. 1  %) 6.52 (4.07- 10.45) <0.001 
Vaccination reduces the risk to infect family members 84/463 (1 8 . 1 %) 27/766 (3.5%) 6.07 (3.86-9.52) <0.001 
Vaccination can reduce work pressure 405/463 (87.5%) 286/764 (37.4%) 1 1 .67 (8.55-1 5.94) <0.001 
Perceived barriers 
Vaccination is useful despite the constant flow of visitors 31 4/463 (67.8%) 1 52/767 (1 9.8%) 8.53 (6.55-1 1 . 1 0) <0.001 
Not against vaccination in general 450/462 (97.4%) 71 6/766 (93.5%) 2.62 (1 .38-4.97) 0.002 
Vaccination is not only offered to reduce costs 368/463 (79.5%) 509n68 (66.3%) 1 .97 (1 .50-2.58) <0.001 
Vaccination is not only offered to reduce sick leave 352/463 (76.0%) 481 /767 (62.7%) 1 .89 (1 .46-2.44) <0.001 
Experienced side-effects in the past 61 /459 ( 1 3.3%) 64n55 (8.5%) 1 .66 (1 . 1 4-2.40) 0.009 
Side-effects in the past are no reason for not getting vaccinated this 279/454 (61 .5%) 1 03/751 ( 1 3.7%) 1 0.03 (7.57-1 3.28) <0.001 
year 
Expecting no side-effects after vaccination 256/463 (55.3%) 304/764 (39.8%) 1 .87 (1 .48-2.36) <0.001 
Expecting no allergic reactions or autoimmune disease after 436/461 (94.6%) 697/765 (91 . 1  %) 1 .  70 (1 .06-2. 73) 0.026 
vaccination 
O'I  
A f t e r  g e t t i n g  v a c c i n a t e d  o n c e  y o u  d o  n o t  h a v e  t o  g e t  v a c c i n a t e d  4 2 2 / 4 6 3  ( 9 1 . 1  % )  6 9 9 / 7 6 5  ( 9 1 . 4 )  
0 . 9 7  ( 0 . 6 5 - 1 . 4 6 )  N S  
O'I  
e v e r y  y e a r  
V a c c i n a t i o n s  d o  n o t  r e d u c e  r e s i s t a n c e  3 4 7 / 3 4 7  ( 1 0 0 . 0 % )  
5 3 2 / 5 3 2  ( 1 0 0 . 0 % )  
V a c c i n a t i o n  d o  n o t  c a u s e  i n fl u e n z a  i n f e c t i o n  3 9 2 / 3 9 2  ( 1 0 0 . 0 % )  6 0 9 / 6 0 9  ( 1 0 0 . 0 % )  
V a c c i n a t i o n  i s  n e c e s s a r y ,  e v e n  t h o u g h  p a t i e n t s  a r e  p r o t e c t e d  b y  t h e i r  4 5 0 / 4 6 0  ( 9 7 . 8 % )  7 0 3 / 7 5 0  ( 9 3 . 7 % )  3 . 0 1  ( 1 . 5 1 - 6 . 0 2 )  
0 . 0 0 1  
o w n  v a c c i n a t i o n  a l r e a d y  
C u e s  t o  a c t i o n  
K n o w i n g  t h e r e  i s  a n  a d v i c e  f r o m  t h e  D u t c h  H e a l t h  C o u n c i l  3 0 1 / 4 6 5  ( 6 4 . 7 % )  
4 6 6 / 7 6 8  ( 6 0 . 7 % )  1 . 1 9  ( 0 . 9 4 - 1 . 5 1 )  
N S  
H a v i n g  k n o w l e d g e  o n  t h e  c o n t e n t s  o f  t h i s  a d v i c e  3 1 2 / 4 6 5  ( 6 7 . 1 % )  4 3 3 / 7 7 0  ( 5 6 . 2 % )  1 . 5 9  ( 1 . 2 5 - 2 . 0 2 )  
< 0 . 0 0 1  
A t t i t u d e s  
F i n d i n g  i t  i m p o r t a n t  t h a t  H C W s  d o  n o t  i n f e c t  p a t i e n t s  4 4 1 / 4 6 4  ( 9 5 . 0 % )  5 8 8 / 7 6 0  ( 7 7 . 4 % )  
5 . 6 1  ( 3 . 5 7 - 8 . 8 2 )  
< 0 . 0 0 1  
H C W s  s h o u l d  g e t  v a c c i n a t e d  t o  e n s u r e  c o n t i n u i t y  o f  c a r e  2 8 0 / 4 6 2  ( 6 0 . 6 % )  6 3 / 7 6 5  ( 8 . 2 % )  
1 7 . 1 4  ( 1 2 . 4 7 - 2 3 . 5 7 )  
< 0 . 0 0 1  
A l l  H C W s  s h o u l d  g e t  v a c c i n a t i o n  4 0 7 / 4 6 3  ( 8 7 . 9 % )  2 6 5 / 7 6 6  ( 3 4 . 6 % )  
1 3 . 7 4  ( 1 0 . 0 1 - 1 8 . 8 6 )  < 0 . 0 0 1  
N o t  f i n d i n g  i t  i m p o r t a n t  t h a t  H C W s  h a v e  f r e e d o m  o f  c h o i c e  
6 0 / 4 6 4  ( 1 2 . 9 % )  3 1 / 7 6 4  ( 4 . 1  % )  
3 . 5 1  ( 2 . 2 4 - 5 . 5 1 )  
< 0 . 0 0 1  
c o n c e r n i n g  i n f l u e n z a  v a c c i n a t i o n  
I n  c a s e  o f  i n f l u e n z a  o u t b r e a k  u n v a c c i n a t e d  H C W s  s h o u l d  b e  b a n n e d  
9 6 / 4 6 3  ( 2 0 . 7 % )  1 4 7 / 7 6 4  ( 1 9 . 2 % )  1 . 1 0  ( 0 . 8 2 - 1 . 4 6 )  
N S  
f r o m  w o r k  
I n  c a s e  o f  i n f l u e n z a  o u t b r e a k  u n v a c c i n a t e d  H C W s  s h o u l d  b e  b a n n e d  5 9 / 4 6 2  ( 1 2 . 8 % )  2 5 / 7 5 9  ( 3 . 3 % )  
4 . 3 0  ( 2 . 6 5 - 6 . 9 7 )  
< 0 . 0 0 1  
f r o m  w o r k  w i t h o u t  p a y m e n t  
H C W s  s h o u l d  g e t  v a c c i n a t i o n  b e c a u s e  o f  t h e i r  d u t y  n o t  t o  h a r m  3 8 9 / 4 6 2  ( 8 4 . 2 % )  2 6 2 / 7 6 1  ( 3 4 . 4 % )  
1 0 . 1 5  ( 7 . 5 8 - 1 3 . 5 8 )  < 0 . 0 0 1  
I n f l u e n z a  v a c c i n a t i o n  s h o u l d  b e c o m e  m a n d a t o r y  f o r  H C W s  i n  2 2 9 / 4 6 2  ( 4 9 . 6 % )  1 1 6 / 7 6 4  ( 1 5 . 2 % )  
5 . 4 9  (  4 . 2 0 - 7  . 1 8 )  
< 0 . 0 0 1  
h o s p i t a l s  
S o c i a l  i n fl u e n c e s  
P e o p l e  c l o s e  t o  m e  t h i n k  i t  i s  i m p o r t a n t  f o r  m e  t o  g e t  v a c c i n a t i o n  
2 6 3 / 4 6 1  ( 5 7 . 0 % )  1 3 7 / 7 6 5  ( 1 7 . 9 % )  
6 . 0 9  ( 4 . 6 9 - 7 . 9 1 )  
< 0 . 0 0 1  
M y  c o l l e a g u e s  t h i n k  i t  i s  i m p o r t a n t  fo r  m e  t o  g e t  v a c c i n a t i o n  2 7 2 / 4 6 3  ( 5 8 . 7 % )  
1 9 5 / 7 6 5  ( 2 5 . 5 % )  
4 . 1 6  ( 3 . 2 5 - 5 . 3 3 )  
< 0 . 0 0 1  
T h e  c h i e f  o f  d e p a r t m e n t  s h o u l d  r e c o m m e n d  v a c c i n a t i o n  
3 5 9 / 4 6 3  ( 7 7 . 5 % )  2 6 1 / 7 6 6  ( 3 4 . 1  % )  6 . 6 8  ( 5 . 1 3 - 8 .  7 0 )  
< 0 . 0 0 1  
F i n d i n g  i t  i m p o r t a n t  t o  d o  w h a t  p e o p l e  c l o s e  t o  m e  t h i n k  
3 1 6 / 4 6 3  ( 6 8 . 3 % )  3 3 0 / 7 6 3  ( 4 3 . 3 % )  
2 . 8 2  ( 2 . 2 1 - 3 . 6 0 )  




I would definitely get influenza vaccination, if . . .  
- I t  would be at convenient time 
- I could get it on my own ward 
- It would be rewarded 
- I would get a reminder 
425/443 (95.9%) 
4 1 1 /442 (93.0%) 
259/433 (59.8%) 
357/441 (81 .0%) 
Cl, confidence interval; NS, non-significant; a Odds ratios cannot be estimated. 
1 79/751 (23.8%) 
1 97/748 (26.3%) 
1 34/745 ( 1 8 .0%) 
1 42/751 ( 1 8.9%) 
75.45 (45.73-1 24.47) 
37.08 (24.87-55.30) 
6.79 (5. 1 9-8.87) 





Determinants multivariately associated with influenza vaccination uptake 
The multivariate analysis resulted in an 1 1 -item final prediction model with two 
demographic and nine behavioural determinants (Table 5). Age >40 years, the presence 
of a chronic illness, awareness of personal risk and awareness of risk of infecting 
patients, trust in the effectiveness of the vaccine to reduce the risk of infecting patients, 
the HCWs' duty to do no harm and their duty to ensure continuity of care, finding 
vaccination useful despite the constant flow of visitors and having knowledge of the 
Health Council's advice, social influence and convenient time for vaccination were all 
independently associated with vaccine uptake. The ROC AUC corrected for 
overoptimism for the final model (Cheur = 892 - 65/892 = 0.92) including all 11 
determinants was 0.95 (95% Cl: 0.94-0.96). When only demographic factors were 
included in the model, the AUC was 0.63 (0.60-0.67). Adding behavioural determinants 
lifted the AUC to 0.95 (0.94-0.96). 
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Table 5 Multivariate logistic regression analysis: determinants associated with influenza vaccination compliance in hospital-based health care workers 
(HCWs) (n = 1 1 20) 
Determinants 
Demographic 
Age > 40 years 
Chronic i llness 
Behavioural 
Aware of personal risk for influenza infection 
Aware of risk of infecting patients 
Vaccination reduces risk of infecting patients 
Vaccination is useful despite the constant flow of visitors 
Having knowledge on the contents of the Health Council's advice 
HCWs should get vaccinated to ensure continuity of care 
HCWs should get vaccinated because of their duty not to harm 
People around me think it is important for me to get vaccination 
I would definitely get influenza vaccination if it would be at a 
convenient time 
Cl, confidence interval. 
0\ 
\0 
Vaccinated (n= 431 ) 
273/431 (63.3%) 
93/431 (21 .6%) 
1 41 /431 (32.7%) 
369/431 (85.6%) 




361 /431 (83.8%) 
248/431 (57.5%) 
41 3/431 (95.8%) 
Unvaccinated (n= 714) Odds ratio (95% Cl) P-value 
344/71 4  (48.2%) 2.65 ( 1 . 76-4.00) <0.001 
49/7 1 4  (6 .9%) 3 .37 ( 1 .82-6.22) <0.001 
47/71 4  (6.6%) 2.80 ( 1 .62-4.84) <0.001 
323/71 4  (45.2%) 2.54 ( 1 .59-4.05) <0.001 
22/7 1 4  (3. 1 %) 3.68 ( 1 .71 -7.93) 0.001 
1 43/7 1 4  (20.0%) 1 .88 ( 1 .24-2.84) 0.003 
398/71 4  (55.7%) 2.41 ( 1 .58-3.69) <0.001 
60/7 14  (8.4%) 2 . 1 5 ( 1 .37-3.39) 0 .001 
246/714  (34.5%) 2.22 ( 1 .41 -3.50) 0.001 
1 30/7 1 4  ( 1 8 .2%) 1 .74 ( 1 . 1 4-2.65) 0 .0 1 0  
1 74/7 14  (24.4%) 28.9 1  ( 1 5.90-52.58) <0.001 
DISCUSSION 
This questionnaire study suggested that a multivariate model containing a combination 
of two demographic and nine behavioural determinants was accurate in the prediction of 
influenza vaccine uptake among HCWs in Dutch hospitals. These determinants can be 
used to develop effective implementation programs in health care settings and may be of 
use in the planning for immunisation during a pandemic. 
This study has several strengths. First, an extensive questionnaire based on a 
literature search was used. This questionnaire addressed demographic, behavioural, 
organizational and self-efficacy determinants, making it very unlikely to have missed 
predictors of influenza vaccination. Second, this is one of few studies using multivariate 
analysis to assess the independent value of the determinants. Third, this is one of the 
first studies on this subject conducted in hospitals rather than long term care homes. 
There are several differences between hospitals and care homes, for example, hospitals 
tend to be larger, making their organization a lot more complicated, and the average 
level of education of employees is more diverse. Fourth, a relatively large number of 
HCWs was included, contributing to the study's power. Fifth, the determinants were 
largely in accordance with findings from previous studies. 11 · 12 ·1 7-2° For example, as in our 
study, Quigley and Hayes also observed increasing vaccine uptake with age and 
reductions of uptake when respondents perceived the vaccine as ineffective. 19 
Potential limitations of this study are the response rate and the possibility of 
response bias. The response rate was 39% which is within the expected range, and 
mean age and sex were similar for all HCWs of the UMCs. Also, in these study 
departments, physicians and nurses are relatively overrepresented as compared with 
total hospital personnel. Since most determinants confirm other studies, we believe that 
the developed model is representative for the HCW population. 
How can these determinants be used to develop an intervention programme? 
The process of intervention design can be divided into six steps: (1 ) a needs 
assessment, (2) specification of proximal programme objectives, (3 ) selection of theory­
based methods and practical strategies for inducing change, (4) planning the 
programme, (5) planning of programme adoption and implementation, and (6) planning 
for evaluation. The data from this study are part of the needs assessment and may be 
used to specify the programme objectives. For example, sex and presence of illness are 
associated with uptake, but cannot be changed. However, these determinants might be 
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of use to define specific subgroups for the intervention. Perceived risk and potential 
reduction by vaccination can be changed by effective educational methods that focus on 
increasing knowledge such as information leaflets, websites, group presentations and 
videos with role models. Ethical issues such as 'do no harm' need to be targeted with 
more intensive activities such as small group discussions and role models in health care 
management. Social influence also requires a more comprehensive approach including 
discussions at department level and discussion evoking items such as buttons indicating 
that personnel took the vaccine. Finally, logistics need to be worked out to reduce efforts 
to get the vaccine such as the introduction of mobile carts for the distribution of vaccine. 
Due to the disappointing vaccination rates so far, the ethics of mandatory 
vaccination for HCWs are being explored. Arguments in favour of this measure are the 
professional responsibility of HCWs and their duty to do no harm. An important counter­
argument is the personal autonomy of HCWs. While this debate continues, research 
should continue to identify interventions to optimise vaccine uptake. In conclusion, an 
influenza vaccination implementation programme targeting the determinants identified in 
this study may be effective in increasing vaccine uptake. Further evidence for the impact 
of such a programme is needed. 
7 1  
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Background Influenza transmitted by health care workers (HCWs) is a potential threat 
to frail patients in acute health care settings. Therefore, immunizing HCWs against 
influenza should receive high priority. Despite recommendations of the World Health 
Organization, vaccine coverage of HCWs remains low in all European countries. This 
study explores the use of intervention strategies and methods to improve influenza 
vaccination rates among HCWs in an acute care setting. 
Methods The Intervention Mapping ( IM) method was used to systematically develop and 
implement an intervention strategy aimed at changing influenza vaccination behaviour 
among HCWs in Dutch University Medical Centers (UMCs). Carried out during the 
influenza seasons 2009/2010  and 201 0/20 1 1 ,  the interventions were then qualitatively 
and quantitatively evaluated by way of feedback from participating UMCs and the 
completion of a web-based staff questionnaire in the following spring of each season. 
Results The IM method resulted in the development of a transparent influenza 
vaccination intervention implementation strategy. The intervention strategy was offered 
to six Dutch UMCs in a clustered Randomized Controlled Trial (RCT), where three 
UMCs were randomized for intervention, and three UMCs acted as controls. A further 
two UMCs elected to have the intervention. The qualitative process evaluation showed 
that HCWs at four of the five intervention UMCs were responsive to the majority of the 
1 1  relevant behavioural determinants resulting from the needs assessment in their 
intervention strategy compared with only one of three control UMCs. The quantitative 
evaluation among a sample of HCWs revealed that of all the developed communication 
materials, HCWs reported the posters as the most noticeable. 
Conclusions Our study demonstrates that it is possible to develop a structure9 
implementation strategy for increasing the rate of influenza vaccination by HCWs in 
acute health care settings. The evaluation also showed that it is impossible to expose all 
HCWs to all intervention methods (which would have been the best case scenario). 
Further study is needed to (1 ) improve HCW exposure to intervention methods; (2) 
determine the effect of such interventions on vaccine uptake among HCWs; and (3 ) 




Influenza is an annual respiratory infection which has the capacity to cause severe 
morbidity and mortality, particularly among frail hospitalized patients. The influenza 
attack rate among health care workers (HCWs) can be considerable, 1 with studies 
showing that more than 75% continue to work after infection.2•3 As HCWs can transmit 
influenza to their patients, immunizing them against influenza is an extremely important 
measure to protect patients from the viral infection.4•5 Such vaccination has proven to be 
effective in preventing influenza infection among HCWs themselves since they are 
generally young and able to mount a more effective immune response when compared 
to frail patients.6 In a recent systematic review, Osterholm et al. found a significant 
pooled influenza vaccine efficacy with an estimated reduction in influenza of 59% among 
young adults.7 Whilst the number of available studies is limited, influenza vaccination 
has also been shown to reduce influenza-like illness-related absenteeism of HCWs,8 
which is essential to preserve continuity of care. Using a micro-simulation hospital 
department model, Van den Dool et al. demonstrated that, although no herd immunity 
can be achieved, there is an inverse linear relationship between the number of 
vaccinated HCWs and the number of infected hospital patients, meaning that each 
additional HCW who is immunized against influenza adds to the preventive effect.9 
These clinical trial studies demonstrating the effects of immunizing HCWs against 
influenza on patient outcomes were all conducted in long-term care facilities, 10 and it 
should be noted that acute care hospital settings are very different compared to long­
term care as they have a higher patient turnover, which hampers the applicability of 
findings from long-term care settings to acute care settings. 9 
Following guidelines set by the World Health Organization, the Dutch Health 
Council has (as of 2007) recommended influenza vaccination for HCWs in contact with 
high-risk patients in the Netherlands, but vaccine coverage of HCWs has been low. For 
example, in 2006 and 2008 in all eight Dutch University Medical Centers (UMCs) 
vaccination uptake among HCWs ranged from 0% to 28%, with an average uptake of 
1 3 %. Such low vaccine coverage appeared to be consistent with European figures 
reported in a study by Blank et al. , which showed low influenza vaccine coverage of 
HCWs in 11 European countries, with a maximum coverage of a low 26% in the Czech 
Republic.11 
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Using special interventions, it is possible to increase influenza vaccine coverage 
of HCWs in acute health care settings. In a before-after trial from Spain, Llupia et al. 
demonstrated an increase in vaccine coverage of HCWs from 23 % in 2007 /2008 to 3 7% 
in 2008/2009 by means of a promotional and educational strategy, 12 but they did not 
report a systematic method for developing their strategy. In the Netherlands, Looijmans­
van den Akker et al. developed a systematic program to increase vaccine uptake among 
HCWs in nursing homes. After the intervention, the influenza vaccine uptake in the 
intervention group was on average 9% higher than in the control group (p=0.02). 
However, it should be noted that the applicability of these findings to acute care settings 
is likely to be limited. 13 To extract the full value of an influenza vaccination strategy in 
hospitals, a theoretical framework that underpins the development of such a strategy is 
essential, especially for future applications. For the study reported in this paper, we have 
used the Intervention Mapping (IM) method to systematically plan, develop and evaluate 
the process of an influenza vaccination implementation strategy. 14 To the best of our 
knowledge, our study is the first report on the development of an implementation 
strategy that targets influenza vaccine uptake among HCWs in acute care settings which 
includes a process evaluation. The effects of the developed intervention program on 
actual behaviour, and the clinical outcomes, will be separately reported as part of a 
cluster randomized controlled trial. 
METHODS 
SETTING AND TRIAL DESIGN 
This report outlines the development of the intervention and process evaluation as part 
of an intervention trial conducted in the Netherlands during the seasons 2009/2010 and 
2010/2011 [trial number NCT01 481 467]. With the permission from the Board of 
Directors, and with permission from the Dutch Association of UMCs (Nederlandse 
Federatie van Universitair Medische Centra), all eight Dutch UMCs participated in the 
study. Six UMCs agreed to be randomized to receive either the intervention (3 UMCs) or 
act as controls (3 UMCs), and two UMCs chose to implement the developed intervention 
program (the 'external intervention UMCs'). Formal ethical approval to conduct the 
implementation trial, according to the Dutch Law of Research with Humans, was not 
required (Medical Ethical Committee, University Medical Center Groningen, Netherlands, 
No. 2009.267). The study was conducted in accordance with the Dutch Law for the 
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Protection of Personal Data (Wet Bescherming Persoonsgegevens), and the Declaration 
of Helsinki [http://www.wma.net/e/policy/b3 .htm]. 
The Intervention Mapping ( IM) method14 was used to develop, implement and 
evaluate the process of the intervention strategy for HCWs. The IM method is a 
framework for systematically developing health education interventions, and can be used 
as part of the dynamic process of planning intervention strategies in health education. 
The process of developing and evaluating an implementation strategy is composed of six 
steps: 1 )  a needs assessment; 2) establishment of proximal program objectives; 3 )  
development of theory-based methods and practical strategies; 4) program planning; 5) 
adoption and implementation of the program; and 6) program evaluation (see Figure 1 ). 
DEVELOPING THE PROGRAM ACCORDING TO THE IM METHOD 
Step one: Needs assessment 
To gain insight into how to improve the influenza vaccine coverage of HCWs, we first 
assessed the relevant determinants of influenza vaccination behaviour. In 2008, prior to 
the onset of the 2009 trial, a questionnaire-based study was performed among HCWs of 
five selected departments from the group of eight participating University Medical 
Centers (UMCs).15  Based on the Health Belief Model and the Behavioural Intention 
Model demographical, behavioural and organizational determinants were assessed.16•1 7  
Multivariate analysis of the responses resulted in an 11 -item prediction model, with two 
relevant demographic and nine behavioural determinants (the results of which are 
presented in Table 1 ). The final prediction model showed a high discriminative value 
(area under the receiver operating curve: 0.95), meaning that on the basis of the 
presence or absence of these determinants, vaccination behaviour of 95% of HCWs can 
be accurately predicted. 
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Table 1 Determinants associated with influenza vaccination uptake among health care workers 
(HCWs) resulting from the needs assessment 
Determinants Odds Ratio Changeability8 Category Target Groupb 
Demographic 
Age >40 years 2.65 Not applicable Not applicable 
Chronic illness 3.37 Not applicable Not applicable 
Behavioural 
Aware of personal risk for influenza infection 2.80 + Knowledge 2 
Aware of risk of infecting patients 2.54 + Knowledge 2 
'Vaccination reduces risk of infecting patients' 3 .68 + Knowledge 2 
'Vaccination is useful despite the constant flow 1 .88 + Knowledge 2 
of visitors' 
Aware of the contents of the Health Council's 2.41 + Knowledge 2 
Advice 
'HCWs0 should get vaccinated to ensure 2.1 5 + Common interest 3 
continuity of care' 
'HCWs should get vaccinated because of their 2.22 + Common interest 3 
duty to do no harm' 
'People around me think it is important for me 1 .74 +/- Social impact 3 
to get vaccinated' 
'I would definitively get vaccinated if it was 28.91 + Organizational 1 ,2,3 
available at a convenient time' 
a - : not changeable, + : changeable as discussed in our 1 0-person research team under supervision of 
a communication expert. 
b Target group 1 :  HCWs who deliberately comply with vaccination. 
Target group 2: HCWs who deliberately do not comply with vaccination. 
Target group 3: HCWs who unintentionally do not comply with vaccination. 
0 HCWs: health care workers. 
Step two: Proximal program objectives 
Each of the 11  determinants associated with influenza vaccination compliance were 
discussed by our 10-person research team (the principal researchers/authors of this 
study) in order to determine which behavioural determinants could reasonably be 
changed through an implementation strategy. Decisions were taken by consensus, using 
an independent facilitator with expertise in the area of influenza vaccination from the 
National Institute of Health and the Environment (Bilthoven, the Netherlands). For these 
discussions, the core research team of the ten principal researchers was expanded by 
inclusion of the UMC research contacts (physicians from the departments of 
Occupational Health and Environment, or from the departments of Microbiology) who 
were in charge of the planning and implementation of the annual influenza vaccination 
strategy in their hospitals. Based on the measures of association (odds ratios) obtained 
from the 2008 questionnaire study, 15 and in order to demonstrate the independent 
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relevance of the determinants for potential change in behaviour (Table 1 }, the discussion 
group divided the determinants into different categories so as to target the use of 
methods/materials. The following categories were identified: knowledge; common 
interest; social impact; and organizational (see Table 1 ). 
One of the critical assessments in developing an implementation strategy for 
changing behaviour is exploring whether the person's behaviour is intentional or not. The 
research team identified three different target groups among HCWs: (1 ) HCWs who 
deliberately choose to comply; (2) HCWs who deliberately choose not to comply; and (3 ) 
those HCWs who unintentionally do not comply with vaccination. The varying 
methods/materials are separated according to target groups in the IM matrix, but in best 
practice all three target groups were exposed to all developed methods in line with the 
proximal objectives (see Table 2). 
Table 2 Proximal program objectives and methods 
Determinants Proximal Program Objectives Methods/materials 
Demographic 
Age >40 years Not applicable due to limited - Not applicable 
changeability 
Chronic il lness Not applicable due to limited - Not applicable 
Behavioural 
Aware of personal 
risk for influenza 
infection 
Aware of risk of 
infecting patients 
changeability 
Create awareness among 
HCWsa of the risk to get 
infected with influenza and it's 
consequences 
Create awareness among 
HCWs of the risk to transmit 
influenza to patients and how 
vaccinating HCWs can prevent 
this 
'Vaccination reduces HCWs being convinced that 
risk of infecting vaccinating HCWs against 
patients' influenza will reduce the risk of 
transmission to patients 
'Vaccination is 
useful despite the 
constant flow of 
visitors' 
HCWs being convinced that 
vaccinating HCWs is useful 
despite the constant flow of 
visitors 
- Provide information on influenza, 
transmission and risks through an 
information stand at the UMC restaurants, 
a website, a folder and plenary meetings 
- Polls and a quiz on the intranet 
- Video testimonials with role models 
- Provide information on influenza and the 
risk of transmission to patients through an 
information stand at the UMC restaurants, 
a website, a folder and plenary meetings 
- Polls and a quiz on the intranet 
- Video testimonials with role models 
- Provide information on influenza and the 
effectiveness of vaccination through an 
information stand at the UMC restaurants, 
a website, a folder and plenary meetings 
- Polls and a quiz on the intranet 
- Video testimonials with role models 
- Provide information on influenza and the 
effectiveness of vaccination through an 
information stand at the UMC restaurants, 
a website, a folder and plenary meetings 
- Polls and a quiz on the intranet 
- Video testimonials with role models 
8 1  
Aware of the 
contents of the 
Health Council's 
Advice 
Create awareness among 
HCWs on the existence and 
contents of the guideline 
developed by the Dutch Health 
Council 
'HCWs should get HCWs understand the ethical 
vaccinated to ensure aspects of this matter and the 
continu ity of care' need to ensure continu ity of 
care 
- Provide and explain contents of the 
advice on the intranet or website 
- Explain and discuss in a plenary meeting 
- Explain and discuss ethical aspects 
(plenary meeting, website) 
- Video testimonials with role models 
- Involve Board of Directors (e.g .  first 
vaccination, be present at vaccination, 
column) 
- Distribute badges to vaccinated HCWs 
saying 'deliberately vaccinated for you' to 
start the discussion 
'HCWs should get HCWs understand the ethical - Explain and discuss ethical aspects 
vaccinated because aspects of vaccinating HCWs (plenary meeting, website) 
of their duty to do no and that this is part of their duty _ Video testimonials with role models 
harm' of care 
'People around me 
think it is important 
for me to get 
vaccinated' 
' I  would definitively 
get vaccinated if it 
was available at a 
convenient time' 
Create awareness of the 
importance of vaccination 
among those close to the 
HCWs 
Create a more convenient 
approach 
- Involve Board of Directors (e .g. first 
vaccination ,  be present at vaccination, 
column) 
- Distribute badges to vaccinated HCWs 
saying 'deliberately vaccinated for you' to 
start the discussion 
- Personal invitation letter with information 
folder and a link to the website at the 
home address 
- Poster with clear practical information on 
location and time 
- Personal invitation at home address with 
location and time 
- Extended vaccination hours which take 
changing shifts into account 
a HCWs: health care workers. 
Step three: Theory-based methods and practical strategies 
To influence the behaviour of a target group, a wide range of intervention 
methods/materials is required and these need be propagated through different channels 
and means. 14 Bartholomew et al., for example, provides theoretical methods for major 
behavioural determinants as well as for all higher environmental levels. 14 After reviewing 
the literature pertaining to vaccine studies2· 1 B-21 the research team agreed on the 
methods to be implemented. As no simple practical strategies or methods exist that 
guarantee success,22 we took the different target groups into account when developing 
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the tools. Examples of methods at the individual level included: participation in 
information meetings; consciousness raising by way of letters of invitation for 
vaccination; persuasive communication (such as a dedicated website with clear 
messages) ; interactive learning through 'frequently asked questions' or polls on a 
website; tailored to different target groups. HCWs who intentionally do not comply with 
influenza vaccination, need to be provided with clear information in order to eliminate 
any possible misconceptions or misunderstandings (e.g. on absence of vaccine effects 
or risk of serious adverse effects) so that they may change their views. In contrast, for 
HCWs who unintentionally remain unvaccinated it is more important to increase their 
awareness of their behaviour and its possible consequences. Testimonials from role 
models (e.g. members of the Board of Directors or Heads of Departments), where the 
reasons to comply with the vaccination program are provided, can play an important role 
in this awareness change. Thus, by actively promoting the vaccination campaign, and by 
demonstrating the importance of vaccination in a variety of ways, vaccine coverage of 
HCWs was expected to be improved. 
Step four: Program planning 
The topics and channels of the strategy methods were discussed individually by the lead 
investigator with members of the research team. After a number of meetings, consensus 
was reached in each UMC about the program methods to be used, and the best way to 
design and produce them. Common formats and sample materials were developed and 
pre-tested by the research team, which were subsequently adapted by the 
communication departments of the individual UMCs. A dedicated website, 
www.bewustgepriktvooru.nl (in Dutch), was developed by a web designer using the 
structure and contents produced by the research team. The Dutch Federation of UMCs 
(the NFU) and the Dutch association of nurses and nursing assistants (the V&VN) 
indicated their support by their approval for their logos to be displayed on the website. In 
order to stimulate discussion among HCWs, badges were developed with the tagline 
"bewust geprikt voor u" (Dutch for 'deliberately vaccinated for you'), to be handed out to 
HCWs after vaccination. The badges were designed by an external designer in two 
forms, one for HCWs working on regular wards, and a child-friendly badge for HCWs 
working on the paediatric ward (showing a hedgehog). In support of the intervention, the 
research team also provided written information about the relevance of influenza 
vaccination for HCWs and about the time and location of vaccination, for use on 
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individual hospital intranet websites and/or in folders and leaflets. To engage HCW staff 
in the project, a quiz was also developed that was made available on the project website. 
The effective exchange and availability of these developed materials to members of the 
research team, and the contact persons of the intervention UMCs was facilitated by 
making them accessible on a secured section of the project website. 
Step five: Adoption and implementation of the program 
To achieve the highest impact, the implementation of the developed strategy needed to 
be arranged in a programmatic and structured fashion. As a first step, the intervention 
UMC contacts and relevant communication staff were visited by the communication 
expert to explain and discuss the timelines and program of the implementation strategy 
before and during the vaccination campaign. For further assistance, all UMC contact 
persons were able to pose questions, or to initiate discussions on the secured section of 
the central project website. During the vaccination campaign members of the research 
team were also available for questions and advice. The team also developed news items 
for use by UMC communication officers to raise awareness among HCWs. In line with 
current practice, all intervention UMCs were free to choose the methods that were most 
appropriate to them. The three control U MCs were asked to carry out their own annual 
influenza vaccination program as planned, without putting more efforts into their strategy 
than normal, and without using any of the intervention program materials and/or 
strategies that were developed by the research team. 
Step six: Program evaluation 
Both a qualitative and quantitative process evaluation was carried out. Part of the 
qualitative process evaluation was conducted through the completion of set checklists by 
the contact person from each intervention UMC. In addition, annual communication 
reports on the influenza vaccination campaign were compiled by the communication 
offices of all UM Cs, providing summaries of the evaluation of the intervention program by 
the teams involved in the organization of the influenza vaccination program. In addition, 
UMC contacts were invited to comment on the methods/materials used in the 
intervention campaign. The checklists and reports were then reviewed for the number of 
behavioural determinants that the actual implementation strategy at each of the UMCs 
targeted. These are presented as a 'yes/no' per determinant (see Table 3 ). 
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Table 3 Evaluation of the use of behavioura l  determinants in 
implementers of the intervention UMCs (n is given) 
vaccination campaign by 
Determinants Intervention External 
Aware of personal risk for influenza infection 
Aware of risk of infecting patients 
'Vaccination reduces risk of infecting patients' 
'Vaccination is useful despite the constant flow of visitors' 
Aware of the contents of the Health Council's Advice 
'HCWsa should get vaccinated to ensure continuity of care' 
'HCWs should get vaccinated because of their duty to do no harm' 
'People around me think it is important for me to get vaccinated' 
' I  would definitively get vaccinated if it was available at a convenient time' 
a HCWs: health care workers. 
UMCs 






















To obtain more detailed quantitative information on the process variables, in both 
intervention and control UMCs, we developed a web-based questionnaire for HCWs of 
the five selected departments that were also involved in the 2008 questionnaire study by 
Hopman et al. (two intensive care units, internal medicine, paediatric ward and 
neonatology).15 An email invitation with a link to the web-based questionnaire was sent 
to the heads of the five departments after both influenza study seasons, requesting them 
to invite their HCW staff to complete the questionnaire. The study participants included 
nurses, physicians and support staff. The questionnaire assessed vaccination 
determinants as well as possible exposure to the developed materials, e.g. folders, 
posters, the website and testimonials, and how these were rated (e.g. 'have you noticed 
posters in your UMC'; 'did you like them'; rated on a 5-point Likert scale). 
RESULTS OF THE PROCESS EVALUATION 
Qualitative process evaluation in the intervention and control UMCs 
Table 3 shows the qualitative evaluation of the methods that were applied in both 
intervention and control UMCs. Though the intervention program focused on the specific 
determinants according to the study of Hopman et al, 15 the control UM Cs might 
independently also have focused their program on one or more of these determinants. 
With the exception of the determinants "Vaccination is useful despite the constant flow of 
visitors" and "People around me think it is important for me to get vaccinated", the 














with fewer by the control UMCs. Both intervention and control UMCs targeted the 
determinant "awareness of risk". 
From the communication reports derived from the intervention UMCs, it became 
evident that (1 ) longer opening hours for administration of the vaccine, (2) more 
vaccination locations, and (3 ) the use of mobile carts appeared to be associated with an 
increased vaccine uptake among HCWs. Providing information on influenza and 
vaccination by different means (intranet, posters, magazine and letters) was found to be 
very useful. Although there was not much difference in the level of involvement of the 
Boards of Directors of the intervention UMCs compared with the control UMCs, the self­
reported impression by the UMC evaluation teams was that such involvement led to 
positive intentions among HCWs. Two intervention UMCs organized plenary and 
interactive meetings for HCWs where information on influenza, the influenza vaccination 
and the determinants was provided, and where HCWs were given the opportunity to ask 
questions. In contrast, in the communication reports of the control UMCs it was stated 
that the information provided to staff was too limited, and with only one control UMC 
organizing a plenary information meeting. 
Quantitative evaluation of the implementation process in the intervention group 
In the quantitative evaluation, a sample of HCWs from five selected departments of the 
participating UMCs was asked to complete an anonymous web-based questionnaire. In 
the spring of 201 0, 2,255 HCWs were approached, of whom 678 (249 from intervention 
UMCs) completed the questionnaire (response rate of 3 0.1 %). In the spring of 2011 , 
4,885 HCWs were invited to participate in the questionnaire with 908 (303 from 
intervention UMCs) responses (response rate of 1 8.6%). Baseline data of participants 
were similar across study seasons and UMCs. Respondents were predominantly female 
(in 2009/2010 88.9% in the 'external intervention group' and 86. 7% in the 'intervention 
group', p= 0.554). The proportion of HCWs older than 45 years was similar across 
seasons and groups, ranging from 3 7.8% to 42.7%. More nursing staff than physicians 
participated in the questionnaire (nursing staff ranging from 86.4% to 99.2%), and overall 
response rates varied by department, with the highest response rates in the paediatric 
ward and the lowest response rates in the internal medicine department. 
Table 4 summarizes the questionnaire results from the intervention UMCs across 
study seasons concerning the usage of the developed tools in their UMC. As the findings 
for the three 'intervention UMCs' and the two 'external intervention UMCs' were similar, 
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the results for both sets of UMCs were combined. In the pandemic influenza season of 
2009/201 0, approximately 25% of HCWs attended an information meeting on influenza. 
One year later, approximately 1 0% of HCWs attended such an information meeting. In 
the pandemic season (2009/201 0) the badges were handed out to around 3 2.9% of 
HCWs, while in the 201 0/2011 season this number was almost halved (1 6.6%). In 
addition, a higher proportion of the handed-out badges was worn in the pandemic 
season than in the 201 0/2011 influenza season. Of all the developed communication 
materials, HCWs reported the posters as the most noticeable. 
Table 4 Quantitative evaluation : percentage of health care workers (HCWs) within intervention 
UMCS during study year 2009/201 0 and 201 0/201 1  that used and appreciated the methods/ 
materials 
Methods/materia ls 
Visited the website 
Attended information meeting 
Badge was handed out 
Wore the badge 
Rated the badge as appeal ing 
Rated the poster(s) as appealing 
Rated the folder as appealing 
Rated the video(s) as appealing 
















n = 303 HCWs 
(%) 
1 9.7  







In this study we have demonstrated how the IM method by Bartholomew et al. 14 can be 
applied to develop a structured immunization strategy to increase the influenza vaccine 
coverage of HCWs in acute care settings. According to the process evaluation we were 
able to implement such a strategy in participating hospitals. Compared with the Dutch 
study performed by Looijmans-van den Akker et al. in nursing homes, our IM-based 
intervention achieved an increased attendance rate of HCWs at information meetings of 
24% in the 'pandemic' 2009/201 0 influenza season, and 9% in the 'normal' 201 0/2011 
influenza season, when compared with the observed 7% participation rate in the nursing 
home study. 13 Our evaluation showed that posters were an efficient tool for use in acute 
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care settings as these were most commonly noticed by the HCWs. However, it appeared 
to be impossible to achieve a 100% exposure of every HCW to all materials, which 
would be the best case scenario. 
At the core of this implementation study was the systematic planning of the 
program and the selection of methods according to the IM method, in consultation with a 
communication expert. Using a number of discussion sessions the team agreed upon 
and developed different methods/materials to be directed at the different target groups. 
The inclusion of an assessment of the needs of each intervention UMC enhanced the 
program's applicability. The diversity of backgrounds of the research team members 
(ranging from physicians to hospital hygienists) was considered an advantage since this 
led to a wider perspective during the development of the different implementation tools. 
A possible limitation to the current study may be the observed discrepancy 
between the findings of the qualitative and quantitative evaluation. In the qualitative 
evaluation, most of the three 'intervention' and the two 'external intervention' UMCs 
reported that the majority of the nine behavioural determinants were taken into account, 
and that most of the proposed methods were implemented. However, the quantitative 
questionnaire results showed that the actual exposure of HCWs to these developed tools 
appeared suboptimal. This discrepancy may in part be due to the lower response rates 
to the web-based questionnaire, notably during the second study season. Although the 
response rate in the first season was rated 'quite high' for such evaluations and 
'acceptable' during the second season, bias may have occurred such that respondents 
were more negative (or positive) regarding the program than the average HCW. Since 
we did not pursue a non-responder study, the direction of such potential bias remains 
undetermined. In the nursing home study by Looijmans et al, 13 a clear trend towards 
higher vaccine coverage of HCWs was observed when nursing homes implemented 
more components of the intervention program. Therefore, whilst it is clearly difficult to 
achieve full exposure to the different program elements, future programs should consider 
exposure to all intervention program elements as part of their aim of achieving optimal 
influenza vaccine coverage.22 
Another possible limitation of this study was the widespread pandemic of new 
influenza A(H1 N1)  that occurred during the study period. Our evaluation showed that 
during an influenza pandemic methods/materials were used and rated differently when 
compared with the normal (seasonal) influenza period. For instance, more HCWs 
attended information meetings on influenza and vaccination in the pandemic season 
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than during the normal season. It should also be noted that the influenza pandemic 
caused a lot of anxiety and media attention in the Netherlands and in the participating 
hospitals. In particular, it was predicted that many hospital admissions could be expected 
as well as understaffing of hospitals by HCWs' absenteeism. As a consequence, extra 
efforts were made towards vaccinating HCWs against new influenza A(H1 N1 ). Although 
this external effect will have interfered with the purpose and conduct of the randomized 
intervention trial in the pandemic year, the increased attention was national and can be 
assumed to have been similar for both intervention and control UMCs. Therefore the 
conclusions from our study based on relative performance of the intervention and control 
UMCs should still be valid. 
CONCLUSIONS 
A structured implementation strategy for promoting influenza vaccination amongst HCWs 
was developed using the IM method and trialled over two influenza seasons in 5 UMCs. 
A process evaluation showed that the intervention could be successfully implemented in 
acute health care settings. Whilst the evaluation showed increased vaccination uptake 
by HCW staff of the participating UMCs, it also showed that it was impossible to expose 
all HCWs to all intervention methods (which would be the best case scenario). Further 
study is needed to (1 ) improve HCW exposure to intervention methods; (2) evaluate the 
effect of such interventions on vaccine uptake among HCWs; and (3 ) assess the impact 
on clinical outcomes among patients in hospitals where such interventions are enacted. 
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Figure 1 Intervention mapping method (adapted from Bartholomew et al).14 
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Step 1 Needs assessment 
- Describe the problem and the target population 
- Distinguish environmental and behavioural determinants 
- Review key determinants 
Step 2 Proximal program objectives 
- State expected changes in behaviour and environment 
- Specify performance objectives 
- Specify important, changeable determinants 
- Differentiate the target population (subgroups) 
- Define proximal intervention objectives 
Step 3 Theory-based methods and practical strategies 
- Brainstorm on methods 
- Translate methods into strategies 
- Organize methods and strategies at each level 
Program planning 
- Operationalize strategies into plans 
- Design program components and materials 
- Pre-test program materials with target groups 
Adoption and implementation of the program 
- Develop a linkage system 
- Specify adoption and implementation of performance objectives 
- Develop an implementation plan 
Step 6 Program evaluation 
- Develop an evaluation model 
- Develop effect and process evaluation questions 
- Develop indicators and measures 
- Specify evaluation designs 
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Nosocomial influenza is a large burden in hospitals. Despite recommendations from the 
World Health Organization to vaccinate health care workers against influenza, vaccine 
uptake remains low in most European countries. We performed a pragmatic cluster 
randomised controlled trial in order to assess the effects of implementing a multi-faceted 
influenza immunisation programme on vaccine coverage in hospital health care workers 
(HCWs) and on in-patient morbidity. We included hospital HCWs of three intervention 
and three control University Medical Centers (UMCs), and 3 ,3 67 patients. An 
implementation programme was offered to the intervention UMCs to assess the effects 
on both vaccine uptake among hospital staff and patient morbidity. In 2009/10, the 
coverage of seasonal, the first and second dose of pandemic influenza vaccine as well 
as seasonal vaccine in 2010/11 was higher in intervention UM Cs than control UM Cs (all 
p<0.05). At the internal medicine departments of the intervention group with higher 
vaccine coverage compared to the control group, nosocomial influenza and/or 
pneumonia was recorded in 3 .9% and 9. 7% of patients of intervention and control 
UM Cs, respectively (p=0.01 5). Though potential bias could not be completely ruled out, 
an increase in vaccine coverage was associated with decreased patient in-hospital 
morbidity from influenza and/or pneumonia. 
Trial registration number NCT01 481 467 (www.clinicaltrials.gov) 
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INTRODUCTION 
The value of vaccinating health care workers (HCWs) against influenza has been subject 
of debate over decades. In the United States (US), despite respective immunisation 
recommendations since 1981, vaccine coverage among HCWs was only 63.5% in 
2010/11. 1 In the United Kingdom (UK), the Netherlands and other European countries, 
coverage is even lower.2•3 Several arguments support influenza vaccination of HCWs. 
First, each year, influenza causes substantial morbidity and mortality among vulnerable 
patients in hospitals and nursing homes.4-6 Since contacts between patients, visitors and 
HCWs are frequent in such settings, and HCWs who are infected with mild symptoms 
often continue to work,7 epidemics can easily develop and can be large.8 Second, 
prophylaxis with neuraminidase inhibitors can be effective, but viral resistance may 
develop rendering these drugs less effective during influenza infections and such a 
strategy has not been routinely implemented in health care settings. Third, immunisation 
with the inactivated influenza vaccine has been shown in a large meta-analysis of 
randomised controlled trials among healthy adults representative of the HCWs 
population to be 59% effective in preventing laboratory-confirmed influenza infection.9 
Fourth, a mathematical model for a 30-bed hospital predicted that seven HCWs need to 
be vaccinated to prevent one influenza infection in a patient. 1° Finally, despite some 
methodological constraints, a meta-analysis of four large randomised controlled trials in 
long-term care institutions showed significant reductions in patients presenting influenza­
like illness and patient mortality in settings with high vaccine coverage among HCWs 
versus control settings with low coverage. 1 1 
In the Netherlands, a high influenza vaccine uptake is reached among those 
belonging to risk groups for influenza. Each year, in October/November, general 
practitioners immunise patients aged 60 years or older and patients with risk-elevating 
diseases with stable high vaccination uptake rates above 71 % across most parts of the 
Netherlands. 12 However, if younger than 60 years and admitted for the first time with a 
high-risk diagnosis, patients are mostly not immunised since they did not belong to a risk 
group before. Also they are infrequently vaccinated in the hospital since there is no 
vaccination programme for hospitalised patients in the Netherlands. 
In contrast, in both the Netherlands and most other European countries, vaccine 
uptake among HCWs remains low and influenza vaccination programmes have been 
voluntary. To be effective in reaching high vaccine coverage against influenza, a large 
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variety of behavioural and organisational factors has to be targeted13 and a setting- and 
culture- specific quantitative need assessment is essential to focus the programme on 
the most influential factors.14 
We applied the Intervention Mapping (IM) method15 to structure the development 
of an influenza vaccination programme targeted at hospital staff. We here report the 
results of an evaluation of this programme. In the study, University Medical Centers 
(UMCs) from the Netherlands participated during the 2009/1 0  and 201 0/11 influenza 
seasons. We primarily set out to determine the effects of the programme on vaccine 
coverage among HCWs using a pragmatic cluster randomised controlled trial. As clinical 
assessments from hospital settings are lacking, we also set out to determine the effects 
on patient outcomes during the studied influenza seasons. 
METHODS 
Design, setting and participants 
We aimed to assess the clustered effects of a multi-faceted influenza vaccination 
programme on influenza vaccine coverage in HCWs as well as the effect on influenza 
morbidity in hospitalised patients in UMCs in the Netherlands. In our trial, a cluster is the 
unit of randomisation defined as one UMC. In this study, we consider HCWs to be all 
employees working in the hospital. The study period included the influenza seasons 
2009/10 and 2010/11 . 
To reach the objectives we conducted a pragmatic cluster randomised trial 
because the developed influenza vaccine implementation programme was best applied 
at hospital level rather than at individual level. All eight UMCs (Erasmus Medical Center, 
Rotterdam; Academic Medical Center, Amsterdam; University Medical Center, 
Groningen; University Medical Center, Utrecht; University Medical Center, Maastricht; 
Free University Medical Center, Amsterdam; University Medical Center, Nijmegen; 
Leiden University Medical Center, Leiden) were invited to participate in the trial. After 
permission from the Dutch Federation of UMCs, the board of directors of six of the eight 
UMCs agreed to randomisation at cluster level. The board of directors of the two 
remaining UMCs refused to be randomised because their institutions had already 
undertaken considerable efforts to raise influenza vaccine coverage among staff, but 
they agreed to act as external controls. Unfortunately, the two UMCs did not give 
permission to collect patient data. 
98 
At baseline, policies for the randomised UMCs were either to offer influenza 
vaccination to selected health care workers or not to vaccinate at all, and the highest 
vaccine coverage in any UMC was estimated at just below 27%. The baseline vaccine 
coverage in the external UMCs was somewhat higher reaching levels as high as 
estimated at 37%, and there was more experience with immunistion campaigns. 
UMCs are tertiary referral centers each taking care of special hospitalised patient 
populations in the eight geographical regions of the Netherlands where they are placed. 
Acute care is delivered for a large number of patients who are admitted for a wide variety 
of indications. 
In May 2009, prior to the upcoming 2009/10 influenza season, six UM Cs were 
randomly allocated by computer (using the procedure Random in SPSS version 1 8.0) 
into two clusters, either the intervention or the control group, by a researcher blinded to 
the identity of the UMCs. Since the UMCs were about similar in size, number of HCWs 
and annual number of hospitalisations, we did not match before randomisation. Since we 
conducted a pragmatic study, the outcome of randomisation was neither blinded for the 
research group nor for the lead contacts of the UMCs. Although most HCWs were aware 
that they were targeted for vaccination, they did not know to which arm their UMC was 
randomly allocated. The study period covered the period from the first influenza 
vaccination campaign in September/October 2009 to the end of the influenza season 
2010/11 .  The protocol of the trial was waived by the medical ethical committee of the 
University Medical Center Groningen for ethical approval according to the Dutch Law of 
Research with Humans (No. 2009.267). The study was conducted in accordance with 
the Dutch Law for the Protection of Personal Data (Wet Bescherming 
Persoonsgegevens) and the Declaration of Helsinki.16 
Intervention 
In November and December 2008, prior to the trial start in 2009, we conducted a survey 
to assess which behavioural and organisational factors were associated with vaccine 
uptake among hospital staff of the UMCs. 17 An 11 -item prediction model with nine 
behavioural and two demographic predictors could be developed that was highly 
accurate in discriminating vaccinated from non-vaccinated staff in approximately 95% of 
the study population. Subsequently, we used the Intervention Mapping (IM) method to 
thoroughly plan, develop and evaluate a programme that was d irected at HCWs in order 
to influence their behaviour towards immunisation. 15· 1 8  This IM method is a theoretical 
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framework to systematically develop health education interventions and can be used as 
part of the dynamic process of planning intervention strategies in health education. It 
contains six consecutive steps: (i) a needs assessment, (ii) creating a matrix of proximal 
programme objectives, (iii) selecting theory-based intervention methods and practical 
strategies, (iv) programme planning, (v) adopting and implementing the programme, and 
(vi) monitoring and programme evaluation. 
Various educational tools were developed following the proximal objectives 
based on the needs assessment (Box). Prior to the immunisation campaign in 
September 2009 and 201 0, the programme educational tools were offered to the lead 
contact persons from the departments of occupational health of each UMC in the 
intervention and external group. These departments, in close collaboration with the 
communication units, are responsible for the influenza vaccination campaign. 
Information on the methods was provided to them by communication experts within the 
research group and they were encouraged to communicate the methods at various 
levels including the board of directors, heads of departments and staff members. The 
intervention and external group were allowed to make their own choices and decisions 
regarding the implementation of programme elements. An evaluation of the process 
showed that intervention and external UMCs targeted most of the behavioural 
determinants and choose to implement a variety of the developed methods, whereas the 
control UMCs targeted less determinants (Figure). 1 8  However, actual exposure of HCWs 
to these methods was variable and in 2009 largely affected by the pandemic 
preparedness plans. Lead contacts from the control group did not receive the developed 
methods and were encouraged to follow their usual influenza vaccination policy. We did 
not seek to influence vaccine coverage among patients. 
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Box Behavioural determinants associated with vaccine uptake and developed health education 
methods to increase influenza vaccine uptake, the Netherlands, 2009 
Behavioural determinants Developed health education methods 
Awareness of personal risk 
for influenza infection 
- Provision of information on influenza, transmission and risks 
through an information stand at the UMC restaurants, a website, 
a folder and plenary meetings 
- Polls and a quiz on the intranet 
- Video testimonials with role models 
Awareness of risk of infecting - Provision of information on influenza and the risk of trans-
patients mission to patients through an information stand at the UMC 
restaurants, a website, a folder and plenary meetings 
Belief that vaccination 
reduces the risk of infecting 
patients 
Usefulness of vaccination 
despite the constant flow of 
visitors 
Knowledge on the contents 
of the Health Council's 
Advice 
Vaccination of HCWs to 
ensure continuity of care 
Vaccination of HCWs be­
cause of their duty to do no 
harm 
Belief that people around me 
th ink it is important for me to 
get vaccinated 
Willingness to get vaccinated 
if the vaccine was available 
at a convenient time 
- Polls and a quiz on the intranet 
- Video testimonials with role models 
- Provision of information on influenza and the effectiveness of 
vaccination through an information stand at the UMC restau­
rants, a website, a folder and plenary meetings 
- Polls and a quiz on the intranet 
- Video testimonials with role models 
- Provision of information on influenza and the effectiveness of 
vaccination through an information stand at the UMC restau­
rants, a website, a folder and plenary meetings 
- Polls and a quiz on the intranet 
- Video testimonials with role models 
- Provide and explain contents of the advice on the intranet or 
website 
- Explain and discuss in a plenary meeting 
- Explain and discuss ethical aspects (plenary meeting, website) 
- Video testimonials with role models 
- Involve board of directors (e .g. first vaccination ,  be present at 
vaccination, column) 
- Distribute pins to vaccinated HCWs saying 'deliberately vacci­
nated for you' to start the discussion 
- Explain and discuss ethical aspects (plenary meeting, website) 
- Video testimonials with role models 
- Involve board of directors (e.g. first vaccination ,  be present at 
vaccination, column) 
- Distribute pins to vaccinated HCWs saying 'deliberately vacci­
nated for you' to start the discussion 
- Personal invitation letter with information folder and a link to the 
website at the home address 
- Poster with practical information on location and time 
- Personal invitation at home address with location and time 
- Extended vaccination hours which take changing shifts into 
account 
HCW, health care worker; UMC, University Medical Center. 
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Outcomes 
The primary outcome measure of this trial was the influenza vaccine uptake among all 
HCWs at UMC level. Vaccine uptake was expressed as percentage calculated through 
dividing the number of all vaccinated HCWs by the total number of HCWs multiplied by 
100. For financial administrative reasons all immunisations are accurately recorded at 
the hospital level, hence this information was regarded most valid. 
Secondary outcome measures were absenteeism rates among HCWs during 
December of each study year as this is normally the month in which influenza circulates 
at epidemic levels.19  The cumulative absenteeism rates for the month December were 
provided by each department of occupational health of all UMCs after the influenza 
seasons. Vaccine uptake and absenteeism among HCWs were both analysed at cluster 
level. 
As further secondary outcome, patient outcome data from two selected high risk 
departments i.e. paediatrics and internal medicine, were collected retrospectively for all 
patients hospitalised three days or more, to ensure nosocomial exposure during both 
study seasons. In the 2009/10 influenza season, a lower number of patients could be 
included after vaccination of HCWs, since the campaign had begun late in the epidemic, 
whereas we could observe a high number of patients during the complete season of 
201 0/1 1 . The outcomes collected were laboratory-confirmed influenza and/or 
pneumonia, length of hospital stay in days, admittance to intensive care and duration. 
They were compiled by scrutinising computerised discharge letters from the patients' 
medical files and information from the microbiology laboratories by two reviewers. 
Influenza was defined as laboratory-confirmed influenza A (all subtypes) or influenza B 
during hospital stay. Pneumonia was defined as any pneumonia which was clinically 
diagnosed during hospital stay. Since vaccination coverage was different between 
departments, patient data were analysed at department level. Since pneumonia is a 
common complication following influenza, influenza remains often undiagnosed and the 
combined outcome is regarded most accurate and specific. In accordance with previous 
studies among seniors we combined this outcome.1 1  
We were able to  obtain patient outcome data on a large number of  patients in  two 
departments during the influenza seasons. 
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Sample size 
We aimed to include all HCWs from the eight UMCs prior to conducting the study. 
Sample size calculations for cluster randomised studies were applied. Based on the high 
vaccine uptake among patients (around 70%) we expected that we could raise the 
vaccine coverage of staff in the intervention group from 3 7%, the highest vaccination 
rate in all UM Cs as estimated by questionnaire 17 to at least 70% and that the control 
group would remain at 3 7% coverage. We assumed that all eight UMCs would 
participate. A minimum of 3 2  participants per UMC (1 28 per cluster) were needed to 
provide more than 80% power if the intra-class correlation (ICC) was estimated at 1 0% 
and significance level was set at 5%. Given the much higher numbers of HCWs per 
UMC, smaller effects could be detected with adequate power. 
Statistical methods 
Data were analysed using SPSS for Windows, version 1 8.0 and SAS statistical package 
9.1 . All outcomes were analysed at cluster level. In addition, patient outcomes were 
analysed at departmental level. For the primary outcome influenza vaccine coverage and 
absenteeism rates, we calculated risk differences (RD) and relative risks (RR) with their 
corresponding 95% confidence intervals (95% Cl) and the levels of statistical 
significance in the different clusters for both influenza seasons combined. This was done 
by a specifically designed bootstrap program in R statistical software20 to account for 
clustering. To account for dependencies of individual observations within hospitals and 
possible heterogeneity between hospitals we addressed our research questions within 
the generalised linear mixed model framework. To estimate RR, the binomial distribution 
was used employing the logarithmic function as link between the mean of the response 
and the linear part of the model using SAS statistical package. RD were obtained using 
the identity link function and the normal distribution. We calculated RR and 
corresponding 95% Cl as well as levels of statistical significance for the patient 
outcomes pooled over both years after adjustments for small baseline differences of sex 
(see results). We chose to pool the data to obtain a more precise estimate of the effect 
because both seasons were dominated by influenza A(H1 N1 )pdm09 and vaccines 
matched the circulating strain in both seasons. Adjusted differences in duration of 
hospitalisation and intensive care admission between clusters were compared after 
transformation of extreme values to a clinically relevant maximum (3 0 days for hospital 
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At the beginning of the measurements in 2009, the baseline characteristics at the level of 
the whole UMC were determined per group (Table 1 ). On average, the intervention 
UMCs were somewhat larger than control and external UMCs with more staff full time 
equivalents and a higher number of clinical admissions each year. However, the mean 
HCW/patient ratio was comparable for all three groups. The age and sex distribution of 
staff as estimated from a web-based survey in 2009 was similar as well (response rate 
3 0.1 %) (data not presented). The pooled baseline characteristics of patients from the 
selected departments of the intervention and control groups showed similar mean age 
and percentage of men in the intervention and control group (Table 2). The percentage 
of patients from the internal medicine department and study year 2010/11 was also 
similar between both groups. 
Table 1 Baseline characteristics of University Medical Centers, randomised controlled trial in the 
Netherlands, 2009 (n=8) 
Intervention UMCs Control UMCs External UMCs 
(n=3) (n=3) (n=2) 
Mean number of HCWs' fu l l  time equivalents 8,065 
Mean number of clin ical admissions 34,395 
Mean HCW/patient ratio 0.23 
Mean percentage of HCWs older than 40 yearsa 37.8 (SD 48.6) 
Mean percentage of female HCWsa 86.7 (SD 34.0) 
HCW, health care worker; UMC, University Medical Center. 







42.6 (SD 49.6) 42. 1 (SD 49.6%) 
75.6 (SD 43.0) 88.9 (SD 31 .6) 
Table 2 Baseline characteristics of patients in eight University Medical Centers by intervention/ 
control and department, randomised controlled trial in the Netherlands, 2009-201 1  (n=3,367) 
Intervention Intervention UMCs Intervention UMCs Control Control UMCs Control UMCs 
UMCs Department of Department of UMCs Department of Department of 
n=1 ,387 Internal Medicine Paediatrics n=1 ,980 Internal Medicine Paediatrics 
n=769/1 ,804 n=61 8/1 563 n=1 ,035/1 ,804 n=945/1 ,563 
Baseline 
characteristics 
Mean age 35.3 59.8 4.7 34. 1 60.0 5.8 
(years) (range 0-1 01 , (range 1 8-10 1 , (range 0-1 9 ,  (range 0-1 04, (range 1 7-104, (range 0-23, 
SD 31 .0) SD 1 8.8) SD 5 .5) SD 30.4) SD 1 8.3) SD 5.6) 
Male (%) 54.2 51 .2 57.9 51 . 1  50.6 51 .6 
752/1 ,387 394/769 358/61 8 1 ,0 12/1 ,980 524/1,035 488/945 
SD, standard deviation; UMC, University Medical Center. 
None of the outcomes were statistically sign ificant. 
Influenza vaccine uptake 
In both study seasons, influenza vaccine coverage among HCWs was significantly 
higher in the intervention group compared with the control group (Table 2). In 2009 three 
influenza vaccination rounds were offered because of the emergence of the influenza 
A(H1 N1 )pdm09 pandemic virus. In all three groups coverage was highest for the first 
dose of the pandemic vaccine. In the intervention group the absolute difference in 
vaccine coverage compared with the control group, for the first dose of the pandemic 
vaccine was 23 .7% (95% Cl 4.3 % to 47.8%, p<0.05). For the second pandemic vaccine 
dose, coverage was lower in all groups than for the first one, but still 21 .4% higher in the 
intervention than in the control group (95% Cl: 3 .6% to 40. 3%; p<0.05). The external 
UMCs, which were already more active in their vaccination campaign prior to the study 
than the randomised UMCs, reached even higher influenza vaccine uptake rates 
compared to the control UMCs in all vaccination rounds with an outstanding 44.0% 
absolute higher uptake of the first pandemic vaccine dose from 3 8.0% to 82.0% (95% Cl: 
30.0% to 53.7%; p<0.05). In 201 0/11 , when the pandemic threat was no longer an issue, 
coverage of the seasonal influenza vaccine was much lower than the pandemic vaccine 
coverage in the year before for each group. The absolute RD was the intervention and 
external group, respectively, compared with the control group (both p-levels <0.05). 
To obtain more insights into exposure to different programme methods and the 
vaccine uptake, we related the number of targeted determinants to vaccine uptake 
105 
(Figure). There was a clear trend towards increased vaccine coverage if more methods 
were applied. There was a significant correlation between the number of applied 
methods and vaccine coverage for both pandemic vaccines (first pandemic vaccine dose 
Spearman r=0.79, P=0.021 ; second pandemic vaccine dose Spearman r=0.90, 
P=0.003 ). Correlation estimates were not significant for the seasonal vaccines (2009/1 0: 
Spearman r=0.41 ,  P=0.31 7; 201 0/11 : Spearman r=0.27, P=0.51 ). 
Figure Number of targeted behavioural determinants in the influenza vaccination programme 
and vaccine uptake in healthcare workers in University Medical Centers by vaccine, randomised 
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Absenteeism 
Work absenteeism rates among HCWs were recorded for December 2009 and 
December 201 0  (Table 3 ). For both seasons, absenteeism rates were 0. 7% to 1 .2% 
higher (absolute RD) on average in both the intervention and external cluster compared 
with the control group (all p<0.05 except for comparison between external and control 
UM Cs in 201 0  where p>0.05). 
Table 3 I nfluenza vaccine uptake rates and work absenteeism rates for the month of December 
among health care workers in eight University Medical Centers, randomised controlled trial in the 
Netherlands, 2009-201 1  
Intervention Control UMCs External UMCs RD (95% RD (95% 
UMCs Intervention Confidence External Confidence 
vs Control interval) vs Control interval) 
Year 2009 
Seasonal influenza 32.3% 20.4% 48.7% 1 1 .9%" (7.5 - 1 5.5) 28.3%8 (8.6 - 42. 3) 
vaccine uptake (9,022/27,900) (4,572/22,451 ) (8,231 /1 6,893) 
Pandemic influenza 61 .7% 38.0% 82.0% 23.7%8 (4. 3 - 47.8) 44.0%8 (30.0 - 53.7) 
vaccine uptake (first (17,21 2127,900) (8,541/22,451 ) (1 3 ,852/1 6,893) 
dose) 
Pandemic influenza 45.8% 24.4% 56.7% 21 .4%8 (3. 6- 40.3) 32.3%8 (23.4 - 40.5) 
vaccine uptake (1 2,772/27,900) (5,480/22,451 ) (9, 582/1 6,893) 
(second dose) 
Work absenteeism 4.6% 3.4% 4.1 %  1 . 2%8 (0.9 - 1 .7) 0.7%• (0. 2 - 1 .3) 
(December 2009) (1 , 297/27,900) (579/1 7, 229)8 (701 /1 6,893) 
Year 201 0  
Seasonal influenza 28.6% 1 7.8% 27.2% 1 0. 8%" (2.0 - 1 9.9) 9.4%" (1 .0 - 1 7. 2) 
vaccine uptake (8, 176/28,621 ) (4,345/24,459) (4,555/1 6,71 7) 
Work absenteeism 4.6% 3.9% 4.6% 0.7%8 (0. 1 - 1 . 3) 0.7% (-0 .2  to 1 .4) 
(December 201 0) (1 , 31 8/28,621 ) (7 45/1 9,267)b (765/1 6,717) 
RD, risk difference; UMC, University Medical Center. 
·These results are statistically significant. 
b For this variable no data could be obtained from one control UMC. 
Patient outcomes 
Self-reported vaccine coverage in 2009/1 0 and 2010/11 influenza seasons among 
HCWs differed between the two studied departments. In 2009/1 0 coverage of a 
pandemic vaccine in the internal medicine and pediatric departments of intervention 
UMCs was 1 00% and 50%, and 92% and 81 % in control UMCs, respectively. In 
201 0/11 ,  corresponding vaccine coverage were 57% and 50%, and 51 % and 44%, 
respectively. Over the two study years, the probability of being tested for the presence of 
influenza virus during the influenza epidemics was nearly twice as high in the 
intervention cluster compared with the control group, though not statistically significant 
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(Table 4). Despite higher diagnostic testing rates, a diagnosis of influenza and/or 
pneumonia during hospitalisation was made in half as many cases in the internal 
medicine department of intervention UMCs compared with the control UMCs (RR=0.5; 
95% Cl: 0.3 -0.9; p=0.01 5). Nosocomial pneumonia was reduced by a relative reduction 
of 76% (p=0.028). Other characteristics did not significantly differ between groups and 
no statistically significant differences were observed in the paediatric departments. 
Table 4 Pooled analysis of patient outcomes by department for intervention and control of eight 
University Medical Centers, randomised control led trial in the Netherlands, 2009-201 1  (n=3,367) 
Intervention Intervention Control UMCs Control UMCs RR (95% RR (95% 
UMCs U MCs Department Department of Confidence Confidence 
Department Department of of Internal Paediatrics interval) interval) 
of Internal Paediatrics Medicine n=945/1,563 p value p value 
Medicine n=618/1,563 n=1,035/1,804 Department Department of 
n=769/1,804 of Internal Paediatrics 
Medicine 
Outcomes 
Tested for influenza 17.6% 10.4% 7.2% 7.6% 2.1 (0.5 - 8.4) 2.0 (0.7 - 6.1) 
during hospitalisation 121/6881 46/441 "  75/1,035 72/945 p=0.29 p=0.22 
Influenza and/or 3.9% 3.6% 9.7% 1.9% 0.47 (0.3 - 0.9) 2.1 (0.7 - 6.7) 
pneumonia during 30/769 22/618 100/1,035 1 8/945 p=0.015 p=0.19 
hospitalisation 
Pneumonia during 1.4% 1.3% 8.5% 1.1% 0.24 (0.1 - 0.9) 1.5 (0.3 - 7.3) 
hospitalisation 11/769 8/618 88/1,035 10/945 P= 0.03 p=0.65 
Use of intensive care 5.5% 8.3% 7.4% 8.5% 0.7 (0.4 - 1.3) 0.6 (0.1 - 3 .5) 
during hospitalisation 42/769 51/618 77/1,035 80/945 p=0.29 p=0.56 
Mean duration of 10.2 (SD 8.1) 8.7 (SD 7.6) 10.7 (SD 8.4) 8.1 (SD 7.1) 0.96 0.60 
hospitalisation (in (-11.82 to 13.73) (-3.32 to 4 .52) 
days, risk difference p=0.85 p=0.69 
is given)b 
Mean duration of 3.5 (SD 2.3) 3.2 (SD 2.0) 4.4 (SD 2 .5) 4.3 (SD 2.3) -0.91 -1.14 
intensive care use (in n=42 n=51 n=77 n=80 (-1.83 to 0.009) (-1.92 to -0.36) 
days, risk difference p=0.12 p=0.06 
is given)0 
RR, relative risk; SD, standard deviation; UMC, University Medical Center. 
• For this variable no data could be obtained from one intervention UMC. 
b Until 30 days. 
0 Until 7 days. 
DISCUSSION 
In a 2008 publication, Nicoll et al. stated that there is strong evidence for immunising 
HCWs against influenza that take care of the elderly and the chronically ill in long-term 
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care facilities. However, they did not find strong data on whether or not to vaccinate 
HCWs in other health care settings, such as hospitals. 21 
Our study is the first hospital-based trial that showed that adopting a multi­
faceted influenza vaccination programme was associated with improved vaccine 
coverage among HCWs. We also observed a lower risk for nosocomial influenza and/or 
pneumonia in hospitalised patients at the internal medicine departments during two 
consecutive influenza seasons, but we did not observe this effect in the studied 
paediatric departments. 
It is surprising that only a small self-reported higher vaccine uptake in the 
departments of internal medicine led to our observation of a 50% reduction of the RR in 
patient outcomes. There may be several explanations for this finding. Actual vaccine 
coverage differences might have been higher than our self-reported estimates given that 
we observed an absolute higher difference of 23 .7% (from 3 8.0% to 61 .7%) and 11 .9% 
(from 20.4% to 3 2.3 %) respectively at group level in both seasons. Other explanations 
might be that not only vaccine uptake was higher in the intervention UMCs but that the 
programme led to more hygienic measures such as earlier diagnosis of influenza and 
isolation or better compliance with hand hygiene. This agrees with the fact that the 
number of influenza tests was twice higher in the intervention clusters than in the control 
clusters. Alternatively, baseline risks of patient outcomes might by chance have been 
different between the departments. For example, we did not have pre-intervention 
patient outcome prevalences of nosocomial influenza for both clusters. Potential of 
confounding bias cannot be completely ruled out, but is unlikely given similar age and 
sex distributions between the two groups. 
Further, vaccine uptake was measured at the level of the UMCs and could not be 
obtained from all individual departments because of the centralisation of the 
immunisation in most UMCs. Of note, at baseline prior to the trial start, vaccine coverage 
might have been higher in departments of intervention UMCs than in control UMCs. Self­
reported data from HCWs showed, however, that the seasonal influenza vaccine 
coverage in 2008/09 was 44% and 1 4% among HCWs of the internal medicine and 
paediatric departments in intervention UMCs and 54% and 58% in control UMCs, 
respectively, hence baseline differences cannot explain the improved coverage. The 
uptake at UMC level most probably accurately reflects the coverage in most but not all 
departments as observed for the departments of paediatrics and internal medicine. The 
self-reported coverage was almost twice higher than the overall UMC level data because 
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of the high-risk residents of these departments and longer tradition of taking hygienic 
preventive measures against infectious diseases in internal medicine and paediatric 
departments, as compared with most other departments. 
The lead contacts and researchers were not blinded for the allocated strategy; 
hence this may have caused information bias. However, since the numbers of 
administered vaccines is a marker of quality of care in the UMCs and administration has 
financial consequences, it is highly unlikely that such bias has occurred. 
A major strength of the study includes the randomised design which resulted in 
largely comparable HCWs and patient populations over the study years. Also, the 
presence of a control group accounted for natural fluctuation in vaccine coverage as well 
as external factors at a national level, and the presence of an external group confirming 
the positive correlation between a targeted campaign and influenza vaccine uptake 
among HCWs was a major strength. Moreover, the size of the trial HCWs population and 
patient population was more than adequate to obtain highly precise estimates of the 
main effects. Finally, in day-to-day practice swabbing is not routinely done and can 
therefore not have affected differentially the intervention and control UMCs. 
The work absenteeism rate was 1 .2 HCWs per 100 HCWs higher in the whole 
month of December 2009 in the intervention than in control clusters. Since testing for 
influenza appeared to be more frequent in intervention than control UMCs, if anything, it 
is likely a marker of stricter working rules applied during influenza seasons in the 
intervention compared with control UMCs. Obviously, routine swabbing of all patients 
suspected of influenza would have been the ideal study outcome. Because the 
pandemic threat was over in 201 0,22 the absolute risk difference for the trial population 
was down to 0.7 per 100 HCWs during the latter study season. One participating UMC 
from the control group could not reliably obtain absenteeism data at their UMC level. 
However, department specific data that could be obtained showed similar rates as within 
similar departments of the other control UM Cs. 
The participating hospitals were tertiary centers and the observed effects may not 
necessarily be applicable to all types of hospitals. In a survey among administrators of all 
hospitals in the Netherlands in 2010 with a response rate of over 53 %, we observed that 
the average vaccine coverage of staff reported by the administrators was comparable 
with the coverage in control UMCs (1 7.7% versus 1 7.8% in our study).23 Interestingly, in 
that survey we observed a clear association between economic spending on the 
immunisation programme in these hospitals and vaccine coverage, with higher 
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programme spending (>1 ,250 Euro versus s1 ,250 Euro) leading to 9% improved 
coverage (24% versus 1 5%; 95% Cl for the difference: 0.7% to 1 7%). We also observed 
in our trial that the higher the number of determinants targeted, the higher vaccine 
uptake in both study seasons (Figure). Although evidence is scarce, the introduction of a 
thoroughly developed programme likely leads to improved coverage in any type of 
hospital. 
In 2009, the influenza A(H1 N1 )pdm09 pandemic also affected the Netherlands, 
starting in early October and ending in December 2009. Following the advice from the 
World Health Organization and the Dutch Health Council, the Ministry of Health decided 
that risk patient groups should be prioritized for pandemic vaccination against this new 
influenza variant. HCWs were considered both as an important potential transmitter of 
influenza to risk patients and essential in the care of patients during a pandemic and 
were considered a target group for pandemic vaccination. As in most other countries, the 
pandemic was associated with enormous media attention and fear in the community. 
Therefore, in summer of 2009, all UMCs installed their pandemic response team and 
prepared for a worst case scenario.24 The installed preventive measures were very 
costly, reaching hundred thousands of Euros per UMC, and led to pressure on both 
management and HCWs. It was therefore unexpected to see that despite general 
circumstances, both the intervention and external cluster reached higher vaccine 
coverage than the controls. 
After the pandemic was declared over and it appeared to be much less severe 
than had initially been feared,24 we hypothesized that many HCWs were displeased 
about the pressure on them and the measures taken. In 2010/11 , therefore, seasonal 
vaccine coverage was half the coverage of the first dose of pandemic vaccine, and 
despite higher coverage in the intervention than the control cluster, it remained below a 
staggering low of 30%. 
In conclusion, our results suggest that a multi-faceted influenza vaccination 
programme for hospital HCWs is effective in raising vaccine uptake among HCWs. 
Although bias cannot be completely ruled out, an increase in vaccine coverage was 
associated with a decrease in influenza and/or pneumonia among patients during 
hospitalisation. Given the current evidence for annual risks of influenza complications in 
hospital and benefits of vaccination, and the low voluntary coverage, mandatory 
programmes should be seriously considered. 
1 1 1  
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Cost-effectiveness of a multi-faceted program to 
increase influenza vaccine coverage among health care 







Objective To determine the cost-effectiveness of implementing a hospital-based multi­
faceted influenza immunization program among health care workers (HCWs) in the 
Netherlands. 
Design Cost-effectiveness analysis from a societal perspective alongside a cluster 
randomized controlled trial. 
Setting University Medical Centers (UMC) in the Netherlands during the influenza 
seasons of 2009/201 0  and 2010/2011 . 
Participants Hospital staff of three intervention (n=27,900 in 2009), three control 
(n=22,451 ) and two external non-randomized intervention UMCs (n=1 6,893 ), and 3 , 367 
patients admitted to the departments of pediatrics and internal medicine during both 
influenza epidemics. 
Intervention Vaccination implementation program offered to staff of intervention and 
external UMCs, but not to control UMCs. 
Outcome measures Primary clinical outcome measures were influenza vaccine 
coverage among health care workers (HCWs), work absenteeism and patient morbidity. 
Primary economical outcome measure was the cost-benefit of the program. 
Results In both seasons, the vaccine coverage among HCWs improved in the 
intervention compared with the control cluster with risk differences ranging from 11 .9 per 
1 00 HCWs for the seasonal vaccine in 201 0  to 23 .7 per 1 00 HCWs for the first pandemic 
vaccine in 2009 (all p<0.05). When comparing patients from intervention with control 
UMCs, influenza and/or pneumonia was reduced by 2.7 per 1 00 patients (p<0.05) 
across both departments (i.e. pediatrics and internal medicine). In a base-case scenario 
with no vaccine coverage, annual costs of influenza were estimated at €3 89,264 for an 
average UMC of 8,000 HCWs and 6,000 patients hospitalized during an epidemic. If the 
vaccine coverage was increased to 23 . 7% as observed for the intervention cluster, the 
program's savings were estimated at €2,993 . 
Conclusions Adoption of the program improved the influenza vaccine coverage among 
hospital staff and was associated with decreased patient morbidity from influenza and/or 
pneumonia. The hospital immunization program resulted in cost-savings and more 
efforts to increase vaccination coverage among HCWs should be considered. 
Trial registration number NCT01 481 467 
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INTRODUCTION 
Despite the available clinical evidence, influenza vaccination coverage among health 
care workers remains very low. It has been widely recognized that immunizing health 
care workers against influenza has a direct and an indirect medical effect.1 ·5 It decreases 
influenza infection among healthy adults, reduces the probability of viral transmission in 
health care settings, and indirectly benefits vulnerable patients by reducing the 
probability of becoming infected. In the United States in 2010/2011 , only 63 .5% of staff 
accepted the vaccine.7 In Europe, health care workers are even more noncompliant with 
reported vaccine coverage's lower than 30%. 8·9 
Despite methodological shortcomings, in four trials conducted in long-term care 
settings, 14 a decrease in patient morbidity or mortality was observed after vaccine 
coverage was increased. For acute care settings where patients are being treated during 
epidemics such data are still not available. And, while influenza immunization is safe and 
relatively cheap, evidence on the economic benefits is virtually absent10, but crucial for 
hospital managers and policy makers to support such a program. 
The Intervention Mapping method has been used to structure the development of 
an influenza vaccination program targeted at hospital staff. University medical centers 
from the Netherlands participated during the 2009/2010 and 201 0/2011 influenza season 
in a cluster-randomized controlled trial. This paper reports the economic results of this 
program for an average hospital with 8.000 staff members and 6.000 patients 
hospitalized during an epidemic from a societal perspective. 
METHODS 
Trial design, setting and participants 
The trial study design has been reported earlier. 1 1  In brief, the aim was to assess the 
clustered effects and cost-effectiveness of a multi-faceted influenza vaccination program 
in University Medical Centers (UMCs) in the Netherlands. The study period included two 
influenza seasons (2009/201 0  and 201 0/2011 ). A cluster randomized trial was 
conducted because the developed influenza vaccine implementation program was best 
applied at the level of the hospital rather than individuals. The board of directors of six of 
eight UMCs agreed on randomization at the cluster level. Two UMCs refused to be 
randomized because of the effort already put into the vaccination program. UMCs are 
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regarded tertiary referral centers each taking care of specialized patient populations in 
approximately one-eighth of the Netherlands, but acute care is delivered for large 
numbers of patients who are admitted for a wide variety of indications. General 
practitioners immunize patients 60 years or older and patients with risk-elevating 
diseases in October/November of each year with stable high vaccination uptake rates 
above 71 % across most parts of the Netherlands.9·1 2  However, if younger than 60 and 
admitted for the first time with a high-risk diagnosis, patients are either not immunized or 
they infrequently receive their vaccine in the hospital. 
Intervention 
The Intervention Mapping (IM) method was used to thoroughly plan, develop and 
evaluate an intervention program that was directed at HCWs in order to influence their 
behaviour towards immunization. 1 3 The method contains six consecutive steps: a needs 
assessment, creating a matrix of proximal program objectives, selecting theory-based 
intervention methods and practical strategies, planning the program, adopting and 
implementing the program, and monitoring and program evaluation. Prior to the 
immunization campaign in the month September 2009 and 201 0, the developed 
educational tools were offered to the lead contact persons from the departments of 
occupational health of each UMC in the intervention and external group. These 
departments are, together with the communication units responsible for the influenza 
vaccination campaign. Lead contacts from the control group did not receive the 
developed methods and were encouraged to follow their usual influenza vaccination 
policy. No attempts were made to increase vaccine coverage among patients. 
Clinical Outcomes 
The primary outcome measure of this trial was the influenza vaccine uptake among all 
HCWs at UMC level. Vaccine uptake was measured by means of actual count data of all 
vaccinated persons and divided by the total HCW population as provided by the lead 
contacts of the departments of occupational health of each UMC. Secondary outcome 
measures were absenteeism rates among HCWs during the month December of each 
study year as this was the month in which influenza circulated at epidemic levels.14 
Further, as secondary outcome patient outcome data from two selected high risk 
department (i.e. Pediatrics and Internal Medicine) were collected retrospectively for all 
patients who were hospitalized three days or more to ensure nosocomial exposure 
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during both study epidemic seasons. The outcomes were laboratory-confirmed influenza 
and/or pneumonia, length of hospital stay, use and duration of intensive care and were 
collected by scrutinizing computerized discharge letters and laboratory outcome data 
from the microbiology laboratories by two reviewers. Influenza was defined as 
laboratory-confirmed influenza A (all subtypes) or influenza B during hospital stay. 
Pneumonia was defined as any pneumonia which was clinically diagnosed during 
hospital stay. 
Cost estimates 
The cost estimates associated with the immunization program were based on Dutch 
guidelines for cost-effectiveness research. 15 The cost prices were indexed to the 2011 
level use price-index figures per year. For example, if the cost price in 2009 for 
hospitalization in an academic hospital was estimated at € 575, the used cost price for 
2011 was calculated as €575+ (€ 575*0.01 3 )  = € 582.48 (year 201 0); € 582.45+(€ 
582.45*0.023 ) = € 595.87 (year 2011 ). 
Direct medical costs, direct non-medical costs and indirect non-medical costs 
related to the study objective have been taken into account. For an overview of the 
model parameters used, see Table 1 .  
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Table 1 Model parameters 
Parameter 
Employees (number) 
Patients (total number of patients per 
UMC) 
Patients (number of patients in hospital 
who are exposed to the same risk as 
patients in the departments where the 
clinical trial was performed) 
Vaccination coverage old (%) 
Vaccination coverage new (%) 
Work absence due to ILi (%) 
GP visit following ILi 
Use of OTC with ILi  











1 %  
Antibiotic use following G P  visit (%) 20% 
Decrease of productivity because of ILi 4 
(in days) 
Vaccine effectiveness in reducing ILi  
Probability of attracting influenza/ 
pneumonia in hospital 
Cost 
GP visit 
Treatment hospital acquired influenza/ 
Pneumonia 
OTC medicine 
Productivity loss per day 
Antibiotics 
Vaccination related costs 
20% 
1 1 .74% 
€ 29.01 
€1 ,013 .00 
€6.62 
€21 2.81 
€7. 1 8  
€1 5.00 
Reference Remarks 
Riphagen 201 311 Average of UMCs 
Riphagen 201 311 Average of UMCs during influenza season 
(2 months) 
Assumption Average of UMCs 
Base case 
Riphagen 201 311 Trial data 
VI/ark absence registration control UMCs 
Postma 200516 
Postma 200518 
Assumption & Postma 200516 Proportion of persons vaccinated and 
experiencing side effects following 
vaccination 
Postma 200516 
Palmer 201 017; Saxen 1 9991g; 
Wilde 1 99921 
Jefferson 201 06 
Riphagen 201 311 
CVZ 201 015; Riphagen 201 311 
In case of 0% vaccination coverage of 
HCWs; proportion tested positive in hospitals 
Rozenbaum 201022; CVZ 201015 Based on longer hospital stay of 1.7 day 
(Rozenbaum) 
Postma 200516 
CVZ 201 015; Riphagen 201 311 
Postma 200516 
Assumption 
Cost per day in academic hospital is € 596 
euro in 2011 (CVZ). Total cost per treatment 
of hospital aquired pneumonia is therefore 
1 .7*596 euro 
Average number of working hours per day 
is 7.2 (36 contracthours per week/5=7.2). 
Weighted average productivity costs are 
calculated using age and sex distribution 
of trial data and productivity costs from 
guidelines healtheconomic research (CVZ) 
and corrected for inflation. Costs per hour 
are 29.56 euro 
Costs for vaccine, administration, vaccination 
campagne 
UMCs, University Medical Centers; ILi ,  influenza like illness; GP, general practitioner; OTC, over the counter. 
Costs associated with the immunization program 
The cost estimates of the influenza vaccination program were estimated at €1 5.00 per 
staff member and include the costs for the vaccine, the communication and 
implementation of the program. 1 0  In the study by Hak et al., the potential cost-savings 
were determined using plausible, but theoretical, effects in a UMC setting using the data 
from the University Medical Center Groningen. For the administration, a nurse gross 
salary (scale 9) per month was assumed with 5 minutes for vaccination of one staff 
member and another 5 minutes for correction of inefficiency (waiting time). The assumed 
costs currently assume a linear relationship between the number of persons vaccinated 
and the total cost for the vaccination campaign. Indirect costs due to productivity loss for 
administration of the vaccine were assumed to be virtually absent because of the 
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elasticity in working hours. The vaccine efficacy for preventing ILi was assumed to be 
20%.6 
Direct medical effect cost estimates 
The direct medical effects of immunizing staff members against influenza are associated 
with seeking medical care for influenza. Direct medical costs associated with influenza 
were based on Dutch estimates from Postma et al. 16 and Hak et al.10  in combination with 
data from a web-based questionnaire carried out in 2009 and 20 10 as part of the trial. 
The questionnaire was sent to all staff members of internal medicine and pediatrics as 
well as three other departments (two intensive care departments and neonatology). The 
response rate was 31 % in 2009 and 18% in 2010, and the data were pooled to increase 
statistical power on the outcome variables. The proportion of people seeking primary 
care at the general practice was estimated at 24% with an average of one GP 
consultation (€29.01  ) .  Of all persons with IL i  i t  was assumed that 80% used over-the­
counter (OTC) medications (€6.62) and 20% received an antibiotic (€7 . 18). It was 
assumed that vaccination in this healthy group would not lead to adverse events leading 
to hospital admission. It was assumed that the vaccine caused side effects only in 10% 
of staff members, and that associated GP consultations occurred in 10% of them.16 
Working days lost due to influenza-like illness 
To calculate the productivity loss, the friction costs method was applied. Studies 
reviewing the impact of influenza or influenza like illness on working days lost are very 
heterogeneous in terms of methodology used.17-19  Based on the available literature, four 
days working loss was taking into account for influenza like illness. No differentiation has 
been made between work absence and presenteeism. Based on the work absence 
registration from the university hospitals it was possible to calculate a gender and age 
weighted productivity costs per hour.11· 1 5  The average cost for one day of work loss was 
estimated at € 2 12.81 per day. 
Indirect effect cost estimates 
The indirect medical effect costs estimates were largely based on the costs associated 
with occurrence of morbidity among patients and associated hospital care as observed in 
the trial. Since information on mortality could not be obtained, no effect on patient 
mortality was conservatively assumed. The main outcome was influenza and/or 
1 2 1  
pneumonia during hospital stay. The average costs for this diagnosis was based on the 
estimated increased difference in duration in hospital of 1 .  7 days extra at €1 ,01 3 for 
these patients compared with the other patients without nosocomial influenza and/or 
pneumonia. 
To estimate the effects on the reduction in the incidence of influenza and/or 
pneumonia for different vaccine coverage rates, a linear relationship between vaccine 
coverage rates of HCWs and the proportion of patients with outcomes was assumed 
according to the mathematical model by Van den Dool et al.20 In the estimates, an 
average of 23 .7 per 1 00 additionally vaccinated HCWs in the intervention cluster as 
compared with the control cluster was assumed. The increase in coverage resulted in 
2. 7 per 100 less patients to develop influenza and/or pneumonia. Thus, if the coverage 
would be 100 per 100 HCWs (full coverage), 11 .74 per 100 fewer patients would develop 
influenza and/or pneumonia. This results in a 0.11 7 4% decrease in the outcomes per 1 % 
increase in vaccine coverage of HCWs. 
Cost-effectiveness analysis 
The model was developed using Excel for Windows, version 2007. The basis for the 
analysis is a decision tree in which the direct effect of the influenza immunization for staff 
members is modeled as well as the indirect effects it has on the hospitalized patients. 
The basis for the probability input is in large part based on the trial input data (see 
above) and in part on the existing literature. A univariate sensitivity analysis was 
conducted to obtain the most influential factors in the cost-effectiveness estimates on the 
outcome measure using plausible ranges. For the sensitivity analysis for the base case 
scenario the values presented in Table 1 have been taken into account. For all cost 
items, a range of 10% was taken into account. 
For patients already hospitalized only the excess days of hospitalization which 
were related to the influenza acquired in the hospital have been taken into account in the 
model. Also mortality and short term and long term complications following for example 
pneumonia have not been taken into account. The same applies to the effect the 
program potentially has on the quality of life for patients. 
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RESULTS 
In the base-case scenario assuming no vaccination of staff members in an average U MC 
of 8.000 staff members and 6.000 patients, 3 68 staff members were absent from work 
because of influenza like illness resulting in 1 ,472 days of productivity loss, 88 persons 
visited a general practitioner, 294 used OTC medications and 1 8  persons an antibiotic 
treatment. The costs associated with illness in staff members was estimated at €4,63 8 
for medical care and € 31 3 ,256 for reduced productivity. In addition, 70 patients 
developed influenza and/or pneumonia while hospitalized. The cost associated with the 
extended hospitalization period was estimated at €71 ,3 70. Vaccinating 23 .7% of the 
HCWs with a vaccine efficacy of 20% on ILi resulted in a reduction of work absenteeism 
for 1 7  HCWs and a reduction in the associated nr of persons visiting a GP (four 
persons), OTC use (1 4 persons) and persons using antibiotic treatment (one person) but 
resulted in an increase in the number of persons visiting the GP due to the side effects of 
the vaccination. The costs associated with the vaccination and the direct medical costs 
of the staff members increased with € 3 3 ,408 and the costs for reduced productivity 
decreased with € 1 4,848. In total 1 7  patients were prevented from contracting influenza 
in the hospital and this resulted in a reduction of the extended hospitalization period with 
€ 1 6,91 5. Taking into account the effect of vaccination on both HCWs and patients would 
therefore lead to a cost saving of € 2,993 (for an overview of the results see Tables 2a 
and 2b). 
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Table 2a Vaccination coverage 23. 7% versus 0%. 
Vaccination Vaccination Difference 
coverage (new) coverage (old) 
Health care workers 
Employees (number) 8 ,000 8 ,000 0 
Number of employees vaccinated 1 ,896 1 ,896 
Number of persons who were absent from 351 368 -1 7 
work 
Total number of days absent from work 1 ,402 1 ,472 -70 
GP visit following IL i  84 88 4-
GP visits due to side effects from 1 9  0 1 9  
vaccination 
Number of persons who used OTC 280 294 1 4-
medication 
Number of persons who used antibiotics 1 7  1 8  1 -
Costs 
Vaccination € 28,440 € - € 28,440 
GP visits following ILi € 2,441 € 2,562 € 1 21 -
G P  visits due to side effects vaccination € 550 € - € 550 
OTC use € 1 ,857 € 1 ,949 € 92-
Antibiotic use € 1 21 € 1 27 € 6-
Productivity loss € 298,408 € 3 1 3,256 € 1 4,848-
Total costs health care workers € 331 ,81 6 € 31 7,894 € 1 3 ,922 
Patients 
Number of extended hospitalizations 54 70 1 7-
Costs of extended hospitalizations € 54,455 € 7 1 ,370 € 1 6,9 1 5-
Total costs patients € 54,455 € 71 ,370 € 1 6,91 5-
Total costs (health care workers + € 386,271 € 389,264 € 2.993-
patients) 
GP, general practitioner; IL i ,  influenza like il lness; OTC, over the counter. 
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Table 2b Vaccination coverage 70% versus 0%. 
Vaccination Vaccination Difference 
coverage (new) coverage ( old) 
Health care workers 
Employees (number) 8,000 8,000 0 
Number of employees vaccinated 5600 5600 
N umber of persons who were absent from 31 6 368 -52 
work 
Total number of days absent from work 1 ,266 1 ,472 -206 
GP visit following ILi 76 88 1 2-
GP visits due to side effects from 56 0 56 
vaccination 
Number of persons who used OTC 253 294 4 1 -
medication 
Number of persons who used antibiotics 1 5  1 8  2-
Costs 
Vaccination € 84,000 € - € 84,000 
GP visits following ILi € 2,203 € 2,562 € 359-
GP visits due to side effects vaccination € 1 625 € - € 1 625 
OTC use € 1 ,676 € 1 ,949 € 273-
Antibiotic use € 1 09 € 1 27 € 1 8-
Productivity loss € 269,400 € 31 3,256 € 43, 856-
Total costs health care workers € 359,01 4 € 31 7,894 € 41 , 1 1 9  
Patients 
Number of extended hospitalizations 21  70 49-
Costs of extended hospitalizations € 21 ,41 1 € 71 ,370 € 49,959-
Total costs patients € 21 ,41 1 € 71 ,370 € 49,959-
Total costs (health care workers + € 380,425 € 389,264 € 8,839-
patients) 
GP, general practitioner; IL i ,  influenza like il lness; OTC, over the counter. 
In the univariate sensitivity analyses individual parameters have been adjusted to 
understand the effect it has on the outcomes of the study. The results show that when 
health care costs increase, the savings increase following a vaccination program and 
this is also true when the probability of attracting influenza/pneumonia in the hospital. In 
case the work absence is lower and the decrease in productivity is also lower, the 
potential savings of a program are lower than might be expected following our results. 
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Two scenarios have been reviewed. In the first scenario where the vaccination 
coverage is very high but the disease burden which can be reduced is not significant and 
the efficacy of the vaccine is low and the costs are lower than expected, a vaccination 
program will not be cost-effective. In such a scenario, total net costs can increase up tot 
€ 1 6,000. In the reverse situation, a vaccination program is more cost-effective than 
presented in the results. 
The results show that investing in higher vaccination coverage among HCWs 
leads to a reduction in the disease burden among hospitalized patients which leads to a 
cost saving related to the prevented extended hospitalizations. It also shows that the 
scope of the analyses influences the advice that will be provided to the hospital. 
Because of the linear relationship that is assumed in the model for the 
vaccination costs, an increase in the vaccination coverage to 70% would lead to a 
reduction in the number of HCWs with work absenteeism. It would also result in an 
increase in the costs, mainly due to the vaccination costs of €84,000 but also to a much 
lower number of patients that will be infected and therefore require extended 
hospitalization (49 persons) which reduces the hospitalization costs substantially with 
€ 49,959. With this coverage rate, a cost saving of € 8,839 can be expected (see Table 
3 ). With a vaccination coverage of 23 .7% and a higher vaccine efficacy more HCWs 
would be protected against influenza which also translates to a lower transmission rate 
to hospitalized patients. Both effects would lead to a reduction in the direct medical costs 
for HCWs and lower productivity losses as well as lower costs related to the extended 
hospitalization that is required for patients following hospital acquired influenza. 
DISCUSSION 
This cost-effectiveness study alongside a trial clearly showed potential cost savings from 
the introduction of an influenza vaccination program among hospital staff. Savings were 
both derived from reduced productivity loss and decreased extended hospitalization of 
patients already admitted to the hospital. 
The input for the analysis was largely based on the established effects of the trial, 
and potential limitations and strengths have been discussed earlier. The most important 
parameters were the proportion of staff members absent from work and the percentage 
reduction in nosocomial influenza and/or pneumonia in patients. The absenteeism rate 
(4.6%) was estimated using the work absence registration from the hospitals 
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participating in the trial. In the trial a slight increase in absenteeism rates was reported in 
intervention as compared with control UMCs. It is likely a proxy for more strict 
regulations regarding working when staff has influenza, and is not a result of the 
vaccination program. Therefore it was decided to use the 4.6% for the situation where no 
vaccination was available. Comparing the situation where no vaccination program is 
offered to a vaccination coverage of 23 . 7% and taking into account work absenteeism of 
4.6% following ILi makes the vaccination program cost saving. Higher work absenteeism 
rates increase the effect the vaccination program has on the total savings. 
The proportion of patients with nosocomial influenza and/or pneumonia was also 
an important cost-driver. We observed considerable reduction in the intervention versus 
control UMCs with an estimated 11 .74% being infected during an epidemic. This figure 
agrees with the modeled 1 3 % of nosocomial infection during an epidemic in a 
mathematical model developed by Van den Dool et al.20 
When only taking into account the effect vaccination has on HCWs the business 
case would not be positive and investing in vaccination campaigns for HCWs would not 
be favorable for a hospital. Taking into account the effect it has on patients however 
makes it different because of the health gains that can be reached. 
Vaccinating HCWs has a direct and an indirect effect whereby the indirect effect 
is more significant because it affects mainly frail persons. Would it be considered ethical 
to offer vaccination to a group of persons whereby the benefit of the vaccination program 
lies with another person? From a cost-effectiveness perspective it would be reasonable 
to offer vaccination to HCWs but it remains unclear whether they are willing to receive 
the vaccination which thus leads to a higher vaccination coverage. The results presented 
show that vaccinating HCWs is favorable for patients but does it also legitimate the 
discussion of mandatory vaccination of health care workers in the Netherlands? For the 
authors, more research is needed in different health care settings before this can be 
considered but programs to voluntary increase the vaccination coverage among HCWs 
should definitely be considered. 
The study was performed in academic hospitals in a number of departments and 
the question therefore is whether the results can also be applied to other departments 
and also to for example general hospitals in the Netherlands. However, when applying 
the results of the study to other health care settings it should be taken into account that 
the turnover of patients in different settings can be an important parameter for the 
effectiveness of the vaccination program. 
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To conclude, the vaccination program is likely cost-saving from a societal 
perspective but from the hospital perspective this is not the case. The investments for 
the influenza vaccination program made by hospital management result in higher 
productivity costs and lower direct medical costs related to patients. Within the current 
financial system these investments are not supported by financial incentives. However, 
hospitals might use the vaccination program in their communication strategy to patients. 
Studies are warranted that focus on peripheral hospitals and to focus on translational 
research in order to understand how to increase the vaccine uptake in different settings 
during consecutive years and might become a subject for negotiation between health 
care insurers and hospitals. 
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In this thesis we presented studies that focused on the issue how to increase influenza 
vaccination coverage among Health Care Workers (HCWs) in hospital settings. In 
chapter 2 we showed which factors reported by administrators of Dutch general 
hospitals were associated with influenza vaccine uptake among HCWs. Hospitals in 
which the administrators agreed with positive statements concerning influenza 
vaccination of HCWs had slightly higher vaccine coverage, though not statistically 
significant. Importantly, in hospitals that economically invested more in their vaccination 
campaign in comparison with their counterparts, statistically significantly higher vaccine 
coverage was recorded. In chapter 3 we assessed potential differences in management 
beliefs on influenza vaccination of HCWs between administrators from general hospitals 
and nursing homes, and we concluded that in both health care settings behavioural 
changes are urgently needed in order to increase influenza vaccine coverage, possibly 
through well-developed, structured, implementation programs. In chapter 4 we 
performed a systematic literature search and meta-analysis to determine the most 
important predictors of seasonal influenza vaccine acceptance among HCWs in 
hospitals. After examining 1 3  studies, we found five determinants that were associated 
with a relevant two-fold higher influenza vaccine coverage. In chapter 5 we focused our 
study on health care settings in the Netherlands and assessed which determinants 
predicted influenza vaccination behaviour among HCWs in all Dutch University Medical 
Centers (UMCs). The questionnaire study revealed an accurate and discriminative 
prediction model with two demographic and nine behavioural determinants. In chapter 6 
we described how a multi-faceted influenza vaccination implementation strategy was 
developed based on the need assessment of chapters 4 and 5, using the Intervention 
Mapping method, and how it was applied and evaluated in the intervention UMCs (see 
also chapter 7). The process evaluation showed that more exposure to the intervention 
program elements was associated with higher vaccine coverage among HCWs. In 
chapter 7 we assessed the effects of the developed intervention strategy on both 
influenza vaccine uptake among hospital staff in the UMCs and on patient morbidity 
using a cluster-randomized controlled clinical trial design. The trial study showed that 
vaccine coverage of HCWs increased after implementation of the intervention strategy 
and we also demonstrated that the increase in vaccine coverage among HCWs was 
associated with decreased patient in-hospital morbidity from influenza and/or 
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pneumonia. Finally, in chapter 8 a cost-effectiveness analysis is reported that showed 
that the developed implementation program resulted in cost-savings and is likely cost­
effective. Therefore, hospital managements should advocate the influenza vaccination to 
their HCWs. 
Rationale for immunizing HCWs against influenza 
Influenza is one of the leading causes of epidemic respiratory infections, 1 •2 causing 
severe morbidity and mortality among older persons and persons with acute or chronic 
risk-elevating medical conditions. 3·5 There are several arguments in favour of immunizing 
HCWs working in hospitals against influenza: 
1. Indirect protection of patients 
Some four clinical trial studies demonstrated that immunizing HCWs of nursing homes or 
long-term care facilities against influenza is effective in protecting patients against 
influenza and its possible complications.1·10 The indirect protection of patients is 
hypothesized to be possible as HCWs serve as one of the main vectors for transmitting 
the influenza virus to their patients after infection. In a cohort study Elder et al. showed 
that during a mild influenza epidemic 23 % of non-vaccinated HCWs in acute care had 
serological evidence of influenza and up to 59% remained asymptomatic.1 1  This 
increases the chance to continue to work and infect patients. Importantly, studies from 
the US showed that up to 75% of HCWs continue their work while being symptomatic. 12 
Carman et al. who studied the effects of increasing the coverage of influenza 
vaccination among HCWs on mortality among seniors in a long-term care setting in the 
US, reported that higher vaccine coverage of HCWs was associated with a substantial 
decrease in mortality among patients. 7 A similar effect was observed by Hayward et al 
who used a cluster randomized controlled trial to demonstrate a significant decrease in 
mortality and influenza-like illness among residents in homes where influenza 
vaccination was offered to staff compared to homes where the vaccine was not offered 
to their caregivers. 8 Potter et al. demonstrated a significant reduction in total patient 
mortality from 1 7% to 10% (OR 0.56; 95% Cl 0.40 - 0.80) and an adjusted 43% 
reduction in influenza-like illness in  1 2  geriatric medical long-term-care sites that 
increased the vaccine coverage compared with sites with low vaccine coverage.9 Finally, 
Lemaitre et al. performed a cluster-randomized controlled trial in 40 nursing homes 
showing that the effect of staff influenza vaccination resulted in a 20% reduction in 
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resident all-cause mortality. 10 Hence, Thomas et al. who performed a meta-analysis of 
existing trial studies demonstrated in their Cochrane review that all trials showed benefits 
in both patient morbidity and mortality.13 However, they also reported that there are 
some methodological limitations in that bias cannot be excluded. Several outcomes used 
in the four studies were not specific enough, for instance death from pneumonia is less 
specific than death from pneumonia due to influenza. Further, all studies had inadequate 
HCW vaccine coverage which underestimates the effect that would occur if full coverage 
was achieved. Importantly, the evidence for these effects is mainly observed in nursing 
homes and long-term care facilities, which limits the applicability to HCWs working in 
hospitals. The data of our multicenter controlled trial adds evidence to previous studies 
in favour of vaccinating hospital HCWs against influenza. We showed that an increase in 
vaccine coverage is associated with a decrease in patient in-hospital morbidity from 
influenza and/or pneumonia. 
2. Indirect protection of relatives 
A 2009 review showed that HCWs mainly get immunized against influenza for self­
protection. However, a second self-reported reason to accept the vaccine was to protect 
patients, or family members or colleagues. 14 In chapter 5 we showed that HCWs who are 
aware of their own personal risk of getting influenza are more likely to get vaccinated 
than HCWs who are not (OR 2.8, p<0.001 ). Other studies showed the same effects and 
also concluded that when HCWs were aware of the risk of infecting family members like 
their children they are more likely to get vaccinated. 15 
3. Individual protection 
Seasonal influenza vaccination reduces influenza-confirmed episodes among healthy 
adults by approximately 75% when matched with circulating strains. 16 In 201 O Jefferson 
et al. reviewed 50 reports to assess the effect of vaccination on influenza in healthy 
adults.17 They concluded that when the vaccine matched the circulating viral strains, 4% 
of unvaccinated persons versus 1 % of vaccinated persons developed symptoms of 
influenza (95% Cl 2-5%). Also, vaccination had a modest positive effect on work 
absenteeism, but an effect on hospital admissions or complication rates could not be 
detected, possibly because of inadequate statistical power. So, if healthy people are 
vaccinated against influenza they are less likely to become infected. Recently, 
Osterholm et al. showed in a large meta-analysis of randomized controlled trials among 
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healthy adults that immunization with the inactivated influenza vaccine leads to a 59% 
efficacy (95% Cl 51 -67%) in preventing laboratory-confirmed influenza infection.1 8  As 
healthy adults can be considered representative for HCWs this evidence shows that 
HCWs can be protected against influenza by vaccination. Our observation in internal 
medicine departments that increased influenza vaccine coverage among HCWs was 
associated with reduced influenza morbidity in patients confirms these trial findings. 
4. Productivity loss and continuity of care 
Two double-blind randomized controlled trials demonstrated that influenza vaccination 
can reduce work absenteeism caused by respiratory infections.19•20 Saxen et al. showed 
a statistically significant reduction of 28% in total sick leave days (because of respiratory 
infections), thereby indicating that vaccinating HCWs is very important for the continuity 
of care.20 In our trial, we did not find an association between increased vaccination 
coverage and a reduction of productivity loss in HCWs. However, in our trial HCWs were 
instructed during the peak of the influenza season not to start working if they were not 
feeling well or if they had flu-like symptoms. It is known from literature that even when 
HCWs are feeling ill, they continue to work in around 76% which poses a major risk for 
patients to get infected. 12 Because of potential additional reduction in infected working 
personnel in the intervention group this might be the reason we were not able to 
demonstrate a reduction in productivity loss. 
5. Cost-effectiveness 
In 201 O Hak et al. performed a cost-benefit analysis to assess the annual productivity 
loss among HCWs attributable to influenza, and to estimate the costs and benefits of a 
vaccination program from the employers' perspective.21 They showed in this modelling 
study that the costs due to productivity loss among HCWs are considerably high. 
Therefore, reaching higher vaccine coverage among staff through a vaccination program 
can be cost-saving. As demonstrated in chapter 8, we show similar results in that it is 
cost-saving to vaccinate HCWs, which makes it also more appealing for the hospitals' 
managements to advocate vaccination among HCWs. 
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6. Moral duty not to harm and professional responsibility 
Lastly, there are also several ethical arguments in favour of vaccination. One of the most 
important ethical arguments is the moral duty of all HCWs to do no harm to their 
patients.22 In addition, HCWs serve as a role model for patients in showing that they are 
willing to provide the best possible care to their patients resulting from their professional 
responsibility. 
The pre-pandemic situation in Europe and the Netherlands. 
Since infected HCWs may transmit the influenza virus to individuals at risk of severe 
disease, the WHO has been recommending influenza vaccination for HCWs. Such a 
strategy should also be part of a broader infection control policy in health care settings.23 
The United States Centers for Disease Control and Prevention (CDC) has recommended 
influenza vaccination for HCWs who take care of patients at high risk for significant 
morbidity following an influenza infection already since 198 1 .  24 Despite the available 
evidence and these recommendations, influenza vaccine uptake among HCWs still 
remains low. Maltezou et al. showed that all 27 European Union Member States and 
three additional European countries (Norway, Switzerland and Russia) has been 
recommending HCWs to be vaccinated against influenza, except for Sweden that only 
recommended vaccination during the 2009/201 0  H1 N1 pandemic.25 However, vaccine 
uptake rates among HCWs vary considerably between these countries, from 1 5% in the 
UK and Germany to 25% in Romania and in all these vaccine uptake rates still remain 
very low.26 
As is shown in chapter 4 of this thesis, the vaccine coverage rates of HCWs 
studied in the meta-analysis ranged from as low as 2.1 % 12 to 62% in a more recent 
study from 1999-2000.27 The low vaccine coverage is currently still a problem in the 
Netherlands as we have shown in chapter 7. To further improve vaccine coverage in the 
Netherlands, a guideline for preventing influenza in nursing homes was developed in 
2004,28 while a guideline for hospitals was not developed until 2007 when the Dutch 
Health Council recommended vaccination for HCWs following guidelines from the WHO 
and CDC. The fact that after several years the vaccine coverage is still this low can be 
explained by various arguments against immunizing HCWs working in hospitals against 
influenza. 
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Reasons for HCWs not to get immunized against influenza 
1. Perception of the vaccine's effectiveness 
There are several reasons for the low vaccine coverage as there exist many barriers 
among HCWs against vaccination. The arguments for non-acceptance of the vaccine 
can be divided into two main categories: (1 ) knowledge, beliefs and attitudes or (2) 
accessibility. As expected, vaccinated HCWs believe that the vaccine is more effective 
(in reducing influenza-like illness and vaccine-strain specific illness) than non-vaccinated 
HCWs.29 We showed in the chapters 2 and 5 that the determinant 'knowing that the 
vaccine is effective in preventing influenza transmission' is significantly associated with 
at least a two-times higher vaccine uptake. Unfortunately, most HCWs appear to be 
unaware of these effects or are apparently not able or willing to reconsider their 
arguments once they have made the decision to be immunized or not. 
2. Perception of side effects associated with vaccination 
One of the reasons for refusing vaccination is the fear of side effects. A study assessing 
the attitudes of HCWs towards pandemic influenza A (H 1 N 1 )  vaccination showed that 
concern about the long-term side effects was the main reason for non-vaccination 
among refusers (3 7%).30 Nurses are more likely to refuse the vaccine because of 
possible side effects than doctors as shown by Smedley et al.31 They also conclude that 
in a group of 2 14  healthy HCWs 74% had no side effects and that 1 3 %  of HCWs 
experienced a local reaction. Further, Saxen et al. demonstrated in a randomized 
placebo-controlled double blind trial that vaccination against influenza caused no severe 
side effects.20 The only statistically significant symptom associated with the influenza 
vaccine was local tenderness of the arm. A Dutch study assessing the attitudes of 
general practitioners towards vaccination showed that 6% refused because of the fear of 
side effects. 32 Following these results we found similar evidence in chapter 5 where we 
concluded that the expectation not to have side effects after vaccination was statistically 
significantly associated with influenza vaccination compliance among HCWs (OR 1 .87, 
95% Cl 1 .48 - 2.3 6). 
3. Perception of management/colleagues regarding vaccination is negative 
Looijmans-van den Akker et al. pointed out that the opinions of people close to HCWs 
working in nursing homes are of significant importance.33 The investigators found an 
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odds ratio of 5.3 3  (p<0.001 ) for the determinant to get vaccinated if people close to the 
HCW thought that it was important to be vaccinated. In chapter 2 we found an odds ratio 
of 1 .  7 4 for the same determinant in hospitals (p=0.01 0). This means that the people 
surrounding HCWs, like co-workers, managers and relatives, should also be targeted 
with the right information in the most ideal situation, so that HCWs can make up their 
own decision based on the proper knowledge and are not led by other people's 
misconceptions. 
4. It is difficult to receive the vaccine 
Smedley et al. assessed the possible reasons for poor influenza vaccine uptake among 
HCWs in a survey in the UK.31 They showed that the main perceived barriers for uptake 
were problems with access to vaccine and lack of time to attend. In chapter 5 similar 
results are shown, as the determinant ' I  would get vaccinated if vaccination was 
available at a convenient time' was highly associated with vaccine uptake resulting in an 
odds ratio of 28.9 (95% Cl 1 5.90 - 52.58). 
To conclude, with the new emerging evidence that has been published over the 
past decade, it is important to educate HCWs and their social surroundings, and to 
expand their level of knowledge on influenza as a disease, on their own role as possible 
vectors and on the effects of vaccination. Further, since accessibility of vaccination has 
proven to be a problem this should be one of the most important factors in increasing 
influenza vaccine coverage among HCWs as will be discussed later. 
The effect of the Influenza A (H1 N 1 )  pandemic on influenza vaccine uptake. 
In 2009, the worldwide pandemic with new influenza A (H1 N1 ) caused a lot of distress 
and public concerns. In an attempt to restrict the spread of infection and to get as many 
risk groups vaccinated as possible, vaccines were rapidly produced and disseminated 
throughout many countries worldwide. Overall, hospitals were very active in encouraging 
HCWs to get their influenza vaccine in order to prevent understaffing due to sick leave 
and in order to prevent morbidity and mortality among patients. Most studies assessing 
that particular period of time showed that vaccine uptake increased in this pandemic 
season, even up to 92% (see also chapter 7).30•34 However, the influenza season 
following the pandemic showed a decrease in influenza vaccine uptake among HCWs 
(see also chapter 7).34 This could suggest that anxiety among HCWs caused by the fact 
that young people were actually dying from this new variant of influenza played an 
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important role in getting vaccinated. This situation is different from the regular seasonal 
influenza in that HCWs often feel that they don't need a flu shot because they are not 
afraid to get ill themselves, and even if they do get ill, there are normally few 
complications. This is also demonstrated by Kraut et al., 35 who assessed the attitudes of 
HCWs that were vaccinated against H1 N1 in two groups: those that were routinely 
vaccinated against seasonal influenza and those that were not. They showed that the 
main motivators for getting vaccinated against H 1 N 1 in both groups were concerns 
about personal or family safety. That is consistent with this thesis as we showed in 
chapter 2 that being aware of the personal risk to get infected with influenza is 
associated with an almost three-time higher probability to get vaccinated yourself. HCWs 
that were routinely not being vaccinated against seasonal influenza reported lower levels 
of concern on the seriousness of influenza, their sense of exposure risk and had less 
confidence in the effectiveness of the vaccine compared to the HCWs that were routinely 
vaccinated against seasonal influenza. 35 
How to further improve influenza vaccine coverage among HCWs without mandate 
We studied multiple ways in which we could influence the behaviour and attitudes of 
HCWs so that HCWs could make a deliberate choice in accepting the influenza vaccine 
or not. Our aim was to increase vaccine coverage in this group in order to achieve 
protection not only for the HCWs but mainly for their patients, as we showed in chapter 
7. However, we did not succeed in achieving full vaccine coverage among HCWs. 
In chapter 6 we showed the results of the process evaluation of our vaccine 
implementation strategy. The nine behavioural determinants that resulted from our 
needs assessment in chapter 2 were targeted in the influenza vaccination strategy that 
we developed, in order to raise vaccination behaviour in HCWs. These determinants 
largely cover both the arguments in favour and against influenza vaccination. Tools were 
developed by our research team to target the determinants and to disseminate these. 
However, in the actual implementation these determinants were not all applied by the 
intervention UMCs, as shown in chapter 6. To have highest impact, all determinants 
need to be targeted in order to achieve the most effective vaccination campaign 
possible. Unfortunately, the communication tools that we have developed were not used 
in an optimal way or noticed by the majority of HCWs. For example, the research team 
developed badges that could be handed out after a HCW was vaccinated, showing that 
that HCW had received the vaccine. They were meant as an item that would raise 
14 1  
discussion among HCWs so that they would debate about it on the work floor. However, 
these badges were handed out to only 3 2.9% of HCWs in the intervention UMCs in the 
season 2009/201 0. One year later this number was even halved when only 1 6.6% of 
HCWs were provided with a badge. One explanation for this was resistance from the 
Board of Directors of some UMCs, as some members of the Board of Directors did not 
support this idea. Another tool that was developed by the research team was a website 
providing information about influenza and the vaccination. This website was visited by 
less than 10% of HCWs the first trial season, and one year later by almost 20%. Despite 
this increase, the potential impact of the program might have been increased if all UMCs 
had put the link to the website on their intranet. 
Another reason for differential use of the communication tools is that in the UM Cs 
different departments were responsible for the annual vaccination campaign. In some 
UMCs, the communication staff was the main responsible for the influenza vaccination 
campaign, while in other UMCs the department of occupational health was responsible. 
This caused differences in usage of the communication tools. Also, in the intervention 
UMCs, these departments were asked to change their own routine which hampers 
effective implementation. 
In chapter 7 we demonstrated a significant correlation between the number of 
applied methods and vaccine coverage; showing a clear trend towards increased 
vaccine coverage if more methods were applied. Therefore it is very important for future 
implementation that the intervention strategy is applied with maximal exposure of all 
tools. 
Potential new tools that may prove to be effective 
One of the latest studies demonstrated a positive effect of text messaging on influenza 
vaccine uptake in a low-income, urban population, taking into account the society that is 
connecting increasingly via cellular telephones and the internet. 36 Public reporting of 
institutional influenza vaccine uptake rates among HCWs is another element that might 
be effective in raising vaccine coverage. 37 In this way, HCWs can be informed about the 
way their department and/or their hospital reaches their vaccination goals compared to 
other hospitals. Llupia et al. showed that their intervention increased vaccine coverage 
among HCWs significantly from 23 % before the intervention to 3 7% after the 
intervention. 38 They used 3 lines of activity: (1 ) a high level of institutional support, (2) 
raising awareness in the campaign by weekly educational e-mails, prize drawings and a 
142 
website with photographs of vaccinated HCWs, and (3 ) enhancing accessibility by 
means of mobile vaccination units which routes were spread in advance. 
In conclusion, we can say that there are several possibilities for further 
improvements in the implementation of the vaccination program. Despite all the efforts 
made during the implementation of our strategy, full influenza vaccine coverage among 
HCWs could not be reached since the UMCs did not achieve maximum exposure to the 
determinants. 
Dissemination of the vaccination program in non-academic hospitals 
ZONMW has granted a dissemination project in which it is planned to implement the 
developed intervention strategy in non-academic hospitals in the Northern part of the 
Netherlands. In this project we will take into account the abovementioned drawbacks of 
the UMC project. The tools will be adjusted following the evaluation in chapter 6. The 
new methods used by Llupia et al. , Stockwell et al. and Johnson et al. are also worth to 
take into account.3e-38 Only when the tools are brought under the attention of HCWs, they 
can achieve their maximum effect in increasing influenza vaccine coverage among 
HCWs. 
Should influenza vaccination of HCWs be mandatory or not? 
In the Netherlands influenza vaccination is a voluntary measure taken by HCWs which 
may be the reason for such low uptake rates. Therefore, to reach maximal vaccine 
coverage among HCWs mandatory vaccination is an option that should be considered, 
as we will discuss below. 
With mandatory vaccination we do not mean forced vaccination against one's 
will. Mandatory vaccination is conditional, in that people who refuse vaccination, e.g. for 
religious or philosophic reasons, are refused from their work for a certain period of time. 
There are several arguments in favour of mandatory influenza vaccination.22•39 The most 
important argument is the moral duty of HCWs not to harm their patients. This is 
especially important in the case of influenza where it is known that infecting patients with 
influenza is easily preventable by a once a year single flu shot preceding every influenza 
season. 
Further, the professional responsibility of HCWs also comprises that in order to 
deliver the best possible care for their patients, they adhere to hygienic protocols and are 
also vaccinated against hepatitis B and tested on tuberculosis. In the Netherlands, every 
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HCW is required to be properly vaccinated against hepatitis B when working with 
patients and also must be excluded to have tuberculosis before starting with patient 
care. This is a mandatory measure following the advice of the Dutch Health Council that 
is taken in order to protect HCWs and their patients from these infectious diseases. 
Lastly, despite the fact that influenza vaccination in HCWs has proven to be 
effective in protecting patients from influenza, 7-9·13·19  is cost-effective40 and reduces 
absenteeism, 1 9·20 voluntary vaccination is not sufficient in raising the influenza vaccine 
uptake rates as these remain low (see also chapter 5).26.41 .42 
Arguments against mandatory vaccination are taking away the freedom of choice 
and autonomy of staff, possible damage of morale, possible side-effects from the 
vaccine and the view that vaccination of HCWs is only in the interest of the 
employers. 22A3 Taking away the freedom of choice is a major issue among HCWs. Also, 
many HCWs feel that the distance between HCWs on the work floor and the board of 
directors/managers of the hospitals is too large. The feeling that mandatory vaccination 
is appealing for employers from a financial perspective adds to HCWs' resistance. 
Therefore HCWs disapprove of being forced into mandatory vaccination which, in their 
point of view, interferes with their autonomy. The possible side-effects from the influenza 
vaccine can be considered as minor,20 with certain exceptions like Guillain-Barre 
syndrome.1 7·44 However, considering all arguments together we believe that the benefits 
of protecting patients against influenza outweigh the possible objections of HCWs. 
Of course, the most ideal situation would be a voluntarily based influenza 
vaccination campaign that results in high vaccination coverage rates. However, this 
thesis and several other studies26A1A2A5 show that in the case of voluntary vaccination 
vaccine uptake remains too low. Studies performed in the United States however show 
that mandatory vaccination is associated with influenza vaccine coverage up to 100% as 
demonstrated by Kidd et al.46 They managed to increase their vaccine uptake rate 
among Universital Hospital HCWs from 51 % to a staggering 100% after mandating the 
flu shot. They created a program with an exemption committee where employees could 
admit applications for refusing the vaccine for medical or religious reasons. The 
committee reviewed each application and approved or denied it. Employees who were 
denied were required to receive the vaccine otherwise they were ineligible to report to 
work during the flu-season. A Greek study performed by Maltezou et al. showed that 
there is a higher rate of accepting a mandatory vaccination policy among physicians 
compared to nurses or other medical professions.47 Over 50% of HCWs would accept 
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mandatory influenza vaccination for all HCWs, and over 66% favoured HCWs to be 
mandatory vaccinated against influenza for HCWs who take care for 
immunocompromised patients. They also demonstrated that physicians and nurses 
working in the internal medicine departments had higher acceptance rates towards 
mandatory vaccination than HCWs working in other departments. 
Feemster et al. described their experience with implementing mandatory influenza 
vaccination for HCWs at a tertiary children's hospital in Philadelphia.48 They first 
implemented a mandatory program in targeted groups of HCWs, before expanding it to 
the entire hospital. The concluded that the majority of HCWs (72%) found mandatory 
vaccination to be coercive, but also a vast majority of HCWs (>90%) felt that mandatory 
influenza vaccination was important for protecting patients as well as staff and was part 
of their professional and ethical responsibility. 
Considering all these arguments, the implementation of mandatory vaccination in 
Dutch hospitals should be considered and should ideally be a part of the multi-faceted 
implementation strategy described in chapter 6. However, there is a long way to go 
before HCWs will fully accept this. A future study assessing the attitudes of Dutch 
hospital HCWs towards mandatory influenza vaccination will be helpful in finding the 
proper way to implement it in the Netherlands. 
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SUMMARY 
Influenza is a potential life-threatening viral infection which can be easily prevented by 
vaccination. Health care workers are recommended to be vaccinated against influenza, 
not only to protect them selves but mainly to protect their vulnerable patients. However, 
despite recommendations, vaccine coverage among health care workers is 
disappointingly low since many years. The pandemic with new influenza A (H1 N1 ) 
temporarily raised vaccine coverage among health care workers, showing that if the 
threat is evident, high vaccine coverage is possible. However, after the 2009/201 0 
pandemic season, vaccine coverage has been returned to lower levels. 
This thesis starts in chapter 2 and 3 with two studies exploring the contributing 
factors to influenza vaccine uptake among hospital staff and nursing home staff from the 
management's point of view. Both studies were questionnaire studies where the 
managements of hospitals and nursing homes were questioned about the reasons they 
believed were important for vaccination according to their staff. The first study, among 42 
Dutch general hospitals, showed a low influenza vaccination rate among health care 
workers; only 1 7.7% of them was vaccinated against influenza. Hospitals in which the 
administrators agreed with positive statements concerning the influenza vaccination had 
a slightly higher, but non-significant, vaccine uptake. However, it was demonstrated that 
more economic investments in the vaccination campaign were related with a higher 
vaccine uptake. The second study compared the results from the general hospitals with 
those from Dutch nursing homes. Significant differences between both care institutions 
were amongst others the presence of a written policy on the influenza vaccination; this 
was the case in almost three times as many nursing homes than general hospitals. Also, 
almost three times as many nursing homes administrators compared to general hospital 
administrators believed that mandatory vaccination of staff against influenza would be 
accepted in their institution. 
In chapter 4, a meta-analysis was performed in order to determine which factors 
were associated with seasonal influenza vaccine acceptance among hospital health care 
workers. An extensive literature search in Pubmed and Embase eventually resulted in 1 3  
studies eligible for inclusion in the meta-analysis. We calculated pooled risk ratios and 
identified five determinants that were statistically significant associated with a twofold 
higher vaccine uptake. These determinants were: knowing that the vaccine is effective; 
being willing to prevent influenza transmission; believing that influenza is a highly 
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contagious disease, believing that the prevention of influenza is important and having a 
family member that is usually vaccinated. After this meta-analysis was performed we 
knew which factors were important in international literature for developing new 
vaccination strategies. 
We also wanted to know which factors were associated with influenza vaccine 
uptake among health care workers at a national level. We therefore performed a 
questionnaire study among Dutch health care workers in chapter 5. In 2008, we 
selected five departments from all eight Dutch university medical centers (UMCs) where 
patients were at medium and high risk for influenza: internal medicine, neonatology, 
paediatrics and two intensive care units. Health care workers of these specific wards 
were provided with an anonymous, self-administered paper questionnaire and were 
asked to give their opinion on demographic, behavioural and organizational determinants 
that would predict their vaccination behaviour. In total, 1295 questionnaires were filled 
out (response rate 39%) and 37.6% of all respondents were vaccinated against 
influenza. In the univariate analysis, nine out of 11 demographical determinants were 
significantly related to influenza vaccine uptake. This was also the case for 11 out of 19 
organizational determinants and for 34 out of 39 behavioural determinants. The final 
multivariate analysis resulted in an 11-item final prediction model with two 
demographical and nine behavioural determinants. The accuracy of this prediction model 
was very high with an area under the receiver operating curve of 0.95. 
Chapter 6 describes the planning of a multi-faceted influenza vaccination 
implementation strategy for health care workers in acute health care settings. We used 
the Intervention Mapping method as a framework to systematically plan, develop and 
evaluate the process of an influenza vaccination implementation strategy. The 
Intervention Mapping method can be used as part of the dynamic process of planning 
intervention strategies in health education and is composed of six steps: 1) a needs 
assessment; 2) establishment of proximal program objectives; 3) development of theory­
based methods and practical strategies; 4) program planning; 5) adoption and 
implementation of the program; and 6) program evaluation. Following these steps, the 
11-item prediction model developed in chapter 5 was discussed in a 10-person research 
team to assess their changeability. Based on the measures of association and their level 
of changeability, the determinants were divided into four categories: knowledge; 
common interest; social impact; and organizational. The objectives of all determinants 
were set and methods and materials to achieve the objectives were developed. These 
1 53 
program methods and materials were then drafted into common formats and sample 
materials, and were prepared for implementation. A communication expert supervised 
the whole process. 
After implementation of the program both a qualitative and quantitative process 
evaluation was carried out. In the qualitative evaluation was assessed which parts of the 
implementation program were used by the university medical center. Communication 
reports were also requested, and the contact persons of the UMCs were asked to 
comment on the materials used. Intervention and external UMCs showed more use of 
targeted determinants than the control UMCs. In the quantitative evaluation, a sample of 
health care workers from the earlier mentioned five departments of the Dutch university 
medical centers was asked to complete an anonymous web-based questionnaire. This 
was done in the spring of 201 0  and 2011 , after both study seasons of 2009/201 0 and 
201 0/2011 . The questionnaire contained questions concerning the usage of the 
developed tools in their hospital. Of all the developed communication materials, health 
care workers reported the posters as most noticeable. 
Chapter 7 describes the results of a hospital-based cluster randomized 
controlled trial to assess the effects of the earlier developed multi-faceted program on 
influenza vaccine coverage among health care workers and on patient morbidity. The 
study period included the influenza seasons of 2009/201 0 and 201 0/2011 . All eight 
Dutch university medical centers were invited to participate in the trial. Six of them 
agreed to randomization at cluster level, and were randomized in an intervention group 
(three UMCs) and a control group (three UMCs). The remaining two UMCs (refused 
randomization and) acted as external controls. We included 3 3 67 patients. The primary 
outcome was influenza vaccine uptake among health care workers. Secondary 
outcomes were absenteeism among health care workers in the month of December and 
patient morbidity. 
In both study seasons, influenza vaccine uptake among health care workers was 
significantly higher in the intervention UMCs than in the control UMCs. In the pandemic 
season of 2009/201 0, where three vaccination rounds were offered, the highest absolute 
risk difference was seen for the first dose of the pandemic vaccination, namely 23 .7% 
(95% Cl 4.3 - 47.8). At the internal medicine departments of the intervention group with 
higher vaccine coverage compared to the control group, nosocomial influenza and/or 
pneumonia was recorded in 3 .9% and 9.7% of patients of intervention and control 
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UM Cs, respectively (p=0 .01 5). So an increase in vaccine coverage was associated with 
decreased patient in-hospital morbidity from influenza and/or pneumonia. 
In chapter 8 we assessed the cost-effectiveness of implementing a hospital­
based multi-faceted influenza immunization program among Dutch health care workers. 
We showed that in a base-case scenario with no vaccine coverage, annual costs of 
influenza were estimated at €3 89.264 for an average UMC with 8000 health care 
workers and 6000 patients hospitalized during an epidemic. If the influenza vaccine 
coverage among HCWs was increased to 23 . 7%, as was observed in the intervention 
cluster in 2009, the program's savings were estimated at €2.993 . Therefore we conclude 
that the implementation of this multi-faceted program results in cost-savings, and more 
efforts should be considered to increase vaccination coverage among HCWs in Dutch 
hospitals. 
Finally, we conclude this thesis with a general discussion in chapter 9. First, the 
rationale for vaccinating health care workers against influenza is discussed. Several 
arguments are mentioned; the indirect protection of patients and relatives; individual 
protection of the health care worker; productivity loss because of absenteeism; the cost­
effectiveness of vaccination and finally the moral duty not to harm your patients. Then 
the pre-pandemic situation in Europe and the Netherlands is summarized. In most 
European countries vaccine uptake among HCWs was low before the 2009 H1 N1 
pandemic, and during this pandemic vaccine coverage increased. Further, the reasons 
for HCWs not to get immunized against influenza are discussed. The general discussion 
ends with the question if mandatory vaccination against influenza is an option or not. 
Considering all arguments, mandatory vaccination in HCWs should be considered in the 
Netherlands and should ideally be part of the multi-faceted influenza vaccination 
implementation strategy. Future studies assessing the attitudes of Dutch hospital HCWs 




Influenza is een potentieel levensbedreigende virale infectie die gemakkelijk kan warden 
voorkomen door vaccinatie. Gezondheidszorgwerkers wordt aangeraden zich te laten 
vaccineren tegen de griep, niet alleen om zichzelf te beschermen, maar vooral om hun 
kwetsbare patienten voor infectie te behoeden. Echter, ondanks deze aanbeveling blijft 
de vaccinatiegraad ender gezondheidszorgwerkers al jaren teleurstellend laag. De 
Nieuwe Influenza A(H1 N1 ) pandemie veroorzaakte een tijdelijke verhoging van de 
vaccinatiegraad ender gezondheidszorgwerkers, waaruit blijkt dat als de dreiging 
duidelijk is, een hoge vaccinatiegraad mogelijk is. Echter, na het pandemische seizoen 
van 2009/201 0  is de influenza vaccinatiegraad wederom laag. 
Dit proefschrift begint in hoofdstuk 2 en 3 met twee onderzoeken waarin de 
factoren warden onderzocht die bijdragen aan de influenza vaccinatiegraad ender 
ziekenhuispersoneel en verpleeghuispersoneel, vanuit het oogpunt van het 
management. Seide onderzoeken zijn vragenlijstonderzoeken waarin de directies van 
ziekenhuizen en verpleeghuizen werd gevraagd naar de redenen die zij belangrijk 
achtten voor hun personeel om gevaccineerd te warden. Het eerste onderzoek, dat werd 
uitgevoerd in 42 Nederlandse algemene ziekenhuizen, liet een lage influenza 
vaccinatiegraad ender gezondheidszorgwerkers zien; slechts 1 7, 7% van hen was 
gevaccineerd tegen influenza. Ziekenhuizen waarvan het management de influenza 
vaccinatie ender hun personeel meer positief beoordeelde, hadden een niet-significant 
hogere vaccinatiegraad. Ook werd in dit onderzoek aangetoond dat hogere 
economische investeringen in de vaccinatiecampagne leidden tot een hogere 
vaccinatiegraad. In het tweede onderzoek werden de resultaten van de algemene 
ziekenhuizen vergeleken met Nederlandse verpleeghuizen. Er werden enkele 
significante verschillen aangetoond tussen beide zorginstellingen; zo bleek dat in de 
verpleeghuizen drie keer zo vaak een schriftelijke richtlijn voor de influenza vaccinatie 
aanwezig was. Tevens waren bijna driemaal zoveel managements van verpleeghuizen 
ervan overtuigd dat hun personeel het verplicht stellen van de griepvaccinatie zou 
aanvaarden in vergelijking met de managements van algemene ziekenhuizen. 
In hoofdstuk 4 wordt een meta-analyse beschreven waarin werd onderzocht 
welke factoren geassocieerd zijn met de acceptatie van de seizoens griepprik ender 
gezondheidszorgwerkers in ziekenhuizen. Een uitgebreid literatuuronderzoek in Pubmed 
en Embase resulteerde uiteindelijk in 1 3  geschikte studies die in aanmerking kwamen 
voor inclusie in de meta-analyse. We berekenden gecombineerde risico ratio's (pooled 
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risk ratios) en identificeerden vijf determinanten die statistisch significant geassocieerd 
zijn met een tweevoudig hogere vaccinatiegraad. Deze determinanten zijn: weten dat het 
vaccin effectief is; bereid zijn om de overdracht van influenza te voorkomen; geloven dat 
influenza een zeer besmettelijke ziekte is; ervan overtuigd zijn dat de preventie van 
influenza belangrijk is; en het hebben van een familielid dat gewoonlijk wordt 
gevaccineerd tegen influenza. Na het uitvoeren van deze meta-analyse wisten wij welke 
factoren belangrijk zijn in de internationale literatuur voor het ontwikkelen van nieuwe 
vacci natiestrateg ieen. 
Ook was het belangrijk om te weten welke factoren geassocieerd zijn met de 
influenza vaccinatiegraad onder gezondheidszorgwerkers op een nationaal niveau. We 
hebben daarom een vragenlijstonderzoek uitgezet onder Nederlandse 
gezondheidszorgwerkers, waarvan de resultaten beschreven staan in hoofdstuk 5. 
2008 zijn er vijf afdelingen geselecteerd van alle Nederlandse universitair medisc 
centra (UMCs), waar patienten een gemiddeld tot hoog risico liepen op het oplopen v 
influenza: de afdelingen interne geneeskunde, neonatologie, kindergeneeskunde 1 
twee intensive care afdelingen. Gezondheidszorgwerkers van deze afdelingen werd e1 
anonieme vragenlijst aangeboden waarin hen werd gevraagd hun mening te geven ov 
demografische determinanten, gedragsdeterminanten en organisatorisct 
determinanten die hun vaccinatiegedrag voorspelden. In totaal werden 1 295 
vragenlijsten ingevuld (responspercentage 39%) en 3 7.6% van alle respondenten bleek 
gevaccineerd te zijn tegen influenza. Uit de univariate analyse bleek dat negen van de 
1 1  demografische determinanten significant geassocieerd waren met de acceptatie van 
de influenza vaccinatie. Dit bleek ook het geval te zijn voor 1 1  van de 1 9  
organisatorische determinanten en voor 34  van de 3 9  gedragsdeterminanten. De 
uiteindelijke multivariate analyse resulteerde in een predictiemodel met 1 1  
determinanten; twee demografische determinanten en negen gedragsdeterminanten. De 
nauwkeurigheid van dit model was erg hoog met een oppervlakte onder de 'receiver 
operating curve' van 0.95. 
Hoofdstuk 6 beschrijft de planning van een veelzijdige influenza vaccinatie 
implementatie strategie voor gezondheidszorgwerkers in de acute gezondheidszorg. We 
hebben gebruik gemaakt van de Intervention Mapping methode als kader om een 
influenza vaccinatie implementatie strategie systematisch te plannen, te ontwikkelen en 
het proces te evalueren. De Intervention Mapping methode kan warden gebruikt als deel 
van het dynamische proces voor het plannen van interventie strategieen in voorlichting 
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in de gezondheidszorg en bestaat uit zes stappen: 1 )  een indicatie stelling; 2) het 
vaststellen van proximale programma doelstellingen; 3 )  de ontwikkeling van op theorie 
gebaseerde methoden en praktische strategieen; 4) programma planning; 5) acceptatie 
en implementatie van het programma; en 6) programma evaluatie. 
In navolging van deze stappen werd het predictiemodel dat in hoofdstuk 5 was 
ontwikkeld besproken in een onderzoeksteam bestaande uit tien personen. Hierbij werd 
bekeken in welke mate de determinanten te be'invloeden waren. Op basis van de 
effectmaten en de mate van be·invloedbaarheid, werden de determinanten in vier 
categorieen verdeeld; kennis, gemeenschappelijk belang, sociale invloed en 
organisatorisch. De doelstellingen van alle determinanten werden bepaald en methodes 
en materialen werden ontwikkeld om deze doelstellingen te behalen. Deze methoden en 
materialen werden vervolgens aangepast tot halffabrikaten en klaargemaakt voor de 
implementatie. Dit proces werd gesuperviseerd door een communicatie deskundige. Na 
de implementatie van het programma werd zowel een kwalitatieve als een kwantitatieve 
evaluatie uitgevoerd. In de kwalitatieve evaluatie werd onderzocht welke elementen van 
het implementatie programma waren gebruikt door de universitair medische centra. 
Communicatie rapporten werden opgevraagd, en de contactpersonen van de UMCs 
werd gevraagd hun mening te geven over de gebruikte materialen. lnterventie UMCs en 
externe UMCs lieten zien meer gebruik te hebben gemaakt van de bewuste 
determinanten dan de controle UMCs. Voor de kwantitatieve evaluatie werd opnieuw 
een anonieme vragenlijst verspreid ender gezondheidszorgwerkers van de eerder 
genoemde vijf afdelingen van de UMCs. Dit gebeurde in het voorjaar van 201 0 en 2011 , 
na beide studie seizoenen van 2009/201 0  en 201 0/2011 . De vragenlijst bevatte vragen 
over het gebruik van de ontwikkelde materialen in hun ziekenhuis. Van alle materialen 
die zijn ontwikkeld, beoordeelden gezondheidszorgwerkers de posters als datgene wat 
hun het meest was opgevallen. 
Hoofdstuk 7 beschrijft de resultaten van een geclusterde gerandomiseerde 
gecontroleerde studie (RCT) naar de effecten van het eerder ontwikkelde implementatie 
programma op de influenza vaccinatiegraad ender gezondheidszorgwerkers en naar de 
effecten op de morbiditeit van patienten. De onderzoeksperiode besloeg de 
griepseizoenen van 2009/201 0 en 201 0/2011 . Alie acht Nederlands universitair 
medische centra werden uitgenodigd om deel te nemen aan dit onderzoek. Zes UMCs 
stemden toe om gerandomiseerd te warden op cluster niveau. Zij werden 
gerandomiseerd in een interventie groep (drie UMCs) en een controle groep (drie 
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UMCs). De overige twee UMCs weigerden randomisatie en fungeerden als externe 
controles. 
In totaal zijn 3 3 67 patienten ge'includeerd. De primaire uitkomst was de influenza 
vaccinatiegraad ender gezondheidszorgwerkers. Secundaire uitkomsten waren absentie 
ender gezondheidszorgwerkers in de maand december en morbiditeit ender patienten. 
In beide studie seizoenen bleek de influenza vaccinatiegraad ender 
gezondheidszorgwerkers significant hoger te zijn in de interventie UMCs vergeleken met 
de controle UM Cs. In het pandemische griepseizoen 2009/2010,  waar drie 
vaccinatierondes werden aangeboden, werd het hoogste absolute risicoverschil 
waargenomen veer de eerste pandemische vaccinatie, namelijk 23 . 7% (95% Bl 4.3 -
47.8). Op de afdelingen interne geneeskunde van de interventie groep waar een hogere 
vaccinatiegraad bestond vergeleken met de controle groep, werd bij 3 .9% van de 
patienten nosocomiale influenza en/of een pneumonie geconstateerd in vergelijking met 
9. 7% van de patienten in de controle groep (p=0.01 5). Een verhoging van de 
vaccinatiegraad is dus geassocieerd met een lagere morbiditeit door influenza en/of een 
pneumonie ender gehospitaliseerde patienten. 
In hoofdstuk 8 is de kosten-effectiviteit van het implementeren van een influenza 
vaccinatie programma ender Nederlandse gezondheidszorgwerkers onderzocht. We 
lieten zien dat in een base-case scenario waarin geen gezondheidszorgwerkers zijn 
gevaccineerd, de jaarlijkse kosten veer influenza werden geschat op €3 89.264 veer een 
gemiddeld UMC met 8000 gezondheidszorgwerkers en 6000 patienten die tijdens een 
griepepidemie zijn opgenomen. Als de influenza vaccinatiegraad ender 
gezondheidszorgwerkers werd verhoogd naar 23 . 7%, zeals in het interventie cluster 
werd gezien in 2009, liet het programma een kostenbesparing zien van €2.993 . Wij 
stellen daarin dat de implementatie van een veelzijdig influenza vaccinatieprogramma 
resulteert in een kostenbesparing, en dat er meer pogingen zouden moeten warden 
ondernomen om de vaccinatiegraad ender gezondheidszorgwerkers in Nederlands 
ziekenhuizen te verhogen. 
Deze thesis wordt afgesloten met een algemene discussie in hoofdstuk 9. Als 
eerste wordt de rationale voor het vaccineren van gezondheidszorgwerkers uiteengezet. 
Verschillende argumenten warden genoemd: de indirecte bescherming van patienten en 
familieleden; de individuele bescherming van de gezondheidszorgwerker zelf; 
productiviteitsverlies door absentie; de kosteneffectiviteit van vaccinatie; en uiteindelijk 
de morele plicht om patienten niet te schaden. Daarna wordt de pre-pandemische 
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situatie in Europa en Nederland samengevat. In de meeste Europese landen was de 
vaccinatiegraad ender gezondheidszorgwerkers laag voor het uitbreken van de 2009 
H1 N1 pandemie, om tijdens deze pandemie te stijgen. Verder warden de redenen van 
gezondheidszorgwerkers om zich niet te vaccineren besproken. 
De algemene discussie eindigt met de vraag of het verplicht stellen van de 
influenza vaccinatie een optie is of niet. Als alle argumenten warden beschouwd, zou het 
verplicht stellen van de griepprik in Nederland moeten warden overwogen. In het ideale 
geval zou dit een onderdeel zijn van de veelzijdige influenza vaccinatie implementatie 
strategie. Toekomstige onderzoeken naar de mening van gezondheidszorgwerkers in 
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Angelique Heerings. Beste Angelique, als onderzoeksassistente ben je van onschatbare 
waarde geweest. We hebben bijna alle UMCs samen bezocht voor de dataverzameling, 
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Dankjewel voor je harde werk, je enthousiasme, gezelligheid, handwerkkunsten en voor 
het uiteindelijke Excel schema met alle kleurtjes. Het blijft een kunstwerk! 
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FarmacoEpidemiologie & FarmacoEcomomie te kunnen werken. De secretaresses van 
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Dank aan alle huisartsen met wie ik heb gewerkt en die mij met liefde van het 
huisartsenvak hebben laten proeven. Christian Meijer, Kees Meeder en Johannes Pruijs: 
het was bij jullie in de praktijk dat ik op de allereerste ochtend dat ik werkte al wist dat ik 
huisarts wilde warden. Jullie enthousiasme heeft daar zeker aan bijgedragen. Robert 
Jan Kars: bij jou mocht ik (letterlijk) in de keuken kijken van hoe het eraan toegaat in een 
dorpspraktijk. We hebben enkele zeer waardevolle momenten gedeeld. Rob van 
Kimmenaede: het jaar bij jou in Zutphen was bijzonder leerzaam. Dankjewel veer de 
fijne tijd, voor alles wat je mij geleerd hebt en dat je me zo betrok in je praktijk. Dank oak 
aan alles assistentes van bovengenoemde huisartsen die het werken voor mij een stuk 
gemakkelijker hebben gemaakt. 
Graag wil ik oak de huisartsopleiding Utrecht bedankt voor de mogelijkheid om mijn 
huisartsopleiding te combineren met het doen van promotieonderzoek, en dan oak nag 
eens in Groningen. De combinatie opleiding en onderzoek heb ik erg plezierig gevonden 
en ik weet zeker dat mijn academische ervaring een extra dimensie geeft aan het werk 
in de spreekkamer. 
Lieve Laura. Oak al wonen we helaas niet bij elkaar om de hoek, het blijft bijzonder om 
een vriendschap te hebben waarbij je geen moeite hoeft te doen maar alles gewoon 
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Geert Jan, lieve broer. Door jou vond ik als klein kind ziekenhuizen en dokters al 
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ben trots op je en blij dat ik je vrouw mag zijn. 
En als laatste, lieve Floris. Ons lieve, vrolijke ventje. Oat jij er bent is het grootste wonder 
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kan niet meer stuk als je mij 's ochtends in je bedje je stralende lach schenkt. J ij 
relativeert a lies. lk ben ontzettend dankbaar en gelukkig met jou als onze zoon en ik vind 
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